"_id","cohorts.0.id","cohorts.0.label","dataUseConditions.id","dataUseConditions.label","description","externalReferences.0.id","externalReferences.0.label","followupState.id","followupState.label","histologicalDiagnosis.id","histologicalDiagnosis.label","icdoMorphology.id","icdoMorphology.label","icdoTopography.id","icdoTopography.label","id","individualId","info.callsetIds.0","info.cnvstatistics.cnvcoverage","info.cnvstatistics.cnvfraction","info.cnvstatistics.delcoverage","info.cnvstatistics.delfraction","info.cnvstatistics.dupcoverage","info.cnvstatistics.dupfraction","info.legacyId.0","pathologicalStage","provenance.geoLocation.geometry.coordinates.0","provenance.geoLocation.geometry.coordinates.1","provenance.geoLocation.geometry.type","provenance.geoLocation.properties.ISO3166alpha3","provenance.geoLocation.properties.city","provenance.geoLocation.properties.country","provenance.geoLocation.properties.label","provenance.geoLocation.properties.latitude","provenance.geoLocation.properties.longitude","provenance.geoLocation.properties.precision","provenance.geoLocation.type","provenance.material.id","provenance.material.label","sampledTissue.id","sampledTissue.label","tumorGrade","updated","info.tnm","pathologicalStage.id","pathologicalStage.label","pathologicalTnmFindings.0.id","pathologicalTnmFindings.0.label","tumorGrade.id","tumorGrade.label","individualAgeAtCollection","info.death","info.followupMonths","externalReferences.1.id","externalReferences.1.label","cohorts.1.id","cohorts.1.label","cohorts.2.id","cohorts.2.label","externalReferences.0.description","externalReferences.1.description","externalReferences.2.description","externalReferences.2.id","externalReferences.2.label","info.tumorStage","cohorts.3.id","cohorts.3.label","info.callsetIds.1","externalReferences.3.description","externalReferences.3.id","externalReferences.3.label","info.provenance","provenance.populations.0.confidence","provenance.populations.0.description","provenance.populations.0.type.id","provenance.populations.0.type.label","provenance.populations.1.confidence","provenance.populations.1.description","provenance.populations.1.type.id","provenance.populations.1.type.label","externalReferences.4.description","externalReferences.4.id","externalReferences.4.label","cohorts.4.id","cohorts.4.label","info.cellLine","info.samplesource"
"5bab56c0727983b2e00aaabe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65t","pgxind-kftx26dr","pgxcs-kftvlkeg",649663135,0.226,285129417,0.099,364533718,0.127,"PGX_AM_BS_STLMS-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.944000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaabf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65v","pgxind-kftx26dt","pgxcs-kftvlkex",884591899,0.308,292119686,0.102,592472213,0.206,"PGX_AM_BS_STLMS-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.946000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva663","pgxind-kftx26e3","pgxcs-kftvlkhi",1709417508,0.595,628026650,0.218,1081390858,0.376,"PGX_AM_BS_STLMS-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.953000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva665","pgxind-kftx26e5","pgxcs-kftvlki0",1267019981,0.441,398239630,0.139,868780351,0.302,"PGX_AM_BS_STLMS-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.955000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva667","pgxind-kftx26e7","pgxcs-kftvlkii",1444245444,0.502,297997091,0.104,1146248353,0.399,"PGX_AM_BS_STLMS-19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.956000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66c","pgxind-kftx26ed","pgxcs-kftvlkk1",1067226929,0.371,142711710,0.05,924515219,0.322,"PGX_AM_BS_STLMS-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.961000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaaca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66d","pgxind-kftx26ee","pgxcs-kftvlkkk",579844948,0.202,322089175,0.112,257755773,0.09,"PGX_AM_BS_STLMS-23","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.962000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaace","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66k","pgxind-kftx26em","pgxcs-kftvlkmj",1542128449,0.536,104752489,0.036,1437375960,0.5,"PGX_AM_BS_STLMS-27","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.968000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aabeb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Alveolar soft part sarcoma","PMID:9521467","Kiuru-Kuhlefelt S et al. (1998): DNA copy number changes in alveolar...","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgh4u","pgxind-kftx26ud","pgxcs-kftvlokg",441534638,0.154,295195855,0.103,146338783,0.051,"PGX_AM_BS_AEB-9521467-5A","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.369000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghjm","pgxind-kftx27ca","pgxcs-kftvlt0f",944538605,0.329,51800051,0.018,892738554,0.311,"PGX_AM_BS_AEB-9327749-28",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.822000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghjo","pgxind-kftx27cc","pgxcs-kftvlt0w",869148293,0.302,320357858,0.111,548790435,0.191,"PGX_AM_BS_AEB-9327749-29",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.823000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghjx","pgxind-kftx27co","pgxcs-kftvlt3r",814514402,0.283,814514402,0.283,0,0,"PGX_AM_BS_AEB-9327749-34",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.831000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghku","pgxind-kftx27ds","pgxcs-kftvltd7",440095156,0.153,87200086,0.03,352895070,0.123,"PGX_AM_BS_AEB-9327749-52",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.859000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkw","pgxind-kftx27du","pgxcs-kftvltdn",510615538,0.178,224200223,0.078,286415315,0.1,"PGX_AM_BS_AEB-9327749-53",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.861000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkz","pgxind-kftx27dy","pgxcs-kftvltel",1198239973,0.417,125600124,0.044,1072639849,0.373,"PGX_AM_BS_AEB-9327749-55",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.863000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghl0","pgxind-kftx27e0","pgxcs-kftvltf2",1126848425,0.392,477904238,0.166,648944187,0.226,"PGX_AM_BS_AEB-9327749-56",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.865000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma [grade IV]","PMID:9290705","Packenham JP et al. (1997): Analysis of genetic alterations in uterine...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvghna","pgxind-kftx27gr","pgxcs-kftvlu4f",293704995,0.102,42400042,0.015,251304953,0.087,"PGX_AM_BS_UtLeio-3",,-78.9,35.99,"Point","USA","Durham","United States of America","Durham, United States",35.99,-78.9,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:06.936000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding","NCITgrade-C28082","Grade 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma [grade I, stage C]","PMID:9290705","Packenham JP et al. (1997): Analysis of genetic alterations in uterine...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvghnh","pgxind-kftx27gy","pgxcs-kftvlu6a",772495645,0.269,450146362,0.157,322349283,0.112,"PGX_AM_BS_UtLeio-5",,-78.9,35.99,"Point","USA","Durham","United States of America","Durham, United States",35.99,-78.9,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:06.941000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aae60","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma","PMID:9166930","Armengol G, Tarkkanen M et al. (1997): Recurrent gains of 1q, 8 and...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvghxj","pgxind-kftx27t5","pgxcs-kftvlx4n",224500223,0.078,169400168,0.059,55100055,0.019,"PGX_AM_BS_ET-arm-011","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:07.250000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaea7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0s","pgxind-kftx27x2","pgxcs-kftvly3p",507482721,0.177,51800051,0.018,455682670,0.158,"PGX_AM_BS_ChonSar-lar-08c","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.348000",,,,,,,,"P64Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi14","pgxind-kftx27xh","pgxcs-kftvly6y",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_ChonSar-lar-14a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.358000",,,,,,,,"P34Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi17","pgxind-kftx27xl","pgxcs-kftvly7w",923042480,0.321,0,0,923042480,0.321,"PGX_AM_BS_ChonSar-lar-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.361000",,,,,,,,"P72Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1a","pgxind-kftx27xp","pgxcs-kftvly8u",1358149599,0.472,0,0,1358149599,0.472,"PGX_AM_BS_ChonSar-lar-17a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.364000",,,,,,,,"P52Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1c","pgxind-kftx27xr","pgxcs-kftvly9b",713769698,0.248,115049835,0.04,598719863,0.208,"PGX_AM_BS_ChonSar-lar-17b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.365000",,,,,,,,"P52Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1d","pgxind-kftx27xt","pgxcs-kftvly9r",2029929388,0.706,602440993,0.21,1427488395,0.497,"PGX_AM_BS_ChonSar-lar-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.367000",,,,,,,,"P58Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1h","pgxind-kftx27xx","pgxcs-kftvlyap",1423502296,0.495,748670601,0.26,674831695,0.235,"PGX_AM_BS_ChonSar-lar-20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.369000",,,,,,,,"P24Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf10","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5k","pgxind-kftx282x","pgxcs-kftvlzir",243360377,0.085,243360377,0.085,0,0,"PGX_AM_BS_8834171-szy-05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.497000",,,,,,,,"P61Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5l","pgxind-kftx282z","pgxcs-kftvlzj8",240880022,0.084,90552475,0.031,150327547,0.052,"PGX_AM_BS_8834171-szy-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.498000",,,,,,,,"P38Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [dedifferentiated]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5v","pgxind-kftx283b","pgxcs-kftvlzm0",1200755658,0.418,604911059,0.21,595844599,0.207,"PGX_AM_BS_8834171-szy-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.507000",,,,,,,,"P71Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00ab0ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Primary multicentric angiosarcoma of bone [post chemotherapy and total body irradiation for AML]","PMID:24179665","Thariat J, Peyrottes I et al. (2013): Primary multicentric angiosarcoma of bone: true...","pgxfus-0010","dead","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvgiob","pgxind-kftx28pq","pgxcs-kftvm543",378950887,0.132,95417249,0.033,283533638,0.099,"PGX_AM_BS_24179665-tha-angsarcA","{}",7.27,43.7,"Point","FRA","Nice","France","Nice, France",43.7,7.27,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:08.067000",,,,,,,,"P70Y","1",36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00ab0ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Primary multicentric angiosarcoma of bone [post chemotherapy and total body irradiation for AML]","PMID:24179665","Thariat J, Peyrottes I et al. (2013): Primary multicentric angiosarcoma of bone: true...","pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgioc","pgxind-kftx28ps","pgxcs-kftvm54k",283533638,0.099,0,0,283533638,0.099,"PGX_AM_BS_24179665-tha-angsarcB","{}",7.27,43.7,"Point","FRA","Nice","France","Nice, France",43.7,7.27,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:08.068000",,,,,,,,"P70Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c1727983b2e00ab824","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","poorly differentiated synovial sarcoma","PMID:22053830","Balogh Z, Szemlaky Z et al. (2011): Correlation between DNA ploidy, metaphase high-resolution...","pgxfus-0010","dead","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgl39","pgxind-kftx2bno","pgxcs-kftvmvaw",715035388,0.249,74949610,0.026,640085778,0.223,"PGX_AM_BS_22053830_SS-bal-02","{}",19.04,47.5,"Point","HUN","Budapest","Hungary","Budapest, Hungary",47.5,19.04,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:10.791000",,,,,,,,"P33Y","1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac0c6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS05p13]","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgnvq","pgxind-kftx2f2d","pgxcs-kftvnpb4",317375428,0.11,290866448,0.101,26508980,0.009,"PGX_AM_BS_20164920_LMS05p13","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:13.941000",,,,,,,,,,,"geo:GSE19399",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac250","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodq","pgxind-kftx2foo","pgxcs-kftvnupl",1329127181,0.462,307514884,0.107,1021612297,0.355,"PGX_AM_BS_20159821_MPNST-bre-013","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.481000",,,,,,,,"P26Y","1",79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac252","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodu","pgxind-kftx2fos","pgxcs-kftvnuqj",1636953920,0.569,725961202,0.253,910992718,0.317,"PGX_AM_BS_20159821_MPNST-bre-021","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.484000",,,,,,,,"P18Y","1",15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac255","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodz","pgxind-kftx2foy","pgxcs-kftvnus0",1165492623,0.405,135327390,0.047,1030165233,0.358,"PGX_AM_BS_20159821_MPNST-bre-026","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.489000",,,,,,,,"P22Y","1",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac256","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe0","pgxind-kftx2fp0","pgxcs-kftvnusg",2763479032,0.961,1140622209,0.397,1622856823,0.564,"PGX_AM_BS_20159821_MPNST-bre-029","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.490000",,,,,,,,"P33Y","1",15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac257","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe2","pgxind-kftx2fp2","pgxcs-kftvnusy",1104109901,0.384,446385191,0.155,657724710,0.229,"PGX_AM_BS_20159821_MPNST-bre-032","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.492000",,,,,,,,"P77Y","1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac259","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe5","pgxind-kftx2fp5","pgxcs-kftvnutw",1851316984,0.644,604400129,0.21,1246916855,0.434,"PGX_AM_BS_20159821_MPNST-bre-035","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.494000",,,,,,,,"P42Y","1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe7","pgxind-kftx2fp8","pgxcs-kftvnuud",2832113038,0.985,1257209528,0.437,1574903510,0.548,"PGX_AM_BS_20159821_MPNST-bre-037","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.496000",,,,,,,,"P34Y","1",16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoea","pgxind-kftx2fpc","pgxcs-kftvnuvc",1009805081,0.351,120236424,0.042,889568657,0.309,"PGX_AM_BS_20159821_MPNST-bre-040","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.498000",,,,,,,,"P50Y","0",122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoec","pgxind-kftx2fpe","pgxcs-kftvnuvs",1163881456,0.405,586567547,0.204,577313909,0.201,"PGX_AM_BS_20159821_MPNST-bre-043","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.500000",,,,,,,,"P14Y","0",105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoee","pgxind-kftx2fpg","pgxcs-kftvnuwa",2617449835,0.91,989113185,0.344,1628336650,0.566,"PGX_AM_BS_20159821_MPNST-bre-044","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.501000",,,,,,,,"P17Y","1",5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac260","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeh","pgxind-kftx2fpk","pgxcs-kftvnux8",1486291449,0.517,644670186,0.224,841621263,0.293,"PGX_AM_BS_20159821_MPNST-bre-048","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.504000",,,,,,,,"P35Y","1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac262","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Leg]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoek","pgxind-kftx2fpo","pgxcs-kftvnuy6",1254288828,0.436,423375067,0.147,830913761,0.289,"PGX_AM_BS_20159821_MPNST-bre-050","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.507000",,,,,,,,"P30Y","0",133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac263","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoem","pgxind-kftx2fpq","pgxcs-kftvnuyn",1984268799,0.69,489597598,0.17,1494671201,0.52,"PGX_AM_BS_20159821_MPNST-bre-051","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.508000",,,,,,,,"P73Y","1",8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac264","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Proximal arm]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeo","pgxind-kftx2fps","pgxcs-kftvnuz4",863649586,0.3,659825104,0.23,203824482,0.071,"PGX_AM_BS_20159821_MPNST-bre-052","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.510000",,,,,,,,"P37Y","1",81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac266","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoer","pgxind-kftx2fpw","pgxcs-kftvnv02",1491366828,0.519,825593611,0.287,665773217,0.232,"PGX_AM_BS_20159821_MPNST-bre-056","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.513000",,,,,,,,"P24Y","0",185,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac267","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Intrathoracic]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoet","pgxind-kftx2fpy","pgxcs-kftvnv0j",1489346799,0.518,494635615,0.172,994711184,0.346,"PGX_AM_BS_20159821_MPNST-bre-057","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.514000",,,,,,,,"P24Y","1",32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac268","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeu","pgxind-kftx2fq0","pgxcs-kftvnv10",2120591325,0.738,1024960418,0.357,1095630907,0.381,"PGX_AM_BS_20159821_MPNST-bre-058","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.516000",,,,,,,,"P26Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Under arm]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoex","pgxind-kftx2fq4","pgxcs-kftvnv1y",1099256834,0.382,876843898,0.305,222412936,0.077,"PGX_AM_BS_20159821_MPNST-bre-061","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.519000",,,,,,,,"P59Y","0",142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoez","pgxind-kftx2fq6","pgxcs-kftvnv2f",1323499107,0.46,471638913,0.164,851860194,0.296,"PGX_AM_BS_20159821_MPNST-bre-063","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.520000",,,,,,,,"P62Y","1",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thoracic wall]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof1","pgxind-kftx2fq8","pgxcs-kftvnv2w",1437003163,0.5,557693347,0.194,879309816,0.306,"PGX_AM_BS_20159821_MPNST-bre-064","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.522000",,,,,,,,"P26Y","1",29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Right shoulder]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof2","pgxind-kftx2fqa","pgxcs-kftvnv3e",1350313022,0.47,810871505,0.282,539441517,0.188,"PGX_AM_BS_20159821_MPNST-bre-065","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.523000",,,,,,,,"P53Y","1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof4","pgxind-kftx2fqc","pgxcs-kftvnv3v",1540858905,0.536,635641927,0.221,905216978,0.315,"PGX_AM_BS_20159821_MPNST-bre-067","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.525000",,,,,,,,"P28Y","1",118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof6","pgxind-kftx2fqe","pgxcs-kftvnv4c",1407853388,0.49,769905657,0.268,637947731,0.222,"PGX_AM_BS_20159821_MPNST-bre-068","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.526000",,,,,,,,"P41Y","1",39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac270","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Mediastinum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof7","pgxind-kftx2fqg","pgxcs-kftvnv4s",2510212230,0.873,1444256608,0.502,1065955622,0.371,"PGX_AM_BS_20159821_MPNST-bre-070","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.528000",,,,,,,,"P73Y","1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac275","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Mediastinum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoff","pgxind-kftx2fqq","pgxcs-kftvnv76",1958473088,0.681,680007220,0.237,1278465868,0.445,"PGX_AM_BS_20159821_MPNST-bre-083","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.535000",,,,,,,,"P52Y","1",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac276","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofh","pgxind-kftx2fqs","pgxcs-kftvnv7n",2496649693,0.868,1151180206,0.4,1345469487,0.468,"PGX_AM_BS_20159821_MPNST-bre-086","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.536000",,,,,,,,"P42Y","1",7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac278","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofk","pgxind-kftx2fqw","pgxcs-kftvnv8l",2312561261,0.804,946983195,0.329,1365578066,0.475,"PGX_AM_BS_20159821_MPNST-bre-088","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.539000",,,,,,,,"P32Y","1",40,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Back]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofp","pgxind-kftx2fr2","pgxcs-kftvnva1",196600196,0.068,196600196,0.068,0,0,"PGX_AM_BS_20159821_MPNST-bre-115","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.544000",,,,,,,,"P54Y","1",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofq","pgxind-kftx2fr4","pgxcs-kftvnvai",198170501,0.069,121195682,0.042,76974819,0.027,"PGX_AM_BS_20159821_MPNST-bre-116","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.545000",,,,,,,,"P30Y","0",87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Lung]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofv","pgxind-kftx2fra","pgxcs-kftvnvbw",479964775,0.167,187162556,0.065,292802219,0.102,"PGX_AM_BS_20159821_MPNST-bre-120","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.550000",,,,,,,,"P32Y","1",53,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac28b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgogf","pgxind-kftx2fry","pgxcs-kftvnvhj",1830651586,0.637,654808603,0.228,1175842983,0.409,"PGX_AM_BS_20159821_MPNST-bre-080","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.566000",,,,,,,,"P25Y","1",10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv66","pgxind-kftx2o64","pgxcs-kftvpy4s",808665157,0.281,183954817,0.064,624710340,0.217,"PGX_AM_BS_OSCl-sel-HOS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.961000",,,,,,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv68","pgxind-kftx2o66","pgxcs-kftvpy59",1766719390,0.615,1131100928,0.393,635618462,0.221,"PGX_AM_BS_OSCl-sel-MG-63","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.962000",,,,,,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE8398",,"pgxfus-0010","dead","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgv6c","pgxind-kftx2o6c","pgxcs-kftvpy6q",552546036,0.192,224618789,0.078,327927247,0.114,"PGX_AM_BS_17952124-cig-24","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:21.967000",,,,,,,,,"1",11,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad78a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE8398",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgv6w","pgxind-kftx2o70","pgxcs-kftvpych",759419484,0.264,358181149,0.125,401238335,0.14,"PGX_AM_BS_17952124-cig-14","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:21.984000",,,,,,,,,,,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad791","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma","PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgv77","pgxind-kftx2o7e","pgxcs-kftvpyfu",706260992,0.246,219225665,0.076,487035327,0.169,"PGX_AM_BS_17952124-cig-21","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:21.993000",,,,,,,,,,,"geo:GSE8398",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad794","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line U-2OS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv7c","pgxind-kftx2o7k","pgxcs-kftvpyhb",1667341894,0.58,1031230263,0.359,636111631,0.221,"PGX_AM_BS_OSCl-sel-U-2OS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.998000",,,,,,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae21e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Lower leg, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywp","pgxind-kftx2sfh","pgxcs-kftvr0b4",747336584,0.26,460527249,0.16,286809335,0.1,"PGX_AM_BS_16938566_LMS-lar-01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.739000",,,,,,,,"P44Y","0",138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae223","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Upper arm, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywx","pgxind-kftx2sfr","pgxcs-kftvr0di",498863212,0.174,498863212,0.174,0,0,"PGX_AM_BS_16938566_LMS-lar-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.746000",,,,,,,,"P25Y","0",182.77,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae225","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Hand, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx1","pgxind-kftx2sfv","pgxcs-kftvr0eg",1066993592,0.371,751023957,0.261,315969635,0.11,"PGX_AM_BS_16938566_LMS-lar-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.749000",,,,,,,,"P80Y","1",72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae226","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, deep]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx2","pgxind-kftx2sfx","pgxcs-kftvr0ey",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_16938566_LMS-lar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.750000",,,,,,,,"P61Y","0",211.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae459","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmf","pgxind-kftx2tb3","pgxcs-kftvr8a3",747336584,0.26,460527249,0.16,286809335,0.1,"PGX_AM_BS_LMS-sva-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.914000",,,,,,,,"P44Y","0",138.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmj","pgxind-kftx2tb7","pgxcs-kftvr8b2",498863212,0.174,498863212,0.174,0,0,"PGX_AM_BS_LMS-sva-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.917000",,,,,,,,"P25Y","0",182.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmm","pgxind-kftx2tbb","pgxcs-kftvr8c1",820074047,0.285,412414969,0.143,407659078,0.142,"PGX_AM_BS_LMS-sva-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.919000",,,,,,,,"P55Y","0",137.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae461","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmt","pgxind-kftx2tbj","pgxcs-kftvr8dy",859969166,0.299,472768129,0.164,387201037,0.135,"PGX_AM_BS_LMS-sva-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.925000",,,,,,,,"P59Y","0",193.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae463","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmw","pgxind-kftx2tbn","pgxcs-kftvr8ex",1211003198,0.421,582834380,0.203,628168818,0.218,"PGX_AM_BS_LMS-sva-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.928000",,,,,,,,"P62Y","0",159.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae464","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmy","pgxind-kftx2tbp","pgxcs-kftvr8ff",1066993592,0.371,751023957,0.261,315969635,0.11,"PGX_AM_BS_LMS-sva-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.929000",,,,,,,,"P80Y","1",72.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae465","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmz","pgxind-kftx2tbr","pgxcs-kftvr8fx",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_LMS-sva-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.930000",,,,,,,,"P61Y","0",211.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae46c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznb","pgxind-kftx2tc5","pgxcs-kftvr8jb",1108991426,0.386,530902914,0.185,578088512,0.201,"PGX_AM_BS_LMS-sva-25","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.940000",,,,,,,,"P74Y","1",31.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae46d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznc","pgxind-kftx2tc7","pgxcs-kftvr8jt",1040532638,0.362,551134841,0.192,489397797,0.17,"PGX_AM_BS_LMS-sva-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.941000",,,,,,,,"P70Y","0",55.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae470","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznh","pgxind-kftx2tcd","pgxcs-kftvr8l9",499312420,0.174,381543717,0.133,117768703,0.041,"PGX_AM_BS_LMS-sva-29","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.945000",,,,,,,,"P58Y","1",59.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae472","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznk","pgxind-kftx2tci","pgxcs-kftvr8m7",841827226,0.293,54300054,0.019,787527172,0.274,"PGX_AM_BS_LMS-sva-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.948000",,,,,,,,"P55Y","0",174.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae473","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznm","pgxind-kftx2tck","pgxcs-kftvr8mp",526615032,0.183,149943131,0.052,376671901,0.131,"PGX_AM_BS_LMS-sva-32","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.950000",,,,,,,,"P84Y","1",10.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae475","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgznp","pgxind-kftx2tco","pgxcs-kftvr8nn",1620667386,0.564,773129923,0.269,847537463,0.295,"PGX_AM_BS_LMS-sva-34","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.953000",,,,,,,,"P75Y","0",12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo4","pgxind-kftx2td6","pgxcs-kftvr8rz",832085086,0.289,691418256,0.24,140666830,0.049,"PGX_AM_BS_LMS-sva-43","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.965000",,,,,,,,"P71Y","1",6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae482","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzoa","pgxind-kftx2tde","pgxcs-kftvr8tw",1482766749,0.516,814830231,0.283,667936518,0.232,"PGX_AM_BS_LMS-sva-47","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.971000",,,,,,,,"P64Y","1",64.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae483","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzoc","pgxind-kftx2tdg","pgxcs-kftvr8ue",1134287499,0.395,773623435,0.269,360664064,0.125,"PGX_AM_BS_LMS-sva-48","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.972000",,,,,,,,"P69Y","1",121.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae485","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzof","pgxind-kftx2tdk","pgxcs-kftvr8vd",2094418516,0.728,1203911998,0.419,890506518,0.31,"PGX_AM_BS_LMS-sva-50","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.975000",,,,,,,,"P53Y","1",21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae490","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzox","pgxind-kftx2te7","pgxcs-kftvr90o",799182250,0.278,229542721,0.08,569639529,0.198,"PGX_AM_BS_MFHbo-tar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.991000",,,,,,,,"P44Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae491","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzoz","pgxind-kftx2te9","pgxcs-kftvr915",1013775769,0.353,0,0,1013775769,0.353,"PGX_AM_BS_MFHbo-tar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.992000",,,,,,,,"P50Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae492","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp1","pgxind-kftx2teb","pgxcs-kftvr91n",1175372317,0.409,32800032,0.011,1142572285,0.397,"PGX_AM_BS_MFHbo-tar-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.994000",,,,,,,,"P75Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae493","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp2","pgxind-kftx2ted","pgxcs-kftvr924",761665487,0.265,552926642,0.192,208738845,0.073,"PGX_AM_BS_MFHbo-tar-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.995000",,,,,,,,"P8Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae494","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp4","pgxind-kftx2teg","pgxcs-kftvr92l",1386311669,0.482,322357858,0.112,1063953811,0.37,"PGX_AM_BS_MFHbo-tar-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.996000",,,,,,,,"P47Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae495","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp6","pgxind-kftx2tei","pgxcs-kftvr933",1394441198,0.485,381057937,0.133,1013383261,0.352,"PGX_AM_BS_MFHbo-tar-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.998000",,,,,,,,"P18Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7b4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal sarcoma [Aorta]","PMID:16096408","Sebenik M, Ricci A et al. (2005): Undifferentiated intimal sarcoma of large systemic...","pgxfus-0004","alive","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pb","pgxind-kftx2uni","pgxcs-kftvrkd9",454332585,0.158,32800032,0.011,421532553,0.147,"PGX_AM_BS_VessIntSarc-seb-08-r","{}",-74.14,40.56,"Point","USA","Staten Island","United States of America","Staten Island, United States",40.56,-74.14,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:28.113000",,,,,,,,"P58Y","0",322,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7c2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0px","pgxind-kftx2uob","pgxcs-kftvrklj",1360897768,0.473,626850543,0.218,734047225,0.255,"PGX_AM_BS_AEB-16080954-5","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.133000",,,,,,"NCITgrade-C28079","Grade 3","P50Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pz","pgxind-kftx2uod","pgxcs-kftvrkm1",848536129,0.295,515596882,0.179,332939247,0.116,"PGX_AM_BS_AEB-16080954-6","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.135000",,,,,,"NCITgrade-C28079","Grade 3","P46Y","0",60,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aea46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","PMID:15863129","Baumhoer D, Gunawan B et al. (2005): Comparative genomic hybridization in four angiosarcomas...","pgxfus-0004","alive","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma","icdot-C50.9","Breast, NOS","pgxbs-kftvh1iv","pgxind-kftx2von","pgxcs-kftvrtjx",1152256671,0.401,555812827,0.193,596443844,0.207,"PGX_AM_BS_AngSarc-bau-03","{}",9.93,51.53,"Point","DEU","Goettingen","Germany","Goettingen, Germany",51.53,9.93,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000310","breast","{}","2020-09-10 17:44:29.020000",,,,,,,,"P47Y","0",37,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed5f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2im","pgxind-kftx2wx8","pgxcs-kftvs4nl",1267832391,0.441,223907629,0.078,1043924762,0.363,"PGX_AM_BS_15540165_OS-ati-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.125000",,,,,,,,"P27Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, tibia, fibrohistiocytic]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iu","pgxind-kftx2wxi","pgxcs-kftvs4q3",642858893,0.224,457888705,0.159,184970188,0.064,"PGX_AM_BS_15540165_OS-ati-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.132000",,,,,,,,"P45Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed66","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2ix","pgxind-kftx2wxm","pgxcs-kftvs4r1",319247420,0.111,154494872,0.054,164752548,0.057,"PGX_AM_BS_15540165_OS-ati-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.135000",,,,,,,,"P48Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed67","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, tibia]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iz","pgxind-kftx2wxo","pgxcs-kftvs4ri",934472891,0.325,146497569,0.051,787975322,0.274,"PGX_AM_BS_15540165_OS-ati-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.136000",,,,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed73","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur, small cell]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2ji","pgxind-kftx2wyd","pgxcs-kftvs4xg",542080236,0.189,106000105,0.037,436080131,0.152,"PGX_AM_BS_15540165_OS-ati-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.153000",,,,,,,,"P19Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af78e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma [or MFH]","PMID:12960699","Hostein I, Coindre JM et al. (2003): Comparative genomic hybridization study of paraffin-embedded...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5s4","pgxind-kftx3100","pgxcs-kftvt4zk",198047300,0.069,185547287,0.065,12500013,0.004,"PGX_AM_BS_LPSMFH-LPS6","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:33.737000",,,,,,,,"P30Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Retro abdo, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wx","pgxind-kftx315y","pgxcs-kftvt6j1",930315317,0.324,854198087,0.297,76117230,0.026,"PGX_AM_BS_LMS-STS379","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.885000",,,,,,"NCITgrade-C28078","Grade 2","P17Y","1",33.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Buttock, grade 3, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x3","pgxind-kftx3166","pgxcs-kftvt6ky",743267133,0.259,547089819,0.19,196177314,0.068,"PGX_AM_BS_LMS-STS411","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.890000",,,,,,"NCITgrade-C28079","Grade 3","P72Y","1",25.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af800","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Upper arm, grade 2, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x8","pgxind-kftx316b","pgxcs-kftvt6mf",998539709,0.347,554313991,0.193,444225718,0.155,"PGX_AM_BS_LMS-STS448","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.895000",,,,,,"NCITgrade-C28078","Grade 2","P50Y","0",117.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af804","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, grade 3, ANED]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5xf","pgxind-kftx316j","pgxcs-kftvt6od",346114098,0.12,91700091,0.032,254414007,0.088,"PGX_AM_BS_LMS-STS574","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.900000",,,,,,"NCITgrade-C28079","Grade 3","P73Y","0",16.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af809","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Intraperitoneum, grade --, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5xn","pgxind-kftx316t","pgxcs-kftvt6qr",792020787,0.275,350382689,0.122,441638098,0.154,"PGX_AM_BS_LMS-STS91","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:33.907000",,,,,,,,"P64Y","1",1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb83","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71q","pgxind-kftx32ky","pgxcs-kftvtj7n",549586472,0.191,439891645,0.153,109694827,0.038,"PGX_AM_BS_Chib-LPS01","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.135000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb87","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71w","pgxind-kftx32l6","pgxcs-kftvtj9k",376116064,0.131,353916042,0.123,22200022,0.008,"PGX_AM_BS_Chib-LPS06","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.140000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb90","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh72a","pgxind-kftx32lo","pgxcs-kftvtje0",194160533,0.068,151521575,0.053,42638958,0.015,"PGX_AM_BS_Chib-LPS18","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.152000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh73m","pgxind-kftx32nd","pgxcs-kftvtjsp",845418804,0.294,741543959,0.258,103874845,0.036,"PGX_AM_BS_Chib-MFH15","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.193000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbb5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh73x","pgxind-kftx32nr","pgxcs-kftvtjya",536044211,0.186,478044155,0.166,58000056,0.02,"PGX_AM_BS_Chib-MFH56","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.203000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l4","pgxind-kftx3397","pgxcs-kftvtp9a",2258752815,0.786,688359004,0.239,1570393811,0.546,"PGX_AM_BS_OstSarc-oza-07","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.725000",,,,,,,,"P19Y","0",35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l9","pgxind-kftx339d","pgxcs-kftvtpaq",1666218807,0.58,692786238,0.241,973432569,0.339,"PGX_AM_BS_OstSarc-oza-10","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.729000",,,,,,,,"P13Y","0",34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd35","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lb","pgxind-kftx339f","pgxcs-kftvtpb8",1501280965,0.522,742773633,0.258,758507332,0.264,"PGX_AM_BS_OstSarc-oza-11","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.731000",,,,,,,,"P20Y","0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd41","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lu","pgxind-kftx33a3","pgxcs-kftvtpgz",1223174437,0.425,355501627,0.124,867672810,0.302,"PGX_AM_BS_OstSarc-oza-23","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.748000",,,,,,,,"P16Y","0",29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd44","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lz","pgxind-kftx33a9","pgxcs-kftvtpif",1025257270,0.357,504682149,0.176,520575121,0.181,"PGX_AM_BS_OstSarc-oza-26","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.752000",,,,,,,,"P16Y","0",21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m2","pgxind-kftx33ad","pgxcs-kftvtpje",1441051519,0.501,549761945,0.191,891289574,0.31,"PGX_AM_BS_OstSarc-oza-28","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.755000",,,,,,,,"P34Y","0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd48","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m6","pgxind-kftx33ah","pgxcs-kftvtpkc",333706311,0.116,236006215,0.082,97700096,0.034,"PGX_AM_BS_OstSarc-oza-30","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.758000",,,,,,,,"P12Y","0",26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd49","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m7","pgxind-kftx33aj","pgxcs-kftvtpku",1625674673,0.565,863740888,0.3,761933785,0.265,"PGX_AM_BS_OstSarc-oza-31","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.759000",,,,,,,,"P18Y","0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Tibia, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m9","pgxind-kftx33al","pgxcs-kftvtplb",960795565,0.334,423246068,0.147,537549497,0.187,"PGX_AM_BS_OstSarc-oza-32","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.761000",,,,,,,,"P14Y","0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mc","pgxind-kftx33ap","pgxcs-kftvtpma",1733374586,0.603,825134628,0.287,908239958,0.316,"PGX_AM_BS_OstSarc-oza-34","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.764000",,,,,,,,"P15Y","0",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd55","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Metastasis, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mr","pgxind-kftx33b8","pgxcs-kftvtpqn",1191760467,0.415,597536635,0.208,594223832,0.207,"PGX_AM_BS_OstSarc-oza-43","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.777000",,,,,,,,"P51Y","0",36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd57","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Recurrence, Extraskeletal]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mu","pgxind-kftx33bc","pgxcs-kftvtprn",1315893906,0.458,697918102,0.243,617975804,0.215,"PGX_AM_BS_OstSarc-oza-45","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.780000",,,,,,,,"P53Y","1",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b010f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [sporadic]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8ts","pgxind-kftx34t1","pgxcs-kftvu32d",249211817,0.087,123611691,0.043,125600126,0.044,"PGX_AM_BS_MB-PNST-08","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.087000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9c8","pgxind-kftx35g0","pgxcs-kftvu8tb",673385437,0.234,195401312,0.068,477984125,0.166,"PGX_AM_BS_LipSarc-04","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.654000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ci","pgxind-kftx35gd","pgxcs-kftvu8w6",1108169978,0.385,292481910,0.102,815688068,0.284,"PGX_AM_BS_LipSarc-10","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.662000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cn","pgxind-kftx35gj","pgxcs-kftvu8xm",977361769,0.34,135102239,0.047,842259530,0.293,"PGX_AM_BS_LipSarc-13","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.666000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cu","pgxind-kftx35gr","pgxcs-kftvu8zi",406687641,0.141,236537936,0.082,170149705,0.059,"PGX_AM_BS_LipSarc-17","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.672000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cz","pgxind-kftx35gx","pgxcs-kftvu90y",1205786887,0.419,495848253,0.172,709938634,0.247,"PGX_AM_BS_LipSarc-20","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.676000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9fx","pgxind-kftx35km","pgxcs-kftvu9yg",526328537,0.183,0,0,526328537,0.183,"PGX_AM_BS_FibSarc-04a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.765000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9fy","pgxind-kftx35ko","pgxcs-kftvu9yy",161013540,0.056,0,0,161013540,0.056,"PGX_AM_BS_FibSarc-04b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.766000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, external pelvis]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ga","pgxind-kftx35l3","pgxcs-kftvua2b",1004509380,0.349,51800051,0.018,952709329,0.331,"PGX_AM_BS_FibSarc-10","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.776000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b030b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gw","pgxind-kftx35lu","pgxcs-kftvua8l",859208432,0.299,0,0,859208432,0.299,"PGX_AM_BS_FibSarc-21","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.794000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b030c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gx","pgxind-kftx35lw","pgxcs-kftvua93",1116654340,0.388,115647258,0.04,1001007082,0.348,"PGX_AM_BS_FibSarc-22a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.795000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b030d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gz","pgxind-kftx35ly","pgxcs-kftvua9k",935688811,0.325,0,0,935688811,0.325,"PGX_AM_BS_FibSarc-22b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.796000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b030f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, upper extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9h2","pgxind-kftx35m2","pgxcs-kftvuaak",734750043,0.256,0,0,734750043,0.256,"PGX_AM_BS_FibSarc-24","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.799000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0315","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, thorax]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9hc","pgxind-kftx35me","pgxcs-kftvuadg",275914029,0.096,34400034,0.012,241513995,0.084,"PGX_AM_BS_FibSarc-30","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.807000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0316","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, retroperitoneum]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C48.9","retroperitoneum and peritoneum","pgxbs-kftvh9he","pgxind-kftx35mg","pgxcs-kftvuadx",673664951,0.234,49749770,0.017,623915181,0.217,"PGX_AM_BS_FibSarc-31","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space",,"2020-09-10 17:44:37.808000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b033e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9j7","pgxind-kftx35oq","pgxcs-kftvuax6",675089735,0.235,485553582,0.169,189536153,0.066,"PGX_AM_BS_AdrCortPA-36","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.864000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b033f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9j9","pgxind-kftx35os","pgxcs-kftvuaxo",666277527,0.232,333381029,0.116,332896498,0.116,"PGX_AM_BS_AdrCortPA-37","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.865000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0341","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jc","pgxind-kftx35ow","pgxcs-kftvuaym",414075014,0.144,196600195,0.068,217474819,0.076,"PGX_AM_BS_AdrCortPA-39","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.868000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0344","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jh","pgxind-kftx35p2","pgxcs-kftvub23",472618195,0.164,183543165,0.064,289075030,0.101,"PGX_AM_BS_AdrCortPA-42","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.872000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Skeletal osteosarcoma OB G4, Humerus]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhac6","pgxind-kftx36p0","pgxcs-kftvujz4",740582618,0.258,132793663,0.046,607788955,0.211,"PGX_AM_BS_RadSarc-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.752000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05c6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Extraskeletal osteosarcoma G3, Abdominal wall]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhacb","pgxind-kftx36p6","pgxcs-kftvuk0k",773336319,0.269,605567565,0.211,167768754,0.058,"PGX_AM_BS_RadSarc-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.757000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05c8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Extraskeletal osteosarcoma FS G3, Pelvis, pararectal space]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhace","pgxind-kftx36pa","pgxcs-kftvuk1i",839756899,0.292,511464462,0.178,328292437,0.114,"PGX_AM_BS_RadSarc-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.759000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05d5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Fibrosarcoma G4, Thoracic wall]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhacz","pgxind-kftx36q1","pgxcs-kftvuk7p",1137157544,0.396,1005957414,0.35,131200130,0.046,"PGX_AM_BS_RadSarc-21","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.777000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Fibrosarcoma G4, Thoracic wall]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhad7","pgxind-kftx36qb","pgxcs-kftvuka2",1518550571,0.528,380591306,0.132,1137959265,0.396,"PGX_AM_BS_RadSarc-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.784000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0625","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Humerus]","PMID:11672775","Brisset S, Schleiermacher G et al. (2001): CGH analysis of secondary genetic changes...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhagl","pgxind-kftx36uj","pgxcs-kftvulbo",703279692,0.245,98143080,0.034,605136612,0.21,"PGX_AM_BS_EWS-13","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.886000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0676","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhak8","pgxind-kftx36z3","pgxcs-kftvumgz",684822545,0.238,333491285,0.116,351331260,0.122,"PGX_AM_BS_OS-15","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.996000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0677","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [age under 17a]","PMID:11672768","Zielenska M, Bayani J et al. (2001): Comparative genomic hybridization analysis identifies gains...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhaka","pgxind-kftx36z5","pgxcs-kftvumhg",174658039,0.061,88457954,0.031,86200085,0.03,"PGX_AM_BS_OS-16","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:38.998000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [G1]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhama","pgxind-kftx371n","pgxcs-kftvun2t",394887386,0.137,394887386,0.137,0,0,"PGX_AM_BS_sts-19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.057000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06a8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [G3, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhami","pgxind-kftx371x","pgxcs-kftvun5a",573751567,0.2,221100220,0.077,352651347,0.123,"PGX_AM_BS_sts-lr04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.064000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [G4, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamn","pgxind-kftx3723","pgxcs-kftvun6q",964148308,0.335,125600124,0.044,838548184,0.292,"PGX_AM_BS_sts-lr07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.068000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06ae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma G1a [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhams","pgxind-kftx3729","pgxcs-kftvun87",648594229,0.226,539879565,0.188,108714664,0.038,"PGX_AM_BS_sts-lr10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.072000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06af","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamu","pgxind-kftx372b","pgxcs-kftvun8o",828636191,0.288,306217460,0.107,522418731,0.182,"PGX_AM_BS_sts-lr11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.073000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06b1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamx","pgxind-kftx372f","pgxcs-kftvun9n",958213066,0.333,342829475,0.119,615383591,0.214,"PGX_AM_BS_sts-lr13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.076000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06b7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [G1, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhan7","pgxind-kftx372r","pgxcs-kftvunef",350387341,0.122,350387341,0.122,0,0,"PGX_AM_BS_sts-lr19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.085000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b51","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4c","pgxind-kftx38xc","pgxcs-kftvv411",1420327806,0.494,344393469,0.12,1075934337,0.374,"PGX_AM_BS_EmbSarc3b","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.714000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b52","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4e","pgxind-kftx38xe","pgxcs-kftvv41j",1166422810,0.406,405887061,0.141,760535749,0.265,"PGX_AM_BS_EmbSarc4","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.715000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4h","pgxind-kftx38xi","pgxcs-kftvv42j",1309977861,0.456,226797648,0.079,1083180213,0.377,"PGX_AM_BS_EmbSarc6","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.718000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b7b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Soft tissue tumor [recurrence]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc68","pgxind-kftx38zh","pgxcs-kftvv4li",271314828,0.094,69000069,0.024,202314759,0.07,"PGX_AM_BS_11369052_WDLPS-forus-1-MYX","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.771000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b7c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Soft tissue tumor [recurrence]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc69","pgxind-kftx38zj","pgxcs-kftvv4lz",107300107,0.037,32800032,0.011,74500075,0.026,"PGX_AM_BS_11369052_WDLPS-forus-1-OS","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.772000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b7d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [metastasis]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6b","pgxind-kftx38zk","pgxcs-kftvv4mh",325343389,0.113,157393687,0.055,167949702,0.058,"PGX_AM_BS_11369052_WDLPS-forus-2a","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.774000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b82","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [well differentiated]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6j","pgxind-kftx38zt","pgxcs-kftvv4qt",107300107,0.037,32800032,0.011,74500075,0.026,"PGX_AM_BS_11369052_WDLPS-forus-P","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.781000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c22","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdp","pgxind-kftx398r","pgxcs-kftvv6y7",1826767959,0.635,691006974,0.24,1135760985,0.395,"PGX_AM_BS_LMS-12","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.006000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdz","pgxind-kftx3993","pgxcs-kftvv714",1120450618,0.39,365910549,0.127,754540069,0.262,"PGX_AM_BS_LMS-18","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.014000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcea","pgxind-kftx399h","pgxcs-kftvv74j",897401776,0.312,270121054,0.094,627280722,0.218,"PGX_AM_BS_LMS-5","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.024000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c32","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcef","pgxind-kftx399n","pgxcs-kftvv77q",1625466078,0.565,706773689,0.246,918692389,0.32,"PGX_AM_BS_LMS-8","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.028000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhchx","pgxind-kftx39e1","pgxcs-kftvv89o",714703694,0.249,589682144,0.205,125021550,0.043,"PGX_AM_BS_sarc03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:41.138000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c82","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade IV, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci0","pgxind-kftx39e5","pgxcs-kftvv8an",1064268029,0.37,196757733,0.068,867510296,0.302,"PGX_AM_BS_sarc05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.141000",,,,,,"NCITgrade-C28082","Grade 4",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci3","pgxind-kftx39ea","pgxcs-kftvv8bm",1099594097,0.382,609533366,0.212,490060731,0.17,"PGX_AM_BS_sarc07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.143000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c85","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, local recurrence]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci5","pgxind-kftx39ec","pgxcs-kftvv8c4",1237803441,0.431,299212278,0.104,938591163,0.326,"PGX_AM_BS_sarc08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.145000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c8d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Leiomyosarcoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcih","pgxind-kftx39es","pgxcs-kftvv8hz",1125884014,0.392,928862393,0.323,197021621,0.069,"PGX_AM_BS_sarc16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.156000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1012","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [retroperitoneum, primary, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.9","retroperitoneum and peritoneum","pgxbs-kftvhdne","pgxind-kftx3atn","pgxcs-kftvvl6u",841409495,0.293,603762300,0.21,237647195,0.083,"PGX_AM_BS_LeioMy09","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space",,"2020-09-10 17:44:42.399000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1015","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [uterus, recurrence, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhdnj","pgxind-kftx3att","pgxcs-kftvvl8d",807596273,0.281,300438731,0.105,507157542,0.176,"PGX_AM_BS_LeioMy12","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:42.403000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1017","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [skin, recurrence, grade II]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C44.9","Skin, NOS","pgxbs-kftvhdnm","pgxind-kftx3aty","pgxcs-kftvvl9c",905791479,0.315,41600041,0.014,864191438,0.301,"PGX_AM_BS_LeioMy14","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin",,"2020-09-10 17:44:42.406000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1151","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","uterine leiomyosarcoma","PMID:10958933","Levy B, Mukherjee T et al. (2000): Molecular cytogenetic analysis of uterine leiomyoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhe1w","pgxind-kftx3bbm","pgxcs-kftvvpnu",540032039,0.188,183768769,0.064,356263270,0.124,"PGX_AM_BS_ULMS04","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:42.841000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b12f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:10822134","Schmidt H, Taubert H et al. (2000): Gains in chromosomes 7, 8q, 15q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvheku","pgxind-kftx3bz2","pgxcs-kftvvvig",576618995,0.201,147352531,0.051,429266464,0.149,"PGX_AM_BS_MalBen-PNST-01","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:43.410000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b134b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheoy","pgxind-kftx3c46","pgxcs-kftvvws1",1662461790,0.578,1010336765,0.351,652125025,0.227,"PGX_AM_BS_MFH-MFH11","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.539000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b134c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheoz","pgxind-kftx3c48","pgxcs-kftvvwsj",1718645749,0.598,1188861302,0.414,529784447,0.184,"PGX_AM_BS_MFH-MFH17","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.540000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b134d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep1","pgxind-kftx3c4a","pgxcs-kftvvwt1",1053082348,0.366,687614648,0.239,365467700,0.127,"PGX_AM_BS_MFH-MFH19","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.542000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b134e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep3","pgxind-kftx3c4c","pgxcs-kftvvwti",2010046420,0.699,1101982877,0.383,908063543,0.316,"PGX_AM_BS_MFH-MFH2","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.543000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b134f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep4","pgxind-kftx3c4e","pgxcs-kftvvwu0",1282741885,0.446,866737516,0.301,416004369,0.145,"PGX_AM_BS_MFH-MFH25","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.545000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1351","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep7","pgxind-kftx3c4i","pgxcs-kftvvwuz",1067579106,0.371,593236690,0.206,474342416,0.165,"PGX_AM_BS_MFH-MFH45","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.548000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1353","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepb","pgxind-kftx3c4m","pgxcs-kftvvwvz",1634182625,0.568,817731724,0.284,816450901,0.284,"PGX_AM_BS_MFH-MFH47","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.551000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1354","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepc","pgxind-kftx3c4o","pgxcs-kftvvwwh",1406929358,0.489,752226743,0.262,654702615,0.228,"PGX_AM_BS_MFH-MFH48","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.552000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1357","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheph","pgxind-kftx3c4u","pgxcs-kftvvwxx",92200091,0.032,32800032,0.011,59400059,0.021,"PGX_AM_BS_MFH-MFH56","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.557000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1358","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepj","pgxind-kftx3c4w","pgxcs-kftvvwye",1399231767,0.487,730428934,0.254,668802833,0.233,"PGX_AM_BS_MFH-MFH9","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.559000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepm","pgxind-kftx3c50","pgxcs-kftvvwze",885615527,0.308,418091371,0.145,467524156,0.163,"PGX_AM_BS_MFH-T101","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.562000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepo","pgxind-kftx3c52","pgxcs-kftvvwzv",1730472107,0.602,944528956,0.329,785943151,0.273,"PGX_AM_BS_MFH-T102","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.563000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepp","pgxind-kftx3c54","pgxcs-kftvvx0d",1328133162,0.462,739161449,0.257,588971713,0.205,"PGX_AM_BS_MFH-T103","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.565000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepr","pgxind-kftx3c56","pgxcs-kftvvx0v",1364305347,0.475,821087750,0.286,543217597,0.189,"PGX_AM_BS_MFH-T104","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.566000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhept","pgxind-kftx3c58","pgxcs-kftvvx1d",1489839035,0.518,985906790,0.343,503932245,0.175,"PGX_AM_BS_MFH-T105","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.568000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1360","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepw","pgxind-kftx3c5c","pgxcs-kftvvx2c",1811581511,0.63,848586826,0.295,962994685,0.335,"PGX_AM_BS_MFH-T108","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.571000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1364","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq3","pgxind-kftx3c5k","pgxcs-kftvvx4a",1181440605,0.411,789876071,0.275,391564534,0.136,"PGX_AM_BS_MFH-T128","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.576000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1366","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq6","pgxind-kftx3c5o","pgxcs-kftvvx59",1844542467,0.642,1031217652,0.359,813324815,0.283,"PGX_AM_BS_MFH-T80","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.579000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b149d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Osteoblastic]","PMID:10640139","Mertens F, Larramendy M et al. (2000): Radiation-associated sarcomas are characterized by complex...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhf48","pgxind-kftx3cn0","pgxcs-kftvw1ii",740582618,0.258,204146119,0.071,536436499,0.187,"PGX_AM_BS_RadAssSarc-1192-87","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.016000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf6a","pgxind-kftx3cpi","pgxcs-kftvw25y",648288063,0.225,280349999,0.098,367938064,0.128,"PGX_AM_BS_stt-05","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.078000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14e5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf7i","pgxind-kftx3cqz","pgxcs-kftvw2j4",645633457,0.225,296168703,0.103,349464754,0.122,"PGX_AM_BS_stt-33","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.115000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Sarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf8g","pgxind-kftx3cs2","pgxcs-kftvw2su",596812111,0.208,238636749,0.083,358175362,0.125,"PGX_AM_BS_stt-55","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.141000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf8o","pgxind-kftx3csc","pgxcs-kftvw2va",682912453,0.238,539512312,0.188,143400141,0.05,"PGX_AM_BS_stt-61","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.149000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1503","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf8w","pgxind-kftx3csm","pgxcs-kftvw2xp",800248960,0.278,533747846,0.186,266501114,0.093,"PGX_AM_BS_stt-67","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.156000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1512","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid liposarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9l","pgxind-kftx3ctg","pgxcs-kftvw352",263938900,0.092,0,0,263938900,0.092,"PGX_AM_BS_stt-88","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.176000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1517","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma, well differentiated","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9t","pgxind-kftx3ctp","pgxcs-kftvw37g",455146418,0.158,158821583,0.055,296324835,0.103,"PGX_AM_BS_stt-94","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.183000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1573","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdz","pgxind-kftx3cyu","pgxcs-kftvw4hv",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_AEB-10534175-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.309000",,,,,,"NCITgrade-C28078","Grade 2","P34Y","0",47,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b157c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, soft tissue]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfee","pgxind-kftx3czc","pgxcs-kftvw4o6",622482836,0.217,51800051,0.018,570682785,0.198,"PGX_AM_BS_AEB-10534175-23b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.321000",,,,,,"NCITgrade-C28078","Grade 2","P64Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1585","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, clavicle]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfes","pgxind-kftx3czu","pgxcs-kftvw4sl",1423502296,0.495,748670601,0.26,674831695,0.235,"PGX_AM_BS_AEB-10534175-30","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.333000",,,,,,"NCITgrade-C28079","Grade 3","P24Y","1",49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1588","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, humerus]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfex","pgxind-kftx3d00","pgxcs-kftvw4u1",814944810,0.283,216443197,0.075,598501613,0.208,"PGX_AM_BS_AEB-10534175-33","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.337000",,,,,,"NCITgrade-C28079","Grade 3","P43Y","1",25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b158e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, humerus]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhff7","pgxind-kftx3d0c","pgxcs-kftvw4wy",966131897,0.336,154913909,0.054,811217988,0.282,"PGX_AM_BS_AEB-10534175-39","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.346000",,,,,,"NCITgrade-C28079","Grade 3","P56Y","1",44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1595","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, gluteal muscle]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhffi","pgxind-kftx3d0r","pgxcs-kftvw50c",2029929388,0.706,602440993,0.21,1427488395,0.497,"PGX_AM_BS_AEB-10534175-45","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.355000",,,,,,"NCITgrade-C28079","Grade 3","P58Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b159b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Pelvis]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhffs","pgxind-kftx3d13","pgxcs-kftvw53a",224500223,0.078,169400168,0.059,55100055,0.019,"PGX_AM_BS_EWSRT-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.363000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b15a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Knee region]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhfgc","pgxind-kftx3d1r","pgxcs-kftvw597",604502231,0.21,0,0,604502231,0.21,"PGX_AM_BS_EWSRT-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.380000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1704","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Thigh, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwb","pgxind-kftx3dl7","pgxcs-kftvwa8d",70594787,0.025,61500060,0.021,9094727,0.003,"PGX_AM_BS_MPNST-01","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.860000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1707","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Abdominal cavity, grade GII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwg","pgxind-kftx3dld","pgxcs-kftvwa9t",2314190997,0.805,746482941,0.26,1567708056,0.545,"PGX_AM_BS_MPNST-04","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.865000",,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1708","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Inguinal region, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwi","pgxind-kftx3dlf","pgxcs-kftvwaaa",744472707,0.259,158710142,0.055,585762565,0.204,"PGX_AM_BS_MPNST-05","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.866000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1709","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [local recurrence, Pelvis, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwj","pgxind-kftx3dlh","pgxcs-kftvwaas",535643599,0.186,426993955,0.149,108649644,0.038,"PGX_AM_BS_MPNST-06","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.868000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b170c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Retroperitoneum, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwo","pgxind-kftx3dln","pgxcs-kftvwac8",1136117465,0.395,144800143,0.05,991317322,0.345,"PGX_AM_BS_MPNST-09","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.872000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b170d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Inguinal region, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwq","pgxind-kftx3dlp","pgxcs-kftvwacq",411580028,0.143,138300138,0.048,273279890,0.095,"PGX_AM_BS_MPNST-10","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.873000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b170e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Upper arm, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfws","pgxind-kftx3dlr","pgxcs-kftvwad7",1883937753,0.655,404444222,0.141,1479493531,0.515,"PGX_AM_BS_MPNST-11","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.875000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1710","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Thoracic wall, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwv","pgxind-kftx3dlv","pgxcs-kftvwae7",1433562413,0.499,318000317,0.111,1115562096,0.388,"PGX_AM_BS_MPNST-13","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.878000",,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1715","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, primary tumor, Inguinal region, grade GI]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfx3","pgxind-kftx3dm5","pgxcs-kftvwagn",691401245,0.24,417560551,0.145,273840694,0.095,"PGX_AM_BS_MPNST-18","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.884000",,,,,,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1717","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfx6","pgxind-kftx3dm9","pgxcs-kftvwahm",649109673,0.226,522395887,0.182,126713786,0.044,"PGX_AM_BS_MetSarc-tar-01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.887000",,,,,,,,"P38Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1718","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfx8","pgxind-kftx3dmb","pgxcs-kftvwai3",649109673,0.226,522395887,0.182,126713786,0.044,"PGX_AM_BS_MetSarc-tar-01M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.888000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b171b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxd","pgxind-kftx3dmi","pgxcs-kftvwajk",728018055,0.253,625617953,0.218,102400102,0.036,"PGX_AM_BS_MetSarc-tar-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.893000",,,,,,,,"P75Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b171c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxf","pgxind-kftx3dmk","pgxcs-kftvwak2",728018055,0.253,625617953,0.218,102400102,0.036,"PGX_AM_BS_MetSarc-tar-03M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.894000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b171d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxg","pgxind-kftx3dmm","pgxcs-kftvwakj",627465838,0.218,121346036,0.042,506119802,0.176,"PGX_AM_BS_MetSarc-tar-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.895000",,,,,,,,"P18Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b171e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxi","pgxind-kftx3dmo","pgxcs-kftvwal1",627465838,0.218,121346036,0.042,506119802,0.176,"PGX_AM_BS_MetSarc-tar-04M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.897000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1721","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxn","pgxind-kftx3dmu","pgxcs-kftvwamh",930269074,0.324,738530245,0.257,191738829,0.067,"PGX_AM_BS_MetSarc-tar-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.901000",,,,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1722","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxp","pgxind-kftx3dmw","pgxcs-kftvwamy",930269074,0.324,738530245,0.257,191738829,0.067,"PGX_AM_BS_MetSarc-tar-06M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.902000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1723","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxq","pgxind-kftx3dmy","pgxcs-kftvwang",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.904000",,,,,,,,"P22Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1724","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxs","pgxind-kftx3dn0","pgxcs-kftvwany",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.905000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1729","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [storiform-pleomorphic, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy0","pgxind-kftx3dna","pgxcs-kftvwaqe",987202805,0.343,722780686,0.251,264422119,0.092,"PGX_AM_BS_MetSarc-tar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.912000",,,,,,,,"P54Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b172a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [storiform-pleomorphic, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy2","pgxind-kftx3dnc","pgxcs-kftvwaqv",987202805,0.343,722780686,0.251,264422119,0.092,"PGX_AM_BS_MetSarc-tar-10M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.913000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b172d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [storiform-pleomorphic, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy7","pgxind-kftx3dni","pgxcs-kftvwasc",457719362,0.159,402301690,0.14,55417672,0.019,"PGX_AM_BS_MetSarc-tar-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.917000",,,,,,,,"P70Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b172e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [storiform-pleomorphic, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfy8","pgxind-kftx3dnk","pgxcs-kftvwast",457719362,0.159,402301690,0.14,55417672,0.019,"PGX_AM_BS_MetSarc-tar-12M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.919000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1733","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfyh","pgxind-kftx3dnu","pgxcs-kftvwaxb",583361912,0.203,443229163,0.154,140132749,0.049,"PGX_AM_BS_MetSarc-tar-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.926000",,,,,,,,"P57Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1734","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfyi","pgxind-kftx3dnw","pgxcs-kftvwaxt",583361912,0.203,443229163,0.154,140132749,0.049,"PGX_AM_BS_MetSarc-tar-15M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.927000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b179a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [abdomen, recurrence]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgct","pgxind-kftx3dtm","pgxcs-kftvwcd8",539124728,0.188,393613875,0.137,145510853,0.051,"PGX_AM_BS_PNST-08","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.067000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [mediastinum, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdb","pgxind-kftx3du7","pgxcs-kftvwcik",858099895,0.298,500964454,0.174,357135441,0.124,"PGX_AM_BS_PNST-16c","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.083000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [thorax wall, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdc","pgxind-kftx3du9","pgxcs-kftvwcj1",891849649,0.31,409464362,0.142,482385287,0.168,"PGX_AM_BS_PNST-16d","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.084000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [right thigh, primary]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdm","pgxind-kftx3dum","pgxcs-kftvwclz",1341466550,0.467,90841058,0.032,1250625492,0.435,"PGX_AM_BS_PNST-22","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.093000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17ad","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [neck, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdo","pgxind-kftx3duo","pgxcs-kftvwcmg",625235751,0.217,60900060,0.021,564335691,0.196,"PGX_AM_BS_PNST-23a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.094000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17ae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [neck, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdq","pgxind-kftx3duq","pgxcs-kftvwcmy",676386267,0.235,60900060,0.021,615486207,0.214,"PGX_AM_BS_PNST-23b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.095000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17af","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [neck, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdr","pgxind-kftx3dus","pgxcs-kftvwcng",702787136,0.244,60900060,0.021,641887076,0.223,"PGX_AM_BS_PNST-23c","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.097000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17b0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [neck, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdt","pgxind-kftx3duu","pgxcs-kftvwcnx",836277516,0.291,51300051,0.018,784977465,0.273,"PGX_AM_BS_PNST-23d","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.098000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1925","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhguy","pgxind-kftx3efj","pgxcs-kftvwhwa",934857767,0.325,187593718,0.065,747264049,0.26,"PGX_AM_BS_HG-Osarc-05","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.614000",,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1930","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvg","pgxind-kftx3eg6","pgxcs-kftvwi1m",513831290,0.179,272192412,0.095,241638878,0.084,"PGX_AM_BS_HG-Osarc-24","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.630000",,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1931","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvi","pgxind-kftx3eg8","pgxcs-kftvwi24",1267832391,0.441,223907629,0.078,1043924762,0.363,"PGX_AM_BS_HG-Osarc-25","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.631000",,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1936","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvq","pgxind-kftx3egi","pgxcs-kftvwi4j",892714641,0.311,264343245,0.092,628371396,0.219,"PGX_AM_BS_HG-Osarc-30","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.638000",,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0524","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1a601591-a002-421c-a8e6-1537ef3f70e0","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhhlc","pgxind-kftx3fbf","pgxcs-kftvwpwe",329949903,0.115,82542554,0.029,247407349,0.086,"1a601591-a002-421c-a8e6-1537ef3f70e0","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:46.404000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a054c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-386455aa-441e-4bd2-a0a7-ad2ed278e5e6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhhn7","pgxind-kftx3fdo","pgxcs-kftvwqfq",907321751,0.316,639194772,0.222,268126979,0.093,"386455aa-441e-4bd2-a0a7-ad2ed278e5e6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:46.461000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a059b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bf4fc4a5-ae1e-4363-a440-a841464ae81a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhhqv","pgxind-kftx3fi3","pgxcs-kftvwrk8",2453704512,0.853,1011275244,0.352,1442429268,0.502,"bf4fc4a5-ae1e-4363-a440-a841464ae81a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:46.574000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a05cc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e4a19b22-ced3-4123-863d-2cde750226ee","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhht5","pgxind-kftx3fkp","pgxcs-kftvws9y",1719533572,0.598,732659930,0.255,986873642,0.343,"e4a19b22-ced3-4123-863d-2cde750226ee","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:46.644000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a06f4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-fc7de482-3113-4857-9766-d8268784f9aa","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhi6u","pgxind-kftx3g14","pgxcs-kftvwwid",1859229278,0.647,1003768104,0.349,855461174,0.298,"fc7de482-3113-4857-9766-d8268784f9aa","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:47.394000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0700","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bb4fa564-3128-44cb-a852-2bf4d26cb981","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhi7e","pgxind-kftx3g1s","pgxcs-kftvwwo7",1701904474,0.592,643529773,0.224,1058374701,0.368,"bb4fa564-3128-44cb-a852-2bf4d26cb981","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:47.412000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0717","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5c8a792e-362f-44af-b94e-ed92f70715d6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhi8g","pgxind-kftx3g2z","pgxcs-kftvwwzd",657446166,0.229,302136145,0.105,355310021,0.124,"5c8a792e-362f-44af-b94e-ed92f70715d6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:47.445000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0735","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-659db59d-9d59-457a-a857-dd73e18a17a4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhi9s","pgxind-kftx3g4o","pgxcs-kftvwxg3",798860737,0.278,524621344,0.182,274239393,0.095,"659db59d-9d59-457a-a857-dd73e18a17a4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:47.487000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a085b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-155fb0dc-2c45-46a8-84c9-a1447111bb8c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhin6","pgxind-kftx3gkp","pgxcs-kftvx1ko",1187495505,0.413,794396274,0.276,393099231,0.137,"155fb0dc-2c45-46a8-84c9-a1447111bb8c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:47.897000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0888","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c852155c-abfc-4d54-8dd0-136a27508954","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhip8","pgxind-kftx3gn3","pgxcs-kftvx28h",1869394605,0.65,994008582,0.346,875386023,0.304,"c852155c-abfc-4d54-8dd0-136a27508954","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:47.960000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a093d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d257887-d0f2-40d1-945b-a46db90e63df","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhixi","pgxind-kftx3gwf","pgxcs-kftvx4sa",2819661717,0.981,837341658,0.291,1982320059,0.69,"3d257887-d0f2-40d1-945b-a46db90e63df","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.216000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0947","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0c5a0353-bf76-4a2b-a941-76bf24a8540f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhixz","pgxind-kftx3gwz","pgxcs-kftvx4x3",2179144028,0.758,1001213780,0.348,1177930248,0.41,"0c5a0353-bf76-4a2b-a941-76bf24a8540f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.230000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0958","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bedf1833-c215-49c8-84ff-49f84c192ffd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C16.9","Stomach, NOS","pgxbs-kftvhiyr","pgxind-kftx3gxx","pgxcs-kftvx55a",2204904344,0.767,794792713,0.276,1410111631,0.49,"bedf1833-c215-49c8-84ff-49f84c192ffd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000945","stomach","{}","2020-09-10 17:44:48.254000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a09cc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-6245d97d-1af8-4c78-8bbf-840ee4e7bd44","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhj41","pgxind-kftx3h3q","pgxcs-kftvx6ro",2499486325,0.869,1431783459,0.498,1067702866,0.371,"6245d97d-1af8-4c78-8bbf-840ee4e7bd44","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.416000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0aee","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f854db6b-57cb-4da7-9252-b2ade22c2675","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhjh6","pgxind-kftx3hj6","pgxcs-kftvxawb",1717158895,0.597,519444469,0.181,1197714426,0.417,"f854db6b-57cb-4da7-9252-b2ade22c2675","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:48.827000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0b22","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f7e730b2-be2b-4b47-8a55-2c888758ed6a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhjjj","pgxind-kftx3hm2","pgxcs-kftvxblc",1852924407,0.644,890179015,0.31,962745392,0.335,"f7e730b2-be2b-4b47-8a55-2c888758ed6a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.901000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d22","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d2165554-a30a-49e9-8038-c9539d487a22","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhk6y","pgxind-kftx3icb","pgxcs-kftvxivh",2662979373,0.926,754392318,0.262,1908587055,0.664,"d2165554-a30a-49e9-8038-c9539d487a22","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:49.624000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d76","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-016886f1-1b40-422e-82cb-51307fca8cd4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhkar","pgxind-kftx3igq","pgxcs-kftvxk2x",2285128979,0.795,1061363582,0.369,1223765397,0.426,"016886f1-1b40-422e-82cb-51307fca8cd4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:49.743000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d8a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-9eff3f89-cd15-46ee-ac86-006586e1cefe","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhkbo","pgxind-kftx3ihr","pgxcs-kftvxkcp",2464824049,0.857,881349673,0.307,1583474376,0.551,"9eff3f89-cd15-46ee-ac86-006586e1cefe","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:49.771000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0e7f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b09e1197-d6cd-4a76-8e2f-3b8af97d2390","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkmt","pgxind-kftx3itp","pgxcs-kftvxnuz",784986997,0.273,490013021,0.17,294973976,0.103,"b09e1197-d6cd-4a76-8e2f-3b8af97d2390","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.115000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0eae","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f035a57e-be4d-49ff-a96f-1ca75f4a6b92","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhkoy","pgxind-kftx3iw2","pgxcs-kftvxok4",2334310542,0.812,1070706803,0.372,1263603739,0.44,"f035a57e-be4d-49ff-a96f-1ca75f4a6b92","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:50.182000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ec0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d38f7c9-00dd-47c1-8649-c50574953aab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkpr","pgxind-kftx3iwx","pgxcs-kftvxoss",1934816375,0.673,872718418,0.304,1062097957,0.369,"3d38f7c9-00dd-47c1-8649-c50574953aab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.207000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ec1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4df7599a-680c-452a-b472-2370b8f190a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.2","Myometrium","pgxbs-kftvhkpt","pgxind-kftx3fw1","pgxcs-kftvxota",2084231085,0.725,1032667465,0.359,1051563620,0.366,"4df7599a-680c-452a-b472-2370b8f190a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0001296","myometrium","{}","2020-09-10 17:44:50.208000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ece","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ab26b1f4-9062-49e4-b121-28d5f7fc61b6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkqf","pgxind-kftx3ixn","pgxcs-kftvxozj",2341318174,0.814,627694512,0.218,1713623662,0.596,"ab26b1f4-9062-49e4-b121-28d5f7fc61b6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.227000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ee7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7b8b0be7-184d-4334-88f3-58bf561ce055","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.2","Myometrium","pgxbs-kftvhkrj","pgxind-kftx3iyu","pgxcs-kftvxpbi",2201358915,0.766,1070011772,0.372,1131347143,0.394,"7b8b0be7-184d-4334-88f3-58bf561ce055","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0001296","myometrium","{}","2020-09-10 17:44:50.262000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1033","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-42e7b86b-5089-4042-b0df-ebc37290dcf1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhl6n","pgxind-kftx3jfl","pgxcs-kftvxu2m",1962735786,0.683,807113337,0.281,1155622449,0.402,"42e7b86b-5089-4042-b0df-ebc37290dcf1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:50.729000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1066","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d40b2922-fa6a-4afa-bdbf-7b517384af74","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhl8z","pgxind-kftx3ji4","pgxcs-kftvxutd",670084019,0.233,18036216,0.006,652047803,0.227,"d40b2922-fa6a-4afa-bdbf-7b517384af74","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.800000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a107d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-03a583f8-5976-4f26-a074-a9d058138447","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhla0","pgxind-kftx3jj4","pgxcs-kftvxv4k",1568360375,0.546,968709179,0.337,599651196,0.209,"03a583f8-5976-4f26-a074-a9d058138447","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:50.832000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a10a7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a868d01c-7148-418a-b36c-808dbc7e068d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhlbw","pgxind-kftx3jlb","pgxcs-kftvxvpb",1632152958,0.568,798941967,0.278,833210991,0.29,"a868d01c-7148-418a-b36c-808dbc7e068d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:50.891000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1100","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ccba79c4-8873-478a-ad99-0db99c034a91","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C48.0","Retroperitoneum","pgxbs-kftvhlfx","pgxind-kftx3jpf","pgxcs-kftvxwyd",1856577719,0.646,758072955,0.264,1098504764,0.382,"ccba79c4-8873-478a-ad99-0db99c034a91","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.015000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1142","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-023378d5-5729-407a-9633-9f4dee67c869","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhliw","pgxind-kftx3jso","pgxcs-kftvxxwg",1256695339,0.437,553842156,0.193,702853183,0.244,"023378d5-5729-407a-9633-9f4dee67c869","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.109000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1205","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a9b4f32f-030e-4523-85d6-372dd1a058cb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhlrq","pgxind-kftx3k20","pgxcs-kftvy0nf",1775927854,0.618,1045633028,0.364,730294826,0.254,"a9b4f32f-030e-4523-85d6-372dd1a058cb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:51.384000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1314","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-64235d51-b1b8-46ab-87ef-a7caeb394a6d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhm41","pgxind-kftx3kec","pgxcs-kftvy4hr",1623611185,0.565,655490778,0.228,968120407,0.337,"64235d51-b1b8-46ab-87ef-a7caeb394a6d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.763000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1342","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1ecbab38-1736-465c-9ee2-bf39706c9663","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhm65","pgxind-kftx3hkn","pgxcs-kftvy56y",1678950266,0.584,813880657,0.283,865069609,0.301,"1ecbab38-1736-465c-9ee2-bf39706c9663","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:51.829000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1428","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-18258ddc-34e3-4590-87e7-c11d7a41d0d3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmgk","pgxind-kftx3l08","pgxcs-kftvy8kw",2109282403,0.734,1351543752,0.47,757738651,0.264,"18258ddc-34e3-4590-87e7-c11d7a41d0d3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.155000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1597","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-29928748-9899-49b8-8830-da26ecd88e0e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhmx4","pgxind-kftx3ga2","pgxcs-kftvydsr",2507767300,0.872,1358335062,0.472,1149432238,0.4,"29928748-9899-49b8-8830-da26ecd88e0e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:52.671000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-08011518-9de2-4be0-b0eb-72f099bb7e9f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmyb","pgxind-kftx3liq","pgxcs-kftvye5d",1353698918,0.471,677700175,0.236,675998743,0.235,"08011518-9de2-4be0-b0eb-72f099bb7e9f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.708000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15e7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ed0e5f9d-7df8-4af8-9916-d30139a9b807","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhn0s","pgxind-kftx3ll8","pgxcs-kftvyey5",781156377,0.272,429738676,0.149,351417701,0.122,"ed0e5f9d-7df8-4af8-9916-d30139a9b807","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:52.783000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1832","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-6ab4887a-0067-494f-ad05-b37073aa1471","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhnri","pgxind-kftx3mbi","pgxcs-kftvyn9c",1380177138,0.48,547987254,0.191,832189884,0.289,"6ab4887a-0067-494f-ad05-b37073aa1471","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:53.605000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a18ae","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-14cc693c-a747-470a-88b5-fff9eb3c250d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhnx5","pgxind-kftx3mgt","pgxcs-kftvyp26",1538575017,0.535,787328313,0.274,751246704,0.261,"14cc693c-a747-470a-88b5-fff9eb3c250d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:53.779000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a198b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-cc253802-8deb-46a1-af0f-1649c322dc00","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvho77","pgxind-kftx3mqb","pgxcs-kftvys6m",736561277,0.256,269015438,0.094,467545839,0.163,"cc253802-8deb-46a1-af0f-1649c322dc00","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.099000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a199f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f3aa3f2a-3cc2-4b10-b764-63d1b32a2f5f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.0","Connective, Subcutaneous and other soft tissues of head, face, and neck","pgxbs-kftvho84","pgxind-kftx3jha","pgxcs-kftvysis",631613379,0.22,420900542,0.146,210712837,0.073,"f3aa3f2a-3cc2-4b10-b764-63d1b32a2f5f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003566","head connective tissue","{}","2020-09-10 17:44:54.128000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a19db","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1afcdb32-ae26-4747-a131-54e83dd84a46","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhoau","pgxind-kftx3mti","pgxcs-kftvytco",2042702262,0.711,826192237,0.287,1216510025,0.423,"1afcdb32-ae26-4747-a131-54e83dd84a46","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.216000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1afb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f8495459-caf7-47ca-9b6a-7fe11ff1ba11","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhoo0","pgxind-kftx3n54","pgxcs-kftvyxln",1714534434,0.596,614368372,0.214,1100166062,0.383,"f8495459-caf7-47ca-9b6a-7fe11ff1ba11","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:54.624000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1b17","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-05eaba25-856d-4f14-93c7-2059dfd4f3ab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhopa","pgxind-kftx3l25","pgxcs-kftvyxzc",573471463,0.199,369095786,0.128,204375677,0.071,"05eaba25-856d-4f14-93c7-2059dfd4f3ab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.664000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1b45","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8eacd13b-b2d6-4002-a22d-26fe426e47ab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhord","pgxind-kftx3n89","pgxcs-kftvyyll",1465337136,0.51,658891199,0.229,806445937,0.281,"8eacd13b-b2d6-4002-a22d-26fe426e47ab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.728000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1bd3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-467e7743-8c7e-4a22-ace1-492a9bc17a89","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhoxs","pgxind-kftx3ne8","pgxcs-kftvz0nn",1964219009,0.683,1155524307,0.402,808694702,0.281,"467e7743-8c7e-4a22-ace1-492a9bc17a89","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.927000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1bd4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2fc10297-1618-4eb0-9a66-630e40ea677f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhoxu","pgxind-kftx3kg6","pgxcs-kftvz0o5",1581442734,0.55,864698381,0.301,716744353,0.249,"2fc10297-1618-4eb0-9a66-630e40ea677f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.928000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c50","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e7e97623-5c8a-42b4-abc6-e7b424816713","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp3h","pgxind-kftx3njb","pgxcs-kftvz2f8",2372709797,0.825,754953189,0.263,1617756608,0.563,"e7e97623-5c8a-42b4-abc6-e7b424816713","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.109000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c6b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80690d38-0d5c-4f52-8aad-110769f818c3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp4p","pgxind-kftx3nkh","pgxcs-kftvz2uu",1784459822,0.621,884900189,0.308,899559633,0.313,"80690d38-0d5c-4f52-8aad-110769f818c3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.148000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c99","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2be1c673-33b9-4ac3-897d-a75c3d0266fb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhp6s","pgxind-kftx3nma","pgxcs-kftvz3hj",43135571,0.015,37975653,0.013,5159918,0.002,"2be1c673-33b9-4ac3-897d-a75c3d0266fb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:55.213000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1cc0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8faedd92-d7fa-452a-8210-741118e516f7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","Ovary","pgxbs-kftvhp8j","pgxind-kftx3nnv","pgxcs-kftvz42w",1079560707,0.375,672652421,0.234,406908286,0.142,"8faedd92-d7fa-452a-8210-741118e516f7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000992","ovary","{}","2020-09-10 17:44:55.269000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1db3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-94b19fa7-a291-4ffd-a4e0-4d3e2f48da1d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhpjm","pgxind-kftx3nxp","pgxcs-kftvz7ha",1690009562,0.588,767453634,0.267,922555928,0.321,"94b19fa7-a291-4ffd-a4e0-4d3e2f48da1d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:55.616000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1e3e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e8beea6f-975d-43aa-9bb9-b65f260ff2ee","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhppx","pgxind-kftx3o3t","pgxcs-kftvz9hu",71759041,0.025,71551541,0.025,207500,0,"e8beea6f-975d-43aa-9bb9-b65f260ff2ee","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:55.813000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1eb2","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0bb1b503-fae2-4b9d-9709-25fd66194e8d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhpv8","pgxind-kftx3mzl","pgxcs-kftvzb4i",1940227802,0.675,604110636,0.21,1336117166,0.465,"0bb1b503-fae2-4b9d-9709-25fd66194e8d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.979000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1fce","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-926c06e9-448d-44c2-be23-d3b62cc14c6b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvhq86","pgxind-kftx3ojg","pgxcs-kftvzfab",1309645973,0.456,596652120,0.208,712993853,0.248,"926c06e9-448d-44c2-be23-d3b62cc14c6b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:44:56.375000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a201e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-892e17af-42c6-437a-8816-0441e56362a4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhqbu","pgxind-kftx3omc","pgxcs-kftvzggl",2278794249,0.793,925742913,0.322,1353051336,0.471,"892e17af-42c6-437a-8816-0441e56362a4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:56.486000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a20e1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1fe30a2f-22a6-4f88-9a3a-7a11359cc151","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqkr","pgxind-kftx3ot8","pgxcs-kftvzj9o",1450919916,0.505,323074792,0.112,1127845124,0.392,"1fe30a2f-22a6-4f88-9a3a-7a11359cc151","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:56.760000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2175","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-31eb46e1-aede-4ae4-ab2b-1f85b63da6c9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqrj","pgxind-kftx3oy5","pgxcs-kftvzld1",1925105540,0.67,843172252,0.293,1081933288,0.376,"31eb46e1-aede-4ae4-ab2b-1f85b63da6c9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:56.968000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a21c0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ea02c527-63bd-4793-98c3-86025d2bf13d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhquw","pgxind-kftx3gbs","pgxcs-kftvzmgd",2015489359,0.701,1063566593,0.37,951922766,0.331,"ea02c527-63bd-4793-98c3-86025d2bf13d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.075000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a224b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-b9221759-78fd-4d62-9f55-f7e3d06e02c3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhr15","pgxind-kftx3p5e","pgxcs-kftvzohu",2172502186,0.756,1007807168,0.351,1164695018,0.405,"b9221759-78fd-4d62-9f55-f7e3d06e02c3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.275000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2466","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1857e1ed-2584-4b12-b889-791caf08dc5e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhrpm","pgxind-kftx3jr9","pgxcs-kftvzw7l",2675995118,0.931,686011335,0.239,1989983783,0.692,"1857e1ed-2584-4b12-b889-791caf08dc5e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:58.032000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a259b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-910cd9b0-5bbe-47e5-8f4c-a6e8aa580281","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs3r","pgxind-kftx3pzd","pgxcs-kftw00rv",1895533745,0.659,852648054,0.297,1042885691,0.363,"910cd9b0-5bbe-47e5-8f4c-a6e8aa580281","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.467000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a25b8","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-50906d74-4ce3-4e48-a0fd-605a80ed0f32","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs51","pgxind-kftx3pjw","pgxcs-kftw015t",1527475518,0.531,889324684,0.309,638150834,0.222,"50906d74-4ce3-4e48-a0fd-605a80ed0f32","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.509000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a25bf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-01d4c0b5-ba01-4672-82f0-66a7bd5d0073","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs5d","pgxind-kftx3hg3","pgxcs-kftw0198",859186056,0.299,624932249,0.217,234253807,0.081,"01d4c0b5-ba01-4672-82f0-66a7bd5d0073","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.520000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a268e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-83587c69-b0a0-4e1d-9522-0a580a2467cd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhser","pgxind-kftx3p5e","pgxcs-kftw04b1",735609316,0.256,290659677,0.101,444949639,0.155,"83587c69-b0a0-4e1d-9522-0a580a2467cd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.812000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a26b7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2ce19e06-b543-48fe-9089-7c6b34512f7e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhsgm","pgxind-kftx3q8p","pgxcs-kftw04vj",1240893311,0.432,822582073,0.286,418311238,0.145,"2ce19e06-b543-48fe-9089-7c6b34512f7e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:58.869000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2857","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-855f843c-4fad-46d8-b3c0-4cd45c6998df","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhszg","pgxind-kftx3qmx","pgxcs-kftw0aym",2121998861,0.738,1275165919,0.444,846832942,0.295,"855f843c-4fad-46d8-b3c0-4cd45c6998df","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:59.459000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a28e5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e9c18a21-a583-4031-80d6-4abc8c67fc28","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvht5y","pgxind-kftx3mr1","pgxcs-kftw0czs",639079209,0.223,284522095,0.099,354557113,0.123,"e9c18a21-a583-4031-80d6-4abc8c67fc28","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:59.659000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,"pgxcs-kftw4bgx",,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a58","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c9b51f86-b26b-4329-bb28-a1298d9b7142","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtmq","pgxind-kftx3peq","pgxcs-kftw0igh",1508683658,0.525,805508232,0.28,703175426,0.245,"c9b51f86-b26b-4329-bb28-a1298d9b7142","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.179000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b16","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3e8c0319-b011-4030-b0d4-3ea2f48fe7d8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtvd","pgxind-kftx3q1c","pgxcs-kftw0l73",1787739569,0.622,857806175,0.298,929933394,0.323,"3e8c0319-b011-4030-b0d4-3ea2f48fe7d8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.446000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b17","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5666b6b0-84b1-4a95-a8a6-43d61d0930e1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvhtve","pgxind-kftx3r8o","pgxcs-kftw0l7k",957692326,0.333,547842554,0.191,409849772,0.143,"5666b6b0-84b1-4a95-a8a6-43d61d0930e1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:00.448000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b5d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f0a72e67-1bdb-4561-9826-af117c53bbf2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtyk","pgxind-kftx3qqr","pgxcs-kftw0m8m",2404661523,0.836,1383635658,0.481,1021025865,0.355,"f0a72e67-1bdb-4561-9826-af117c53bbf2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.547000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b63","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3db0de29-f0a6-4cea-bec5-22164e795a43","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhtyu","pgxind-kftx3g3l","pgxcs-kftw0mbk",585203495,0.204,402932940,0.14,182270555,0.063,"3db0de29-f0a6-4cea-bec5-22164e795a43","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:00.555000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2bef","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-87e0c11a-cf75-4877-b4c8-23aa36631b4f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhu57","pgxind-kftx3rec","pgxcs-kftw0oc6",2125245185,0.739,1277636610,0.444,847608575,0.295,"87e0c11a-cf75-4877-b4c8-23aa36631b4f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.753000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2c08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-fb5c61d6-717e-4798-8306-86eb196d5609","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhu6c","pgxind-kftx3rev","pgxcs-kftw0or0",777817451,0.271,468710170,0.163,309107281,0.108,"fb5c61d6-717e-4798-8306-86eb196d5609","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.789000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2dd3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-359fec0b-7bc1-4bb4-a9d9-11eea9366ac6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhv0g","pgxind-kftx3g3l","pgxcs-kftw0vdu",671910185,0.234,469355779,0.163,202554406,0.07,"359fec0b-7bc1-4bb4-a9d9-11eea9366ac6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:01.437000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2de0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-254a48ae-81ee-4334-805c-3aa2a90d1c47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhv12","pgxind-kftx3o6x","pgxcs-kftw0vkn",1985556902,0.691,909005905,0.316,1076550997,0.374,"254a48ae-81ee-4334-805c-3aa2a90d1c47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:01.455000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhv2v","pgxind-kftx3gso","pgxcs-kftw0w7d",2747302698,0.956,1708371712,0.594,1038930986,0.361,"3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.513000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e25","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-cb6ac223-425a-430b-b44b-4a127757621d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhv46","pgxind-kftx3run","pgxcs-kftw0wlt",2023336423,0.704,1002227629,0.349,1021108794,0.355,"cb6ac223-425a-430b-b44b-4a127757621d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:01.555000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2f26","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-901dfd62-799d-4e40-926e-22a5fd859b5a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhvfq","pgxind-kftx3rrq","pgxcs-kftw10bi",1519087533,0.528,703931229,0.245,815156304,0.284,"901dfd62-799d-4e40-926e-22a5fd859b5a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.916000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2fd0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-19c821d5-c05c-42ad-aaca-749565eff239","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhvnf","pgxind-kftx3roe","pgxcs-kftw12qm",1542058243,0.536,661916889,0.23,880141354,0.306,"19c821d5-c05c-42ad-aaca-749565eff239","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:02.154000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a330b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhwp1","pgxind-kftx3sug","pgxcs-kftw1emx",2491265552,0.867,733481110,0.255,1757784442,0.611,"ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:03.316000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a34c2","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-86ae3e79-5c03-480f-8a5a-35bac00cb89d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C40.2","Long bones of lower limb and associated joints","pgxbs-kftvhx8v","pgxind-kftx3t52","pgxcs-kftw1l1a",1958392849,0.681,1124066452,0.391,834326397,0.29,"86ae3e79-5c03-480f-8a5a-35bac00cb89d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003606","limb long bone","{}","2020-09-10 17:45:03.934000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a34c7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Metastatic","TCGA-17a09318-d777-4b79-b321-faa8fc4b0153","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhx93","pgxind-kftx3k1s","pgxcs-kftw1l3s",1485703743,0.517,866520354,0.301,619183389,0.215,"17a09318-d777-4b79-b321-faa8fc4b0153","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:03.941000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a35f2","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7e457156-66d6-4d8c-b159-be33ca845f58","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhxmk","pgxind-kftx3tdo","pgxcs-kftw1pg2",1208877380,0.42,572926263,0.199,635951117,0.221,"7e457156-66d6-4d8c-b159-be33ca845f58","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:04.713000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3641","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-61d4dff3-db42-43cf-a8c4-72cb4719d7be","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhxq4","pgxind-kftx3iqo","pgxcs-kftw1qkw",1093654171,0.38,661688740,0.23,431965431,0.15,"61d4dff3-db42-43cf-a8c4-72cb4719d7be","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:04.824000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3778","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8cb1ebb2-30e4-4cc8-a221-9bcf1867176b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhy46","pgxind-kftx3imc","pgxcs-kftw1v1h",1514837030,0.527,557887027,0.194,956950003,0.333,"8cb1ebb2-30e4-4cc8-a221-9bcf1867176b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:05.261000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3818","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8c227ef2-2f70-4143-81d9-de2fb8ef9607","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhybg","pgxind-kftx3tqo","pgxcs-kftw1xc4",1938681113,0.674,1300282757,0.452,638398356,0.222,"8c227ef2-2f70-4143-81d9-de2fb8ef9607","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:05.485000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a38d7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-94c1cb38-5eca-402d-867b-ab3fe7c30a74","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhyk2","pgxind-kftx3tv2","pgxcs-kftw202y",1618297303,0.563,446935417,0.155,1171361886,0.407,"94c1cb38-5eca-402d-867b-ab3fe7c30a74","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:05.753000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a36","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e25b5088-a3d4-4f3c-8335-308c571f6a30","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhyzv","pgxind-kftx3gu3","pgxcs-kftw256n",580952988,0.202,290554282,0.101,290398706,0.101,"e25b5088-a3d4-4f3c-8335-308c571f6a30","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.246000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a66","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-976afd99-08ba-440d-8ecd-9918ae4279cb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhz23","pgxind-kftx3str","pgxcs-kftw25wz",2219487939,0.772,1121321247,0.39,1098166692,0.382,"976afd99-08ba-440d-8ecd-9918ae4279cb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:06.315000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a7e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a51541c-b1f6-4e7e-aa59-e9c74e938138","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhz37","pgxind-kftx3h3y","pgxcs-kftw268s",1784347253,0.621,908721565,0.316,875625688,0.305,"5a51541c-b1f6-4e7e-aa59-e9c74e938138","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.348000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3abe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-34b60937-76b3-401c-a8dd-3f78e2b20a38","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhz63","pgxind-kftx3sjv","pgxcs-kftw277k",1835878933,0.639,848862528,0.295,987016405,0.343,"34b60937-76b3-401c-a8dd-3f78e2b20a38","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:06.438000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3aec","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f1e4a88f-57b5-4e29-bfb2-d6fc8fdbe209","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhz87","pgxind-kftx3kb2","pgxcs-kftw27ww",722679843,0.251,419870818,0.146,302809025,0.105,"f1e4a88f-57b5-4e29-bfb2-d6fc8fdbe209","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.502000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3b8f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b89ab8af-5c5e-4e75-9c85-d88e6406d182","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvhzfl","pgxind-kftx3qwq","pgxcs-kftw2a8n",1007419100,0.35,555789783,0.193,451629317,0.157,"b89ab8af-5c5e-4e75-9c85-d88e6406d182","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:45:06.734000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3bbf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c0327a7b-4afa-47b5-91b8-93162b16e144","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhzhs","pgxind-kftx3qtc","pgxcs-kftw2aya",1883684534,0.655,770041072,0.268,1113643462,0.387,"c0327a7b-4afa-47b5-91b8-93162b16e144","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.801000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d32","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhzyj","pgxind-kftx3ugf","pgxcs-kftw2gch",1947776504,0.677,809602910,0.282,1138173594,0.396,"ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.324000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d99","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi037","pgxind-kftx3r5b","pgxcs-kftw2hsy",2074585435,0.722,1132804012,0.394,941781423,0.328,"0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.472000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3dd7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-943d3db6-7f56-4be1-8f67-33c2c1c02f0a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3701","Myxoid Leiomyosarcoma","icdom-88963","Myxoid leiomyosarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi05z","pgxind-kftx3i3e","pgxcs-kftw2ipq",1649656971,0.574,823658675,0.286,825998296,0.287,"943d3db6-7f56-4be1-8f67-33c2c1c02f0a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.559000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3eb5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-52254562-f812-4023-bb00-55e2d766eadb","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi0fz","pgxind-kftx3unp","pgxcs-kftw2lyu",2146979987,0.747,913527427,0.318,1233452560,0.429,"52254562-f812-4023-bb00-55e2d766eadb","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:07.869000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3edc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi0hs","pgxind-kftx3p8n","pgxcs-kftw2mhr",1572587273,0.547,448428576,0.156,1124158697,0.391,"ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.924000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3fbb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d22369d7-9f7a-4e54-badc-6c800eeb7e4c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi0rx","pgxind-kftx3us1","pgxcs-kftw2pqp",2581050945,0.898,1346262572,0.468,1234788373,0.429,"d22369d7-9f7a-4e54-badc-6c800eeb7e4c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.234000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a40bd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi13l","pgxind-kftx3uw3","pgxcs-kftw2th5",2576339639,0.896,1180880938,0.411,1395458701,0.485,"5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.595000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a41a1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5402d273-3b02-4bf7-a0a4-625a59fed4cc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi1dw","pgxind-kftx3hhe","pgxcs-kftw2ws4",1536473516,0.534,757606658,0.264,778866858,0.271,"5402d273-3b02-4bf7-a0a4-625a59fed4cc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:08.914000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4242","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96d18f04-a2c7-4f86-a648-c18b5796a2a8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi1l7","pgxind-kftx3lg3","pgxcs-kftw2z58",2027103086,0.705,1049223633,0.365,977879453,0.34,"96d18f04-a2c7-4f86-a648-c18b5796a2a8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:09.141000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a42ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-414e11c3-8430-49a2-b08c-0b496e336cd7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C40.3","Short bones of lower limb and associated joints","pgxbs-kftvi1rc","pgxind-kftx3pj4","pgxcs-kftw315u",1496943656,0.521,1028040786,0.358,468902870,0.163,"414e11c3-8430-49a2-b08c-0b496e336cd7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0013630","short bone","{}","2020-09-10 17:45:09.331000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a432e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a6bbee06-44bf-446a-8d21-550aa6e71960","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi1vv","pgxind-kftx3v62","pgxcs-kftw32l9",2583805977,0.899,1173546689,0.408,1410259288,0.491,"a6bbee06-44bf-446a-8d21-550aa6e71960","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:09.472000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a433a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-20f9b5a5-8c63-43be-9247-1ec3f2d07cea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvi1we","pgxind-kftx3v66","pgxcs-kftw32r3",2633921377,0.916,1200513881,0.418,1433407496,0.499,"20f9b5a5-8c63-43be-9247-1ec3f2d07cea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:09.489000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4351","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi1xg","pgxind-kftx3fpt","pgxcs-kftw332s",1763938100,0.614,655269016,0.228,1108669084,0.386,"e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:09.522000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4359","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3dd4532a-8cfe-4900-8d7e-af4303645705","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi1xt","pgxind-kftx3rck","pgxcs-kftw336o",2228582292,0.775,935651135,0.325,1292931157,0.45,"3dd4532a-8cfe-4900-8d7e-af4303645705","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:09.533000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a453d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ecbc891e-ed99-4541-bda5-ede1f28aba8a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi2jt","pgxind-kftx3vek","pgxcs-kftw3a70",1471574794,0.512,505148002,0.176,966426792,0.336,"ecbc891e-ed99-4541-bda5-ede1f28aba8a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:10.212000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4595","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-20ee01d8-ec14-45f8-a347-a36434fa13b3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvi2nt","pgxind-kftx3gjs","pgxcs-kftw3bge",1185890202,0.412,652786547,0.227,533103655,0.185,"20ee01d8-ec14-45f8-a347-a36434fa13b3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:10.334000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a45eb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-05fc5924-07b1-422e-9d7c-7c0051f72368","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi2rn","pgxind-kftx3k28","pgxcs-kftw3cpn",1831364177,0.637,960897265,0.334,870466912,0.303,"05fc5924-07b1-422e-9d7c-7c0051f72368","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.454000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a470e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-673f7169-6924-42a2-b705-1815d4445044","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi34v","pgxind-kftx3rep","pgxcs-kftw3gx7",2722153331,0.947,824649460,0.287,1897503871,0.66,"673f7169-6924-42a2-b705-1815d4445044","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.862000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a471f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-53fe0909-0df5-49e3-98eb-296d056370ee","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi35n","pgxind-kftx3v2i","pgxcs-kftw3h8s",289165723,0.101,162280992,0.056,126884731,0.044,"53fe0909-0df5-49e3-98eb-296d056370ee","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.886000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4796","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-84c516a9-e31e-486b-b6a6-15d6e2a6ce18","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi3b5","pgxind-kftx3no7","pgxcs-kftw3iys",2520073906,0.877,851657612,0.296,1668416294,0.58,"84c516a9-e31e-486b-b6a6-15d6e2a6ce18","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.053000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a48b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c91f6f45-ebfb-45cc-a0dd-9862b375336c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi3nz","pgxind-kftx3vqj","pgxcs-kftw3n28",1924704644,0.669,1088360550,0.379,836344094,0.291,"c91f6f45-ebfb-45cc-a0dd-9862b375336c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:11.450000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a49bd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96ef5730-651a-4a02-a879-fb5c6bbfff4b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi404","pgxind-kftx3r5t","pgxcs-kftw3qyv",1537157112,0.535,522513538,0.182,1014643574,0.353,"96ef5730-651a-4a02-a879-fb5c6bbfff4b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.824000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a49bf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-884945c4-393f-46d2-b23e-edeb096f8b71","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvi408","pgxind-kftx3vtm","pgxcs-kftw3qzv",2064139825,0.718,1127584045,0.392,936555780,0.326,"884945c4-393f-46d2-b23e-edeb096f8b71","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:11.826000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4b00","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e8ea3d4d-36e5-460f-a0cf-0f40d9bb0c8f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi4eq","pgxind-kftx3utx","pgxcs-kftw3voh",1942741604,0.676,499541812,0.174,1443199792,0.502,"e8ea3d4d-36e5-460f-a0cf-0f40d9bb0c8f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:12.275000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4b08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi4f3","pgxind-kftx3rs2","pgxcs-kftw3vsf",2339964037,0.814,1280802642,0.445,1059161395,0.368,"5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:12.287000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4baa","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-83b89602-d430-4b8c-b29b-ebdecd9415a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi4mf","pgxind-kftx3vza","pgxcs-kftw3y5x",2658144151,0.925,983499215,0.342,1674644936,0.582,"83b89602-d430-4b8c-b29b-ebdecd9415a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:12.515000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4bbe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bcaea097-8911-4503-8af9-e7e0515d1529","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi4nb","pgxind-kftx3l4q","pgxcs-kftw3yfn",2198804728,0.765,811515192,0.282,1387289536,0.483,"bcaea097-8911-4503-8af9-e7e0515d1529","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:12.542000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d44","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-030ed394-9316-4ce3-96e3-680e3bcb1595","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi54z","pgxind-kftx3w33","pgxcs-kftw44az",1064166550,0.37,480467380,0.167,583699170,0.203,"030ed394-9316-4ce3-96e3-680e3bcb1595","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:13.091000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d4f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4c93c0a4-73c4-48ef-91e0-40b2143833bc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi55h","pgxind-kftx3uww","pgxcs-kftw44gu",1807991295,0.629,692376126,0.241,1115615169,0.388,"4c93c0a4-73c4-48ef-91e0-40b2143833bc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:13.106000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d5d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d49488be-65dd-419f-a768-e60d454417a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi564","pgxind-kftx3tch","pgxcs-kftw44np",1855867186,0.646,804469447,0.28,1051397739,0.366,"d49488be-65dd-419f-a768-e60d454417a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.126000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4ebb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-46be2946-a6f4-426a-a589-3a616cb77eca","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5lu","pgxind-kftx3sat","pgxcs-kftw49tj",1940428698,0.675,822175370,0.286,1118253328,0.389,"46be2946-a6f4-426a-a589-3a616cb77eca","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.613000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4eed","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d0246682-f768-4b77-b475-68d9094a705d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5o5","pgxind-kftx3f95","pgxcs-kftw4al7",1774011153,0.617,874004567,0.304,900006586,0.313,"d0246682-f768-4b77-b475-68d9094a705d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.683000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4f12","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80c1a2ac-afff-46c8-b4a6-8f2f46f32211","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5pw","pgxind-kftx3ts9","pgxcs-kftw4b3a",2099979925,0.73,789924984,0.275,1310054941,0.456,"80c1a2ac-afff-46c8-b4a6-8f2f46f32211","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.735000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5067","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-05ecd44b-5e88-47fd-9b4b-566ac6160acf","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi65f","pgxind-kftx3vc4","pgxcs-kftw4g31",93897340,0.033,70138519,0.024,23758821,0.008,"05ecd44b-5e88-47fd-9b4b-566ac6160acf","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.213000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a509a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a5697d2c-8e1a-42be-8ebf-e57d6919ba65","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi67r","pgxind-kftx3vyh","pgxcs-kftw4gv4",1358169217,0.472,976750279,0.34,381418938,0.133,"a5697d2c-8e1a-42be-8ebf-e57d6919ba65","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.285000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a50e5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi6b4","pgxind-kftx3ueq","pgxcs-kftw4hzf",1633487118,0.568,948924216,0.33,684562902,0.238,"96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:14.389000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a50f2","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-784414b9-1f18-4c31-a062-6e5048482e78","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi6bp","pgxind-kftx3qos","pgxcs-kftw4i5y",202417225,0.07,38183748,0.013,164233477,0.057,"784414b9-1f18-4c31-a062-6e5048482e78","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.407000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a510f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-af8434cf-5c2f-48cc-b3ac-132dfb505dbd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi6d1","pgxind-kftx3i3c","pgxcs-kftw4iki",1568328654,0.546,648218419,0.225,920110235,0.32,"af8434cf-5c2f-48cc-b3ac-132dfb505dbd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:14.449000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5118","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2faec76f-76eb-4beb-9b30-02f8fd087fd7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi6df","pgxind-kftx3fbl","pgxcs-kftw4iox",130866471,0.046,36909719,0.013,93956752,0.033,"2faec76f-76eb-4beb-9b30-02f8fd087fd7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.461000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5166","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b6852026-f3ff-4830-b9d6-a998adce6fdd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi6gz","pgxind-kftx3iit","pgxcs-kftw4jtt",1970578710,0.685,911526178,0.317,1059052532,0.368,"b6852026-f3ff-4830-b9d6-a998adce6fdd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:14.570000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a523a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-567ffcaa-e226-438a-8fb7-184dd6f563ae","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi6ql","pgxind-kftx3ucx","pgxcs-kftw4n0t",1677769074,0.584,769749497,0.268,908019577,0.316,"567ffcaa-e226-438a-8fb7-184dd6f563ae","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:14.876000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5288","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-906f883b-ef84-415f-87f6-e248a6ecb9cf","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi6u5","pgxind-kftx3tez","pgxcs-kftw4o4b",648219894,0.225,179414096,0.062,468805798,0.163,"906f883b-ef84-415f-87f6-e248a6ecb9cf","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:14.991000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a529f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-9e87fc03-44ab-4561-b4d5-1e4592b58d66","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi6v6","pgxind-kftx3sku","pgxcs-kftw4oi5",2149355141,0.748,1072582729,0.373,1076772412,0.375,"9e87fc03-44ab-4561-b4d5-1e4592b58d66","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:15.024000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a52e8","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1548e53f-f0dd-4a13-825d-093345664406","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi6yg","pgxind-kftx3gp0","pgxcs-kftw4plg",2066011112,0.719,878724821,0.306,1187286291,0.413,"1548e53f-f0dd-4a13-825d-093345664406","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:15.128000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a52f1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi6yv","pgxind-kftx3icq","pgxcs-kftw4ppx",2524011527,0.878,1030425828,0.358,1493585699,0.52,"7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.141000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5435","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-06990702-c200-403c-ad6f-5cb78a15bf55","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi7dg","pgxind-kftx3i5l","pgxcs-kftw4ufg",1747299411,0.608,693243041,0.241,1054056370,0.367,"06990702-c200-403c-ad6f-5cb78a15bf55","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.591000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5637","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f53143de-2704-4638-94e2-3661c1dbb3b9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi80v","pgxind-kftx3n5l","pgxcs-kftw51yk",2179057948,0.758,901534015,0.314,1277523933,0.444,"f53143de-2704-4638-94e2-3661c1dbb3b9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:16.310000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a566a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi83a","pgxind-kftx3spo","pgxcs-kftw52rb",1618952613,0.563,527548684,0.183,1091403929,0.38,"30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.380000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a57ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1c323559-f2d0-480b-9dab-9ac014fa9c41","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi8j8","pgxind-kftx3t5i","pgxcs-kftw57w0",1066954044,0.371,347971391,0.121,718982653,0.25,"1c323559-f2d0-480b-9dab-9ac014fa9c41","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.869000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5839","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-980d8a35-44ef-415f-b7b2-89a4bc18515b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi8o8","pgxind-kftx3pnl","pgxcs-kftw59gp",1705807032,0.593,791809429,0.275,913997603,0.318,"980d8a35-44ef-415f-b7b2-89a4bc18515b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:17.024000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a58ad","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-988185cf-a54c-4335-a4ab-f59ce3a470ea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.9","Corpus uteri","pgxbs-kftvi8tg","pgxind-kftx3vbs","pgxcs-kftw5b7f",2429697265,0.845,636302559,0.221,1793394706,0.624,"988185cf-a54c-4335-a4ab-f59ce3a470ea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:45:17.189000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5a3c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-784f6b88-9046-4fff-b061-81ee0bb27392","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi9kx","pgxind-kftx3m0j","pgxcs-kftw5gyv",2151668254,0.748,1083826448,0.377,1067841806,0.371,"784f6b88-9046-4fff-b061-81ee0bb27392","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:17.750000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5b1b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-44a95fa6-eb07-4d7f-aa82-a0146f782d53","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.0","Connective, Subcutaneous and other soft tissues of head, face, and neck","pgxbs-kftvi9v2","pgxind-kftx3tyn","pgxcs-kftw5k9g",2123646874,0.739,909508774,0.316,1214138100,0.422,"44a95fa6-eb07-4d7f-aa82-a0146f782d53","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003566","head connective tissue","{}","2020-09-10 17:45:18.064000",,,,,,,,,,,"TCGA-SARC","TCGA-SARC project","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c865cb309d374f2dc2fb445","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievq","pgxind-kftx42ok","pgxcs-kftw749p",940263124,0.327,378705952,0.132,561557172,0.195,"PGX_AM_BS_GSM197635","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.088000",,,,,,,,"P66Y",,,"geo:GSE8046","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM197635","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.9,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c865cb309d374f2dc2fb448","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievv","pgxind-kftx42oq","pgxcs-kftw74b5",1679511679,0.584,663457338,0.231,1016054341,0.353,"PGX_AM_BS_GSM198510","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.092000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198510","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb449","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievx","pgxind-kftx42os","pgxcs-kftw74bn",1559887469,0.543,722728318,0.251,837159151,0.291,"PGX_AM_BS_GSM198600","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.094000",,,,,,,,,,,"geo:GSE8046","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198600","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c865cb309d374f2dc2fb44a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievy","pgxind-kftx42ou","pgxcs-kftw74c5",1675245781,0.583,844253896,0.294,830991885,0.289,"PGX_AM_BS_GSM198601","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.095000",,,,,,,,"P72Y",,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198601","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c865cb309d374f2dc2fb44b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftview0","pgxind-kftx42ow","pgxcs-kftw74cn",780481982,0.271,489259010,0.17,291222972,0.101,"PGX_AM_BS_GSM198614","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.097000",,,,,,,,"P76Y",,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198614","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb455","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM198674","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewh","pgxind-kftx42pg","pgxcs-kftw74hg",1290218754,0.449,623486605,0.217,666732149,0.232,"PGX_AM_BS_GSM198674","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.111000",,,,,,,,"P78Y",,,"PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8046","",,,,,"geo:gpl","geo:GPL2005","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb459","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewn","pgxind-kftx42pp","pgxcs-kftw74je",985382943,0.343,415514970,0.145,569867973,0.198,"PGX_AM_BS_GSM198678","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.116000",,,,,,,,"P60Y",,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,,"geo:gsm","geo:GSM198678","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb45a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewp","pgxind-kftx42pr","pgxcs-kftw74jv",1171231880,0.407,504390290,0.175,666841590,0.232,"PGX_AM_BS_GSM198679","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.118000",,,,,,,,"P69Y",,,"geo:GSE8046","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198679","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb45b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewr","pgxind-kftx42pt","pgxcs-kftw74kd",1363982958,0.474,557153487,0.194,806829471,0.281,"PGX_AM_BS_GSM198680","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.119000",,,,,,,,"P69Y",,,"geo:GSE8046","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL2005","",,,,,"geo:gsm","geo:GSM198680","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865cb309d374f2dc2fb45c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviews","pgxind-kftx42pv","pgxcs-kftw74ku",1536520444,0.534,556337795,0.194,980182649,0.341,"PGX_AM_BS_GSM198681","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.121000",,,,,,,,"P69Y",,,"geo:GSE8046","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"geo:gsm","geo:GSM198681","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c865da009d374f2dc316269","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSE12439","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii64","pgxind-kftx46pw","pgxcs-kftw84iq",512578855,0.178,411561091,0.143,101017764,0.035,"PGX_AM_BS_GSM312343","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.787000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312343","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc31626c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312346","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii69","pgxind-kftx46q2","pgxcs-kftw84k8",1115100387,0.388,528124344,0.184,586976043,0.204,"PGX_AM_BS_GSM312346","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.791000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12439","",,,,,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc31626d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6b","pgxind-kftx46q4","pgxcs-kftw84kq",232834863,0.081,222136862,0.077,10698001,0.004,"PGX_AM_BS_GSM312347","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.792000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312347","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc31626f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6e","pgxind-kftx46q8","pgxcs-kftw84lp",2122922120,0.738,1455589607,0.506,667332513,0.232,"PGX_AM_BS_GSM312349","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.795000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312349","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc316274","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312354","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6m","pgxind-kftx46qi","pgxcs-kftw84o3",634980010,0.221,463458840,0.161,171521170,0.06,"PGX_AM_BS_GSM312354","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.802000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc316276","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6q","pgxind-kftx46qm","pgxcs-kftw84p2",1712668274,0.596,746343140,0.26,966325134,0.336,"PGX_AM_BS_GSM312356","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.805000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312356","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc316278","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6t","pgxind-kftx46qq","pgxcs-kftw84q0",1806171104,0.628,731301668,0.254,1074869436,0.374,"PGX_AM_BS_GSM312358","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.808000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312358","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc316279","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6v","pgxind-kftx46qs","pgxcs-kftw84qi",1628029635,0.566,1128501297,0.393,499528338,0.174,"PGX_AM_BS_GSM312359","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.810000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312359","","arraymap import",,,,,,,,,,,,,,,
"5c865da009d374f2dc31627b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6y","pgxind-kftx46qw","pgxcs-kftw84tb",2125269965,0.739,1265520484,0.44,859749481,0.299,"PGX_AM_BS_GSM312361","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.813000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM312361","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc31627c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312362","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6z","pgxind-kftx46qy","pgxcs-kftw84tt",767266714,0.267,516594261,0.18,250672453,0.087,"PGX_AM_BS_GSM312362","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.814000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc316288","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312374","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7j","pgxind-kftx46rm","pgxcs-kftw84zm",2429798533,0.845,1492887556,0.519,936910977,0.326,"PGX_AM_BS_GSM312374","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.831000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc316289","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7k","pgxind-kftx46ro","pgxcs-kftw8504",1009406540,0.351,637966714,0.222,371439826,0.129,"PGX_AM_BS_GSM312375","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.832000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312375","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc31628c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312378","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7p","pgxind-kftx46ru","pgxcs-kftw851k",1261959811,0.439,669398290,0.233,592561521,0.206,"PGX_AM_BS_GSM312378","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.836000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc316290","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7w","pgxind-kftx46s2","pgxcs-kftw853i",1813458566,0.631,783031554,0.272,1030427012,0.358,"PGX_AM_BS_GSM312382","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.842000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312382","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc316291","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312383","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7y","pgxind-kftx46s4","pgxcs-kftw8540",533000147,0.185,322695382,0.112,210304765,0.073,"PGX_AM_BS_GSM312383","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.844000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc316293","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii81","pgxind-kftx46s8","pgxcs-kftw854y",1046930790,0.364,807039657,0.281,239891133,0.083,"PGX_AM_BS_GSM312385","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.846000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312385","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc31629a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSE12439","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8d","pgxind-kftx46sm","pgxcs-kftw858b",1885133806,0.656,943714840,0.328,941418966,0.327,"PGX_AM_BS_GSM312392","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.856000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312392","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc31629c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8g","pgxind-kftx46sq","pgxcs-kftw859a",373296581,0.13,219111794,0.076,154184787,0.054,"PGX_AM_BS_GSM312394","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.859000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,,"geo:gsm","geo:GSM312394","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc31629e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8j","pgxind-kftx46su","pgxcs-kftw85a9",416576281,0.145,34879375,0.012,381696906,0.133,"PGX_AM_BS_GSM312396","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.861000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM312396","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312398","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8n","pgxind-kftx46sy","pgxcs-kftw85bc",152203870,0.053,137811247,0.048,14392623,0.005,"PGX_AM_BS_GSM312398","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.864000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8q","pgxind-kftx46t3","pgxcs-kftw85cb",697001109,0.242,572592960,0.199,124408149,0.043,"PGX_AM_BS_GSM312400","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.867000",,,,,,,,,,,"geo:GSE12439","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM312400","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSE12439","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8t","pgxind-kftx46t7","pgxcs-kftw85db",449718610,0.156,374500837,0.13,75217773,0.026,"PGX_AM_BS_GSM312402","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.870000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"geo:gsm","geo:GSM312402","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312403","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8v","pgxind-kftx46t9","pgxcs-kftw85dt",1003196336,0.349,490138598,0.17,513057738,0.178,"PGX_AM_BS_GSM312403","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.871000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315237","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii91","pgxind-kftx46th","pgxcs-kftw85fr",1520315510,0.529,698227293,0.243,822088217,0.286,"PGX_AM_BS_GSM315237","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.877000",,,,,,,,,,,"geo:GPL7203","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,
"5c865da209d374f2dc3162ab","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315239","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii95","pgxind-kftx46tl","pgxcs-kftw85gq",2699662705,0.939,1014365662,0.353,1685297043,0.586,"PGX_AM_BS_GSM315239","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.880000",,,,,,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL7203","",,,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,
"5c865dab09d374f2dc317a0b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","myxoinflammatory fibroblastic sarcoma","PMID:19199331","Hallor KH, Sciot R et al. (2009): Two genetic pathways, t(1;10) and amplification...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviibu","pgxind-kftx46ww","pgxcs-kftw86bd",556887456,0.194,488646126,0.17,68241330,0.024,"PGX_AM_BS_GSM315710","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:27.965000",,,,,,,,,,,"geo:GSE12593","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM315710","","arraymap import",,,,,,,,,,,,,,,
"5c865dab09d374f2dc317a0c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","myxoinflammatory fibroblastic sarcoma","geo:GSM315711","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviibw","pgxind-kftx46wy","pgxcs-kftw86bu",776292502,0.27,501317083,0.174,274975419,0.096,"PGX_AM_BS_GSM315711","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:27.967000",,,,,,,,,,,"PMID:19199331","Hallor KH, Sciot R et al. (2009): Two genetic pathways, t(1;10) and amplification...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12593","",,,,,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,
"5c865dbe09d374f2dc318d1b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322063","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviilu","pgxind-kftx4798","pgxcs-kftw89d4",1603708719,0.558,833238141,0.29,770470578,0.268,"PGX_AM_BS_GSM322063","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.277000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12830","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d22","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim5","pgxind-kftx479m","pgxcs-kftw89gh",1486175803,0.517,860328301,0.299,625847502,0.218,"PGX_AM_BS_GSM322076","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.287000",,,,,,,,,,,"geo:GSE12830","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM322076","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d23","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322077","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim7","pgxind-kftx479o","pgxcs-kftw89gz",1003604095,0.349,842072053,0.293,161532042,0.056,"PGX_AM_BS_GSM322077","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.289000",,,,,,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d24","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322078","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim8","pgxind-kftx479q","pgxcs-kftw89hg",1008394991,0.351,845384857,0.294,163010134,0.057,"PGX_AM_BS_GSM322078","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.290000",,,,,,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322079","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviima","pgxind-kftx479s","pgxcs-kftw89hy",1511156054,0.526,875068180,0.304,636087874,0.221,"PGX_AM_BS_GSM322079","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.292000",,,,,,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL4091","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimc","pgxind-kftx479u","pgxcs-kftw89ig",1584602300,0.551,869442765,0.302,715159535,0.249,"PGX_AM_BS_GSM322086","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.293000",,,,,,,,,,,"geo:GSE12830","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM322086","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322087","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimd","pgxind-kftx479w","pgxcs-kftw89iy",1356898124,0.472,1010844155,0.352,346053969,0.12,"PGX_AM_BS_GSM322087","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.295000",,,,,,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d28","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322088","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimf","pgxind-kftx479y","pgxcs-kftw89jf",1473578856,0.513,1044495155,0.363,429083701,0.149,"PGX_AM_BS_GSM322088","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.296000",,,,,,,,,,,"geo:GSE12830","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d29","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322089","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimg","pgxind-kftx47a0","pgxcs-kftw89jx",2170434741,0.755,1290913247,0.449,879521494,0.306,"PGX_AM_BS_GSM322089","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.298000",,,,,,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE12830","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d2b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL4091","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimk","pgxind-kftx47a4","pgxcs-kftw89kf",1884082055,0.655,1118815556,0.389,765266499,0.266,"PGX_AM_BS_GSM322090","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.301000",,,,,,,,,,,"geo:GSE12830","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM322090","","arraymap import",,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d2d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimn","pgxind-kftx47a8","pgxcs-kftw89md",1729726793,0.602,927149153,0.322,802577640,0.279,"PGX_AM_BS_GSM322094","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.304000",,,,,,,,,,,"geo:GSE12830","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM322094","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a450","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip2","pgxind-kftx47d7","pgxcs-kftw8adz",1373064874,0.478,1169288630,0.407,203776244,0.071,"PGX_AM_BS_GSM346704","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.378000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,,"geo:gsm","geo:GSM346704","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a457","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipd","pgxind-kftx47dl","pgxcs-kftw8ahf",1392977415,0.485,1205924838,0.419,187052577,0.065,"PGX_AM_BS_GSM346711","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.388000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,,"geo:gsm","geo:GSM346711","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346715","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipk","pgxind-kftx47dt","pgxcs-kftw8ajf",1424348389,0.495,1275125112,0.444,149223277,0.052,"PGX_AM_BS_GSM346715","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.394000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346716","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipl","pgxind-kftx47dv","pgxcs-kftw8ajx",932248306,0.324,883461545,0.307,48786761,0.017,"PGX_AM_BS_GSM346716","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.395000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a45d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346717","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipn","pgxind-kftx47dx","pgxcs-kftw8akf",622077715,0.216,160507523,0.056,461570192,0.161,"PGX_AM_BS_GSM346717","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.397000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a463","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipx","pgxind-kftx47e9","pgxcs-kftw8ang",121834461,0.042,76990368,0.027,44844093,0.016,"PGX_AM_BS_GSM346723","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.405000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM346723","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a468","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346728","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq5","pgxind-kftx47ek","pgxcs-kftw8apu",377144692,0.131,11197996,0.004,365946696,0.127,"PGX_AM_BS_GSM346728","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.412000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a469","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346729","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq7","pgxind-kftx47em","pgxcs-kftw8aqc",1607626124,0.559,1348305301,0.469,259320823,0.09,"PGX_AM_BS_GSM346729","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.414000",,,,,,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,,"geo:gse","geo:GSE13775","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346730","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiq8","pgxind-kftx47eo","pgxcs-kftw8aqt",1156603218,0.402,292481903,0.102,864121315,0.301,"PGX_AM_BS_GSM346730","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.415000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqa","pgxind-kftx47eq","pgxcs-kftw8arb",478491923,0.166,414454675,0.144,64037248,0.022,"PGX_AM_BS_GSM346731","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.417000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346731","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqc","pgxind-kftx47es","pgxcs-kftw8ars",789218621,0.275,458748504,0.16,330470117,0.115,"PGX_AM_BS_GSM346732","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.418000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM346732","","arraymap import",,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a470","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSE13775","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqi","pgxind-kftx47f0","pgxcs-kftw8atr",1005897874,0.35,173282832,0.06,832615042,0.29,"PGX_AM_BS_GSM346736","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.424000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346736","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a472","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqm","pgxind-kftx47f4","pgxcs-kftw8aup",836545678,0.291,683552322,0.238,152993356,0.053,"PGX_AM_BS_GSM346738","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.426000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM346738","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a473","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSE13775","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqn","pgxind-kftx47f6","pgxcs-kftw8av7",1145351518,0.398,911886247,0.317,233465271,0.081,"PGX_AM_BS_GSM346739","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.428000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346739","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a474","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqp","pgxind-kftx47f8","pgxcs-kftw8avo",1683322260,0.586,295768307,0.103,1387553953,0.483,"PGX_AM_BS_GSM346740","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.429000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,,"geo:gsm","geo:GSM346740","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a476","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqs","pgxind-kftx47fc","pgxcs-kftw8awn",1360906017,0.473,1258349440,0.438,102556577,0.036,"PGX_AM_BS_GSM346742","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.432000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"geo:gsm","geo:GSM346742","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a477","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346743","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqu","pgxind-kftx47fe","pgxcs-kftw8ax5",1655178645,0.576,1452049150,0.505,203129495,0.071,"PGX_AM_BS_GSM346743","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.434000",,,,,,,,,,,"geo:GPL4723","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a47a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqz","pgxind-kftx47fk","pgxcs-kftw8b0e",883422645,0.307,794735722,0.276,88686923,0.031,"PGX_AM_BS_GSM346746","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.438000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,,"geo:gsm","geo:GSM346746","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a47b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346747","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviir0","pgxind-kftx47fm","pgxcs-kftw8b0w",1300423455,0.452,1132548257,0.394,167875198,0.058,"PGX_AM_BS_GSM346747","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.439000",,,,,,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE13775","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL4723","","arraymap import",,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a47d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346749","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviir3","pgxind-kftx47fq","pgxcs-kftw8b1v",217478606,0.076,158711827,0.055,58766779,0.02,"PGX_AM_BS_GSM346749","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.442000",,,,,,,,,,,"geo:GSE13775","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,
"5c865eaa09d374f2dc32ee4a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma [cell line RD]","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","embryonal rhabdomyosarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvilyi","pgxind-kftx4b0l","pgxcs-kftw97dq",1184624921,0.412,432620191,0.15,752004730,0.262,"PGX_AM_BS_GSM185149","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002113","kidney","{}","2020-09-10 17:45:31.691000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"cellosaurus","cellosaurus:CVCL_1649","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM185149","",,,,
"5c865eaa09d374f2dc32ee4b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GPL4894","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvilyk","pgxind-kftx4b0n","pgxcs-kftw97e7",542962290,0.189,221283148,0.077,321679142,0.112,"PGX_AM_BS_GSM185150","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:31.692000",,,,,,,,,,,"geo:GSE7692","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM185150","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0548","",,,,
"5c865eac09d374f2dc32ee90","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM185219","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvim1p","pgxind-kftx4b4l","pgxcs-kftw98dz",178608425,0.062,111617316,0.039,66991109,0.023,"PGX_AM_BS_GSM185219","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:31.791000",,,,,,,,,,,"PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gse","geo:GSE7692","",,,,,"geo:gpl","geo:GPL4894","","arraymap import",,,,,,,,,,,,,,,
"5c865eb109d374f2dc32ef7f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimco","pgxind-kftx4bi2","pgxcs-kftw9bp2",1121069329,0.39,646305059,0.225,474764270,0.165,"PGX_AM_BS_GSM186426","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.125000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"cellosaurus","cellosaurus:CVCL_2544","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM186426","",,,,
"5c865eb109d374f2dc32ef80","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvimcq","pgxind-kftx4bi4","pgxcs-kftw9bpk",1666468642,0.58,941732408,0.328,724736234,0.252,"PGX_AM_BS_GSM186427","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.127000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE7692","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM186427","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_2544","",,,,
"5c865eb109d374f2dc32ef93","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma [cell line RD]","geo:GPL4894","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","embryonal rhabdomyosarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimdl","pgxind-kftx4bj6","pgxcs-kftw9c0z",1047364334,0.364,396206636,0.138,651157698,0.226,"PGX_AM_BS_GSM186446","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.155000",,,,,,,,,,,"geo:GSE7692","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM186446","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_1649","",,,,
"5c865eb109d374f2dc32ef96","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma [cell line Rh30]","cellosaurus:CVCL_0041","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdq","pgxind-kftx4bjc","pgxcs-kftw9c2h",515625954,0.179,291871002,0.102,223754952,0.078,"PGX_AM_BS_GSM186449","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.159000",,,,,,,,,,,"geo:GSM186449","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4894","",,,,
"5c865eb109d374f2dc32ef98","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma [cell line Rh30]","cellosaurus:CVCL_0041","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdt","pgxind-kftx4bjg","pgxcs-kftw9c3g",606620281,0.211,322583424,0.112,284036857,0.099,"PGX_AM_BS_GSM186451","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.162000",,,,,,,,,,,"geo:GSM186451","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL4894","",,,,,"geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,
"5c865eb309d374f2dc32efd3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C76.2","abdomen, NOS","pgxbs-kftvimgh","pgxind-kftx4bms","pgxcs-kftw9cw8",1226504892,0.427,564714125,0.196,661790767,0.23,"PGX_AM_BS_GSM186533","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000916","abdomen","{}","2020-09-10 17:45:32.248000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM186533","","arraymap import",,,,,,,,,,,,,,,
"5c865eb309d374f2dc32efdd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM186543","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C62.9","testis","pgxbs-kftvimgx","pgxind-kftx4bnd","pgxcs-kftw9d12",129142112,0.045,129142112,0.045,0,0,"PGX_AM_BS_GSM186543","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000473","testis","{}","2020-09-10 17:45:32.263000",,,,,,,,,,,"geo:GSE7692","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL4894","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,
"5c865eb309d374f2dc32eff2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM186568","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, nos","pgxbs-kftvimhv","pgxind-kftx4bok","pgxcs-kftw9dd9",152612702,0.053,80889659,0.028,71723043,0.025,"PGX_AM_BS_GSM186568","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.293000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE7692","",,,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f038","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviml2","pgxind-kftx4bsj","pgxcs-kftw9ebb",368544587,0.128,3627852,0.001,364916735,0.127,"PGX_AM_BS_GSM186641","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:32.389000",,,,,,,,,,,"geo:GSE7692","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","geo:gse","geo:gpl","geo:GPL4894","",,,,,"geo:gsm","geo:GSM186641","","arraymap import",,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f050","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, nos","pgxbs-kftvimm5","pgxind-kftx4btw","pgxcs-kftw9ep4",276344419,0.096,218701157,0.076,57643262,0.02,"PGX_AM_BS_GSM186665","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.423000",,,,,,,,,,,"geo:GPL4894","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"geo:gsm","geo:GSM186665","","arraymap import",,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da6c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinoi","pgxind-kftx4d4z","pgxcs-kftw9qo1",272880734,0.095,118044460,0.041,154836274,0.054,"PGX_AM_BS_GSM475469","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.608000",,,,,,,,,,,"geo:GSE19180","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...",,,,,"geo:gsm","geo:GSM475469","","arraymap import",,,,,,,,,,,,,,,
"5c865f1f09d374f2dc33e2fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSE11411","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqr","pgxind-kftx4d7r","pgxcs-kftw9rd0",1655331216,0.576,686401728,0.239,968929488,0.337,"PGX_AM_BS_GSM287989","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.677000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM287989","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0042","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c865f1f09d374f2dc33e2fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSM287990","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqt","pgxind-kftx4d7u","pgxcs-kftw9rdi",1865776283,0.649,725469507,0.252,1140306776,0.397,"PGX_AM_BS_GSM287990","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.678000",,,,,,,,,,,"cellosaurus:CVCL_0042","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE11411","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4091","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c865fd909d374f2dc35ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2i","pgxind-kftx4g3m","pgxcs-kftwah4c",1446761250,0.503,628127728,0.218,818633522,0.285,"PGX_AM_BS_GSM484746","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.693000",,,,,,,,,,,"geo:GSE19449","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,,"geo:gsm","geo:GSM484746","","arraymap import",0.68,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aa6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528896","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuws","pgxind-kftx4m2f","pgxcs-kftwbypq",974120280,0.339,543813734,0.189,430306546,0.15,"PGX_AM_BS_GSM528896","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.124000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aa7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwu","pgxind-kftx4m2h","pgxcs-kftwbyq8",872467567,0.303,554894499,0.193,317573068,0.11,"PGX_AM_BS_GSM528897","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.126000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528897","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aa9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwx","pgxind-kftx4m2l","pgxcs-kftwbytd",867051743,0.302,436161882,0.152,430889861,0.15,"PGX_AM_BS_GSM528899","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.129000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528899","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aaa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528900","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwz","pgxind-kftx4m2n","pgxcs-kftwbytz",558287817,0.194,290667184,0.101,267620633,0.093,"PGX_AM_BS_GSM528900","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.130000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.36,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviux2","pgxind-kftx4m2r","pgxcs-kftwbyuz",1256721844,0.437,672245684,0.234,584476160,0.203,"PGX_AM_BS_GSM528902","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.133000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528902","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7ab1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528907","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxb","pgxind-kftx4m32","pgxcs-kftwbyxe",869174276,0.302,506158240,0.176,363016036,0.126,"PGX_AM_BS_GSM528907","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.140000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aba","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxp","pgxind-kftx4m3k","pgxcs-kftwbz1q",502213588,0.175,291823473,0.102,210390115,0.073,"PGX_AM_BS_GSM528916","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.153000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528916","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7abb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxr","pgxind-kftx4m3m","pgxcs-kftwbz28",1246886353,0.434,593623791,0.206,653262562,0.227,"PGX_AM_BS_GSM528917","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.155000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528917","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7abc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxt","pgxind-kftx4m3o","pgxcs-kftwbz2p",650159485,0.226,424194664,0.148,225964821,0.079,"PGX_AM_BS_GSM528918","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.156000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528918","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5c86618709d374f2dc3b7ac2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuy3","pgxind-kftx4m40","pgxcs-kftwbz5l",194279239,0.068,138223724,0.048,56055515,0.019,"PGX_AM_BS_GSM528924","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.164000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM528924","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618709d374f2dc3b7aca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528932","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyh","pgxind-kftx4m4h","pgxcs-kftwbz9f",371625461,0.129,254548366,0.089,117077095,0.041,"PGX_AM_BS_GSM528932","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.176000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618809d374f2dc3b7acd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuym","pgxind-kftx4m4n","pgxcs-kftwbzav",1397122176,0.486,621179273,0.216,775942903,0.27,"PGX_AM_BS_GSM528935","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.181000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528935","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618809d374f2dc3b7ad0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyr","pgxind-kftx4m4t","pgxcs-kftwbzcd",707249318,0.246,441923923,0.154,265325395,0.092,"PGX_AM_BS_GSM528938","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.185000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528938","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618809d374f2dc3b7aec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv02","pgxind-kftx4m6e","pgxcs-kftwbzpz",1940276534,0.675,728166677,0.253,1212109857,0.422,"PGX_AM_BS_GSM528966","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.226000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM528966","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618809d374f2dc3b7aef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528993","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv07","pgxind-kftx4m6k","pgxcs-kftwc05f",1209459183,0.421,273152361,0.095,936306822,0.326,"PGX_AM_BS_GSM528993","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.230000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618809d374f2dc3b7af0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528970","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv08","pgxind-kftx4m6m","pgxcs-kftwbzry",1861573338,0.648,754558315,0.262,1107015023,0.385,"PGX_AM_BS_GSM528970","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.231000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618809d374f2dc3b7af1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528971","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0a","pgxind-kftx4m6o","pgxcs-kftwbzsg",1457744546,0.507,586873049,0.204,870871497,0.303,"PGX_AM_BS_GSM528971","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.233000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618809d374f2dc3b7afb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528981","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0r","pgxind-kftx4m78","pgxcs-kftwbzxc",2186446171,0.761,970786114,0.338,1215660057,0.423,"PGX_AM_BS_GSM528981","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.248000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE21123","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7afc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0s","pgxind-kftx4m7a","pgxcs-kftwbzxu",164272598,0.057,69879365,0.024,94393233,0.033,"PGX_AM_BS_GSM528982","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.249000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM528982","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c86618909d374f2dc3b7b00","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528986","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0z","pgxind-kftx4m7i","pgxcs-kftwc01w",491689290,0.171,330087416,0.115,161601874,0.056,"PGX_AM_BS_GSM528986","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.255000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b03","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv14","pgxind-kftx4m7p","pgxcs-kftwc03y",1789968933,0.623,875424292,0.304,914544641,0.318,"PGX_AM_BS_GSM528990","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.259000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM528990","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b04","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv16","pgxind-kftx4m7r","pgxcs-kftwc04g",548143024,0.191,201105134,0.07,347037890,0.121,"PGX_AM_BS_GSM528991","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.260000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528991","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b06","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv19","pgxind-kftx4m7v","pgxcs-kftwbzrg",1355785207,0.472,618306950,0.215,737478257,0.257,"PGX_AM_BS_GSM528969","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.263000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM528969","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b07","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528994","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1b","pgxind-kftx4m7x","pgxcs-kftwc05w",1750658560,0.609,856190758,0.298,894467802,0.311,"PGX_AM_BS_GSM528994","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.265000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1c","pgxind-kftx4m7z","pgxcs-kftwc06e",2306120958,0.802,886774093,0.308,1419346865,0.494,"PGX_AM_BS_GSM528995","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.266000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528995","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618909d374f2dc3b7b0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528997","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1f","pgxind-kftx4m83","pgxcs-kftwc07d",1867043815,0.649,976176364,0.34,890867451,0.31,"PGX_AM_BS_GSM528997","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.269000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b0b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1h","pgxind-kftx4m85","pgxcs-kftwc07v",2117571983,0.737,1080698475,0.376,1036873508,0.361,"PGX_AM_BS_GSM528998","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.271000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM528998","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b0d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1k","pgxind-kftx4m89","pgxcs-kftwc08u",1095778207,0.381,540899245,0.188,554878962,0.193,"PGX_AM_BS_GSM529000","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.274000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529000","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b0e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529001","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1m","pgxind-kftx4m8b","pgxcs-kftwc09c",1220876441,0.425,613073042,0.213,607803399,0.211,"PGX_AM_BS_GSM529001","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.275000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b10","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1p","pgxind-kftx4m8f","pgxcs-kftwc0aa",1727542646,0.601,903488830,0.314,824053816,0.287,"PGX_AM_BS_GSM529003","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.278000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529003","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b16","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529009","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1z","pgxind-kftx4m8s","pgxcs-kftwc0d7",380770712,0.132,194061548,0.067,186709164,0.065,"PGX_AM_BS_GSM529009","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.287000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618909d374f2dc3b7b18","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv23","pgxind-kftx4m8w","pgxcs-kftwc0e6",1576923678,0.548,889411666,0.309,687512012,0.239,"PGX_AM_BS_GSM529011","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.290000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529011","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618909d374f2dc3b7b1b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv28","pgxind-kftx4m92","pgxcs-kftwc0fn",1231986880,0.429,514741341,0.179,717245539,0.249,"PGX_AM_BS_GSM529014","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.295000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529014","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b1c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv29","pgxind-kftx4m94","pgxcs-kftwc0g5",1073073661,0.373,561027182,0.195,512046479,0.178,"PGX_AM_BS_GSM529015","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.296000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529015","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b1f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2e","pgxind-kftx4m9a","pgxcs-kftwc0hm",1054925764,0.367,593703640,0.207,461222124,0.16,"PGX_AM_BS_GSM529018","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.301000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529018","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b20","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529019","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2g","pgxind-kftx4m9c","pgxcs-kftwc0i3",1794934108,0.624,978942926,0.341,815991182,0.284,"PGX_AM_BS_GSM529019","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.302000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b21","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529020","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2h","pgxind-kftx4m9e","pgxcs-kftwc0il",893737865,0.311,260843742,0.091,632894123,0.22,"PGX_AM_BS_GSM529020","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.304000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b22","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529021","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2j","pgxind-kftx4m9g","pgxcs-kftwc0j3",896382609,0.312,620451483,0.216,275931126,0.096,"PGX_AM_BS_GSM529021","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.305000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b23","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529022","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2l","pgxind-kftx4m9i","pgxcs-kftwc0jk",2044828919,0.711,1075418942,0.374,969409977,0.337,"PGX_AM_BS_GSM529022","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.307000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618909d374f2dc3b7b25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2o","pgxind-kftx4m9m","pgxcs-kftwc0kk",1312388937,0.456,692273985,0.241,620114952,0.216,"PGX_AM_BS_GSM529024","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.310000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529024","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2q","pgxind-kftx4m9o","pgxcs-kftwc0l2",785575096,0.273,355971277,0.124,429603819,0.149,"PGX_AM_BS_GSM529025","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.311000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529025","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2r","pgxind-kftx4m9q","pgxcs-kftwc0lj",979023009,0.341,464615561,0.162,514407448,0.179,"PGX_AM_BS_GSM529026","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.313000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529026","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618909d374f2dc3b7b28","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","geo:GSM529027","","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2t","pgxind-kftx4m9s","pgxcs-kftwc0m0",320218539,0.111,958649,0,319259890,0.111,"PGX_AM_BS_GSM529027","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.314000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b3d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529048","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3r","pgxind-kftx4may","pgxcs-kftwc0w4",957599876,0.333,412481912,0.143,545117964,0.19,"PGX_AM_BS_GSM529048","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.344000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b3e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3t","pgxind-kftx4mb0","pgxcs-kftwc0wm",1257349209,0.437,528934984,0.184,728414225,0.253,"PGX_AM_BS_GSM529049","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.345000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529049","","arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b3f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529050","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3v","pgxind-kftx4mb2","pgxcs-kftwc0x3",1864720773,0.649,956500278,0.333,908220495,0.316,"PGX_AM_BS_GSM529050","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.347000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b40","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3w","pgxind-kftx4mb4","pgxcs-kftwc0xl",1769689043,0.616,914620537,0.318,855068506,0.297,"PGX_AM_BS_GSM529051","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.348000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529051","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b41","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3y","pgxind-kftx4mb6","pgxcs-kftwc0y2",1544310096,0.537,694726706,0.242,849583390,0.296,"PGX_AM_BS_GSM529052","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.350000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,,"geo:gsm","geo:GSM529052","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b42","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3z","pgxind-kftx4mb9","pgxcs-kftwc0yk",1677421117,0.583,843284351,0.293,834136766,0.29,"PGX_AM_BS_GSM529053","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.351000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529053","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b44","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529055","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv43","pgxind-kftx4mbd","pgxcs-kftwc0zk",1483840337,0.516,710264537,0.247,773575800,0.269,"PGX_AM_BS_GSM529055","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.354000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b45","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv44","pgxind-kftx4mbf","pgxcs-kftwc102",948980411,0.33,426337091,0.148,522643320,0.182,"PGX_AM_BS_GSM529056","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.356000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529056","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b47","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529058","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv48","pgxind-kftx4mbj","pgxcs-kftwc112",1716942191,0.597,795488582,0.277,921453609,0.321,"PGX_AM_BS_GSM529058","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.359000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b48","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv49","pgxind-kftx4mbl","pgxcs-kftwc11k",1448360581,0.504,760231374,0.264,688129207,0.239,"PGX_AM_BS_GSM529059","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.360000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529059","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b49","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4b","pgxind-kftx4mbn","pgxcs-kftwc121",1440426837,0.501,820282231,0.285,620144606,0.216,"PGX_AM_BS_GSM529060","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.361000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,,"geo:gsm","geo:GSM529060","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b4a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529061","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4d","pgxind-kftx4mbp","pgxcs-kftwc12j",1584242582,0.551,851218758,0.296,733023824,0.255,"PGX_AM_BS_GSM529061","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.363000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b4b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529062","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4e","pgxind-kftx4mbr","pgxcs-kftwc131",1857847184,0.646,845218192,0.294,1012628992,0.352,"PGX_AM_BS_GSM529062","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.364000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,,"geo:gse","geo:GSE21123","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.7,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618a09d374f2dc3b7b4f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4l","pgxind-kftx4mbz","pgxcs-kftwc14y",777998145,0.271,305368680,0.106,472629465,0.164,"PGX_AM_BS_GSM529066","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.370000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529066","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b50","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529067","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4m","pgxind-kftx4mc1","pgxcs-kftwc15g",1123131640,0.391,557475960,0.194,565655680,0.197,"PGX_AM_BS_GSM529067","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.371000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b52","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4q","pgxind-kftx4mc5","pgxcs-kftwc16g",1684425282,0.586,821284465,0.286,863140817,0.3,"PGX_AM_BS_GSM529069","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.374000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529069","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86618a09d374f2dc3b7b53","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529070","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4r","pgxind-kftx4mc7","pgxcs-kftwc16y",1919288457,0.668,1016722052,0.354,902566405,0.314,"PGX_AM_BS_GSM529070","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.376000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b57","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529074","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4y","pgxind-kftx4mcg","pgxcs-kftwc1au",1269612963,0.442,607640439,0.211,661972524,0.23,"PGX_AM_BS_GSM529074","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.382000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618a09d374f2dc3b7b58","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529075","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4z","pgxind-kftx4mci","pgxcs-kftwc1bc",576105208,0.2,554656668,0.193,21448540,0.007,"PGX_AM_BS_GSM529075","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.383000",,,,,,,,,,,"geo:GSE21123","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618b09d374f2dc3b7b5c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529079","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv56","pgxind-kftx4mcq","pgxcs-kftwc1d9",491676060,0.171,349661092,0.122,142014968,0.049,"PGX_AM_BS_GSM529079","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.389000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618b09d374f2dc3b7b5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529081","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv59","pgxind-kftx4mcu","pgxcs-kftwc1e7",76941768,0.027,70110041,0.024,6831727,0.002,"PGX_AM_BS_GSM529081","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.392000",,,,,,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,,"geo:gpl","geo:GPL3720","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618b09d374f2dc3b7b6d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv5y","pgxind-kftx4mdp","pgxcs-kftwc1lf",143372018,0.05,11013630,0.004,132358388,0.046,"PGX_AM_BS_GSM529096","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.413000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"geo:gsm","geo:GSM529096","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86618b09d374f2dc3b7b6e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated Liposarcoma [cell line DDLS8817]","cellosaurus:CVCL_M814","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv60","pgxind-kftx4mdr","pgxcs-kftwc1lx",1264364851,0.44,647851694,0.225,616513157,0.214,"PGX_AM_BS_GSM529097","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.414000",,,,,,,,,,,"geo:GSM529097","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE21123","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,
"5c86618b09d374f2dc3b7b70","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated Liposarcoma [cell line FU-DDLS-1]","cellosaurus:CVCL_M815","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv63","pgxind-kftx4mdv","pgxcs-kftwc1mx",831375177,0.289,678122340,0.236,153252837,0.053,"PGX_AM_BS_GSM529099","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.417000",,,,,,,,,,,"geo:GSM529099","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.72,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","geo:gse","geo:GSE21123","",,,,
"5c8661b209d374f2dc3c3629","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537763","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivk9","pgxind-kftx4mv8","pgxcs-kftwc607",1452887708,0.505,635875243,0.221,817012465,0.284,"PGX_AM_BS_GSM537763","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.850000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21530","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537760","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivka","pgxind-kftx4mva","pgxcs-kftwc5ym",1377038220,0.479,486998714,0.169,890039506,0.31,"PGX_AM_BS_GSM537760","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.851000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21530","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkc","pgxind-kftx4mvc","pgxcs-kftwc5z6",1593367841,0.554,877305721,0.305,716062120,0.249,"PGX_AM_BS_GSM537761","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.852000",,,,,,,,,,,"geo:GSE21530","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM537761","","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSE21530","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivke","pgxind-kftx4mve","pgxcs-kftwc5zp",1431306076,0.498,986296155,0.343,445009921,0.155,"PGX_AM_BS_GSM537762","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.854000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM537762","","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSE21530","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkf","pgxind-kftx4mvg","pgxcs-kftwc60o",1699450864,0.591,699503270,0.243,999947594,0.348,"PGX_AM_BS_GSM537764","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.855000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM537764","","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkh","pgxind-kftx4mvi","pgxcs-kftwc616",1880479731,0.654,971680735,0.338,908798996,0.316,"PGX_AM_BS_GSM537765","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.857000",,,,,,,,,,,"geo:GPL4091","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21530","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM537765","","arraymap import",,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c3630","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537767","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkk","pgxind-kftx4mvm","pgxcs-kftwc626",1667728431,0.58,1001873803,0.348,665854628,0.232,"PGX_AM_BS_GSM537767","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.860000",,,,,,,,,,,"geo:GSE21530","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,
"5c86639c09d374f2dc42ed03","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677364","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1a6","pgxind-kftx4tkb","pgxcs-kftwdufu",2125696396,0.739,1233723893,0.429,891972503,0.31,"PGX_AM_BS_GSM677364","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.938000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86639c09d374f2dc42ed04","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1a8","pgxind-kftx4tke","pgxcs-kftwdugc",1193574344,0.415,857196761,0.298,336377583,0.117,"PGX_AM_BS_GSM677365","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.940000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE27392","",,,,,"geo:gsm","geo:GSM677365","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677366","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1aa","pgxind-kftx4tkg","pgxcs-kftwdugu",1591269714,0.553,1103626877,0.384,487642837,0.17,"PGX_AM_BS_GSM677366","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.941000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed06","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677367","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ab","pgxind-kftx4tki","pgxcs-kftwduhc",1018974065,0.354,522251720,0.182,496722345,0.173,"PGX_AM_BS_GSM677367","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.943000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed07","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ad","pgxind-kftx4tkk","pgxcs-kftwduhu",1696105330,0.59,891839745,0.31,804265585,0.28,"PGX_AM_BS_GSM677368","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.944000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE27392","",,,,,"geo:gsm","geo:GSM677368","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1af","pgxind-kftx4tkm","pgxcs-kftwduib",1219957412,0.424,645592566,0.225,574364846,0.2,"PGX_AM_BS_GSM677369","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.946000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677369","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed09","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677370","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ag","pgxind-kftx4tko","pgxcs-kftwduit",1521792964,0.529,912305832,0.317,609487132,0.212,"PGX_AM_BS_GSM677370","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.947000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677371","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ai","pgxind-kftx4tkq","pgxcs-kftwduja",1229907143,0.428,666964591,0.232,562942552,0.196,"PGX_AM_BS_GSM677371","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.949000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ak","pgxind-kftx4tks","pgxcs-kftwdujs",1452575826,0.505,808390993,0.281,644184833,0.224,"PGX_AM_BS_GSM677372","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.950000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677372","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677373","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1al","pgxind-kftx4tku","pgxcs-kftwduka",1184316878,0.412,541009975,0.188,643306903,0.224,"PGX_AM_BS_GSM677373","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.952000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1an","pgxind-kftx4tkw","pgxcs-kftwdukr",1574874721,0.548,843232062,0.293,731642659,0.254,"PGX_AM_BS_GSM677374","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.953000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677374","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677376","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ao","pgxind-kftx4tky","pgxcs-kftwdul9",1560438883,0.543,907409587,0.316,653029296,0.227,"PGX_AM_BS_GSM677376","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.955000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1aq","pgxind-kftx4tl0","pgxcs-kftwduls",2102681784,0.731,1255215322,0.437,847466462,0.295,"PGX_AM_BS_GSM677377","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.957000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE27392","",,,,,"geo:gsm","geo:GSM677377","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed10","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1as","pgxind-kftx4tl2","pgxcs-kftwduma",1813778781,0.631,1101974797,0.383,711803984,0.248,"PGX_AM_BS_GSM677378","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.958000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677378","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed11","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSE27392","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1at","pgxind-kftx4tl4","pgxcs-kftwdumr",2119124130,0.737,1101346196,0.383,1017777934,0.354,"PGX_AM_BS_GSM677379","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.960000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"geo:gsm","geo:GSM677379","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed12","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677380","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1av","pgxind-kftx4tl6","pgxcs-kftwdun9",1589724513,0.553,1020928430,0.355,568796083,0.198,"PGX_AM_BS_GSM677380","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.961000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed13","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677381","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ax","pgxind-kftx4tl8","pgxcs-kftwdunr",1326651475,0.461,680220666,0.237,646430809,0.225,"PGX_AM_BS_GSM677381","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.963000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed14","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GPL13190","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ay","pgxind-kftx4tla","pgxcs-kftwduo9",1405962822,0.489,911325044,0.317,494637778,0.172,"PGX_AM_BS_GSM677382","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.964000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"geo:gsm","geo:GSM677382","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed15","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677383","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b0","pgxind-kftx4tlc","pgxcs-kftwduoq",1977501618,0.688,1053994886,0.367,923506732,0.321,"PGX_AM_BS_GSM677383","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.966000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed17","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b3","pgxind-kftx4tlg","pgxcs-kftwdurn",1625616945,0.565,924382470,0.322,701234475,0.244,"PGX_AM_BS_GSM677385","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.969000",,,,,,,,,,,"geo:GPL13190","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE27392","",,,,,"geo:gsm","geo:GSM677385","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed18","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b5","pgxind-kftx4tli","pgxcs-kftwdus7",1473084561,0.512,813534131,0.283,659550430,0.229,"PGX_AM_BS_GSM677386","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.970000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,,"geo:gsm","geo:GSM677386","","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed19","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677387","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b6","pgxind-kftx4tlk","pgxcs-kftwdusp",1877887370,0.653,923794760,0.321,954092610,0.332,"PGX_AM_BS_GSM677387","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.971000",,,,,,,,,,,"geo:GSE27392","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL13190","",,,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed1a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677388","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b8","pgxind-kftx4tlm","pgxcs-kftwdut7",1590521397,0.553,1181046780,0.411,409474617,0.142,"PGX_AM_BS_GSM677388","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.973000",,,,,,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,
"5c86647809d374f2dc47586d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma [p53mut, Li-Fraumeni syndrome]","geo:GSM847447","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj380","pgxind-kftx4vy1","pgxcs-kftwefk1",1426916231,0.496,1020634935,0.355,406281296,0.141,"PGX_AM_BS_GSM847447","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.449000",,,,,,,,,,,"PMID:22265402","Rausch T, Jones DT et al. (2012): Genome sequencing of pediatric medulloblastoma links...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE34323","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c86649c09d374f2dc478e08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-NEP-1]","cellosaurus:CVCL_0631","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3hr","pgxind-kftx4wa4","pgxcs-kftwej6j",1623257343,0.565,961787230,0.335,661470113,0.23,"PGX_AM_BS_GSM827180","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.752000",,,,,,,,,,,"geo:GSM827180","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,
"5c86649c09d374f2dc478e27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","uterine corpus sarcoma [cell line SKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3j6","pgxind-kftx4wbv","pgxcs-kftwejnv",981668300,0.341,757265608,0.263,224402692,0.078,"PGX_AM_BS_GSM827211","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:51.798000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_3167","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","geo:gsm","geo:GSM827211","",,,,
"5c86649c09d374f2dc478e29","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","ovarian leiomyosarcoma [cell line RKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","ovary","pgxbs-kftvj3j9","pgxind-kftx4wbz","pgxcs-kftwejov",1029523749,0.358,531386605,0.185,498137144,0.173,"PGX_AM_BS_GSM827213","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000992","ovary","{}","2020-09-10 17:45:51.801000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827213","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","cellosaurus","cellosaurus:CVCL_3156","",,,,
"5c86649d09d374f2dc478e54","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Epithelioid hemangioendothelioma [cell line LI90]","cellosaurus:CVCL_0390","","pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91303","Hemangioendothelioma, malignant","icdot-C22.9","liver","pgxbs-kftvj3l9","pgxind-kftx4wef","pgxcs-kftweka2",171702490,0.06,457789,0,171244701,0.06,"PGX_AM_BS_GSM827257","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003704","intrahepatic bile duct","{}","2020-09-10 17:45:51.865000",,,,,,,,,,,"geo:GSM827257","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","geo:gse","geo:GSE20306","",,,,
"5c86649e09d374f2dc478e67","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line NY]","cellosaurus:CVCL_1613","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3m4","pgxind-kftx4wqm","pgxcs-kftwekja",1301755987,0.453,616142736,0.214,685613251,0.238,"PGX_AM_BS_GSM827276","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.894000",,,,,,,,,,,"geo:GSM827276","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c86649e09d374f2dc478e83","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A-673]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3ne","pgxind-kftx4ws7","pgxcs-kftwekz9",306994337,0.107,162022146,0.056,144972191,0.05,"PGX_AM_BS_GSM827304","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.936000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827304","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0080","",,,,
"5c86649e09d374f2dc478e86","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj3nj","pgxind-kftx4wsd","pgxcs-kftwel0r",119957149,0.042,4665921,0.002,115291228,0.04,"PGX_AM_BS_GSM827307","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.940000",,,,,,,,,,,"geo:GSM827307","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL3720","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE20306","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.5,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,
"5c86649f09d374f2dc478e90","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3o0","pgxind-kftx4wsx","pgxcs-kftwel5m",1573544754,0.547,878480668,0.306,695064086,0.242,"PGX_AM_BS_GSM827317","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.955000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827317","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0426","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c86649f09d374f2dc478e92","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3o3","pgxind-kftx4wt1","pgxcs-kftwel6m",701159829,0.244,149451737,0.052,551708092,0.192,"PGX_AM_BS_GSM827319","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.958000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827319","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.46,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0312","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c86649f09d374f2dc478ea9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line G-292 clone A141B1]","geo:GSM827342","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3p5","pgxind-kftx4wuc","pgxcs-kftwelhr",1094428347,0.381,414193396,0.144,680234951,0.237,"PGX_AM_BS_GSM827342","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.991000",,,,,,,,,,,"cellosaurus:CVCL_2909","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c86649f09d374f2dc478eaf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine corpus sarcoma [cell line MES-SA/Dx5]","geo:GSM827348","","pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3pf","pgxind-kftx4wup","pgxcs-kftwelkn",987949337,0.344,321359483,0.112,666589854,0.232,"PGX_AM_BS_GSM827348","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:52",,,,,,,,,,,"cellosaurus:CVCL_2598","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gse","geo:GSE20306","",,,,
"5c8664a009d374f2dc478ebb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-312H]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3pz","pgxind-kftx4wvd","pgxcs-kftwem3v",1152330212,0.401,541748330,0.188,610581882,0.212,"PGX_AM_BS_GSM827383","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.018000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827383","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_2545","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c8664a009d374f2dc478ec3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","fibrosarcoma [cell line Hs 633.T]","geo:GSM827368","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj3qc","pgxind-kftx4wvt","pgxcs-kftweluf",237133165,0.082,166706893,0.058,70426272,0.024,"PGX_AM_BS_GSM827368","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:52.029000",,,,,,,,,,,"cellosaurus:CVCL_0832","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.5,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gse","geo:GSE20306","",,,,
"5c8664a009d374f2dc478ed0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS-240S]","cellosaurus:CVCL_2544","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3qy","pgxind-kftx4wwk","pgxcs-kftwem2u",1088898562,0.379,543811560,0.189,545087002,0.19,"PGX_AM_BS_GSM827381","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.049000",,,,,,,,,,,"geo:GSM827381","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE20306","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gpl","geo:GPL3720","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c8664a009d374f2dc478ed4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS/NP]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3r5","pgxind-kftx4wws","pgxcs-kftwem4u",1429204012,0.497,722386547,0.251,706817465,0.246,"PGX_AM_BS_GSM827385","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.055000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_2546","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827385","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c8664a009d374f2dc478ed8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","uterus sarcoma [cell line MES-SA]","cellosaurus:CVCL_1404","","pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3rc","pgxind-kftx4wx0","pgxcs-kftwem6u",334289523,0.116,212809192,0.074,121480331,0.042,"PGX_AM_BS_GSM827389","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:52.060000",,,,,,,,,,,"geo:GSM827389","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,
"5c8664a109d374f2dc478f00","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line FLYA13]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj3t6","pgxind-kftx4wz9","pgxcs-kftwemqd",655717537,0.228,395291945,0.137,260425592,0.091,"PGX_AM_BS_GSM827429","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:52.120000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_8870","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827429","",,,,
"5c8664a309d374f2dc478f43","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma [cell line GCT]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj3w9","pgxind-kftx4x32","pgxcs-kftwenpi",1222293365,0.425,658195520,0.229,564097845,0.196,"PGX_AM_BS_GSM827496","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:52.218000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_1229","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827496","",,,,
"5c8664a409d374f2dc478f9a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj40b","pgxind-kftx4x80","pgxcs-kftweoyp",1233236019,0.429,564067198,0.196,669168821,0.233,"PGX_AM_BS_GSM827583","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.347000",,,,,,,,,,,"geo:GSE20306","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM827583","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0042","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c8664a509d374f2dc478f9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj40j","pgxind-kftx4x8a","pgxcs-kftwep15",1009270471,0.351,324106722,0.113,685163749,0.238,"PGX_AM_BS_GSM827588","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.354000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_0548","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827588","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5c8665b209d374f2dc4c82e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820995","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6b2","pgxind-kftx501j","pgxcs-kftwfehn",756995622,0.263,485437558,0.169,271558064,0.094,"PGX_AM_BS_GSM820995","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.916000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GSE33153","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6ba","pgxind-kftx501t","pgxcs-kftwfek5",1166836154,0.406,728889313,0.254,437946841,0.152,"PGX_AM_BS_GSM821000","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.923000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GSE33153","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,,"geo:gsm","geo:GSM821000","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82ea","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6be","pgxind-kftx501x","pgxcs-kftwfel5",2035764873,0.708,1134660545,0.395,901104328,0.313,"PGX_AM_BS_GSM821002","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.926000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33153","",,,,,"geo:gsm","geo:GSM821002","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82eb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821003","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bf","pgxind-kftx501z","pgxcs-kftwfeln",589656292,0.205,262148622,0.091,327507670,0.114,"PGX_AM_BS_GSM821003","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.928000",,,,,,"NCITgrade-C14158","High Grade",,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82ec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821004","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bh","pgxind-kftx5021","pgxcs-kftwfem5",1545453001,0.538,681388132,0.237,864064869,0.301,"PGX_AM_BS_GSM821004","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.929000",,,,,,"NCITgrade-C14158","High Grade",,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c8665b209d374f2dc4c82ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821007","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bm","pgxind-kftx5027","pgxcs-kftwfenn",1700213083,0.591,1010095393,0.351,690117690,0.24,"PGX_AM_BS_GSM821007","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.934000",,,,,,"NCITgrade-C14158","High Grade",,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6bp","pgxind-kftx502c","pgxcs-kftwfeon",1317597971,0.458,822576285,0.286,495021686,0.172,"PGX_AM_BS_GSM821009","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.937000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GSE33153","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,,"geo:gsm","geo:GSM821009","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82f2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6br","pgxind-kftx502e","pgxcs-kftwfep5",1296956651,0.451,757060822,0.263,539895829,0.188,"PGX_AM_BS_GSM821010","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.938000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821010","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82f4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bu","pgxind-kftx502i","pgxcs-kftwfeq6",677690731,0.236,459310943,0.16,218379788,0.076,"PGX_AM_BS_GSM821012","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.941000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821012","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c8665b209d374f2dc4c82f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821013","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6by","pgxind-kftx502m","pgxcs-kftwfeqo",1453663675,0.506,792739413,0.276,660924262,0.23,"PGX_AM_BS_GSM821013","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.944000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821015","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bz","pgxind-kftx502o","pgxcs-kftwfero",1695513145,0.59,1062693124,0.37,632820021,0.22,"PGX_AM_BS_GSM821015","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.946000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5c8665b209d374f2dc4c82f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821016","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c1","pgxind-kftx502q","pgxcs-kftwfes6",85759156,0.03,63372618,0.022,22386538,0.008,"PGX_AM_BS_GSM821016","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.947000",,,,,,"NCITgrade-C14158","High Grade",,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c2","pgxind-kftx502s","pgxcs-kftwfeso",1231975786,0.429,859858366,0.299,372117420,0.129,"PGX_AM_BS_GSM821017","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.949000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,,"geo:gsm","geo:GSM821017","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5c8665b209d374f2dc4c82fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820997","","pgxfus-0002","no followup status","NCIT:C3902","Telangiectatic Osteosarcoma","icdom-91833","Telangiectatic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c6","pgxind-kftx502w","pgxcs-kftwfein",1422511490,0.495,704680099,0.245,717831391,0.25,"PGX_AM_BS_GSM820997","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.951000",,,,,,"NCITgrade-C14158","High Grade",,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8665b209d374f2dc4c82fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821021","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c9","pgxind-kftx5030","pgxcs-kftwfeus",2184453077,0.76,1151587048,0.401,1032866029,0.359,"PGX_AM_BS_GSM821021","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.954000",,,,,,"NCITgrade-C14158","High Grade",,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,,"geo:gpl","geo:GPL6801","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86661909d374f2dc4e34a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line 143B]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cr","pgxind-kftx51bi","pgxcs-kftwfq2i",1402234302,0.488,681632469,0.237,720601833,0.251,"PGX_AM_BS_GSM879206","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.085000",,,,,,,,,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE36003","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_2270","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM879206","",,,,
"5c86661909d374f2dc4e34a3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","cellosaurus:CVCL_0312","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7ct","pgxind-kftx51bk","pgxcs-kftwfq30",691578252,0.241,175555038,0.061,516023214,0.179,"PGX_AM_BS_GSM879208","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.087000",,,,,,,,,,,"geo:GSM879208","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL6801","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE36003","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...",,,,
"5c86661909d374f2dc4e34a4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS10]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cv","pgxind-kftx51bm","pgxcs-kftwfq3i",992044581,0.345,465939234,0.162,526105347,0.183,"PGX_AM_BS_GSM879210","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.088000",,,,,,,,,,,"geo:GSE36003","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_9989","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","geo:gsm","geo:GSM879210","",,,,
"5c86661909d374f2dc4e34a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KPD]","geo:GSM879216","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cx","pgxind-kftx51bo","pgxcs-kftwfq40",1192511599,0.415,767492938,0.267,425018661,0.148,"PGX_AM_BS_GSM879216","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.090000",,,,,,,,,,,"cellosaurus:CVCL_B412","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE36003","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gpl","geo:GPL6801","",,,,
"5c86661909d374f2dc4e34a6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line MNNG/HOS CI #5]","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7cy","pgxind-kftx51bq","pgxcs-kftwfq4h",1065381362,0.371,625968078,0.218,439413284,0.153,"PGX_AM_BS_GSM879219","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.092000",,,,,,,,,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE36003","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_0439","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM879219","",,,,
"5c86661909d374f2dc4e34a7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line SJSA-1]","geo:GSM879221","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj7d0","pgxind-kftx51bs","pgxcs-kftwfq4z",816237272,0.284,399633048,0.139,416604224,0.145,"PGX_AM_BS_GSM879221","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:56.093000",,,,,,,,,,,"cellosaurus:CVCL_1697","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE36003","","arraymap import",0.66,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gpl","geo:GPL6801","",,,,
"5c86675409d374f2dc538641","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqe","pgxind-kftx554l","pgxcs-kftwgot0",623126720,0.217,409501098,0.142,213625622,0.074,"PGX_AM_BS_GSM1109929","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.558000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109929","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538649","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109937","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqr","pgxind-kftx5552","pgxcs-kftwgowv",2235406600,0.778,1116267871,0.388,1119138729,0.389,"PGX_AM_BS_GSM1109937","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.569000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc53864c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqw","pgxind-kftx5559","pgxcs-kftwgoye",226180248,0.079,116908403,0.041,109271845,0.038,"PGX_AM_BS_GSM1109940","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.573000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109940","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc53864d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109941","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqx","pgxind-kftx555b","pgxcs-kftwgoyx",1479362867,0.515,940304325,0.327,539058542,0.187,"PGX_AM_BS_GSM1109941","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.575000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538650","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE45573","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar2","pgxind-kftx555h","pgxcs-kftwgp0f",1509656304,0.525,937840710,0.326,571815594,0.199,"PGX_AM_BS_GSM1109944","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.579000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109944","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538652","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar5","pgxind-kftx555l","pgxcs-kftwgoj3",502206885,0.175,395125650,0.137,107081235,0.037,"PGX_AM_BS_GSM1109909","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.582000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109909","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538653","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar7","pgxind-kftx555n","pgxcs-kftwgojl",1779638885,0.619,1341932077,0.467,437706808,0.152,"PGX_AM_BS_GSM1109910","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.583000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109910","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538656","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarc","pgxind-kftx555u","pgxcs-kftwgol2",448145196,0.156,411556963,0.143,36588233,0.013,"PGX_AM_BS_GSM1109913","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.588000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109913","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538657","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjard","pgxind-kftx555w","pgxcs-kftwgolj",1063898725,0.37,609521577,0.212,454377148,0.158,"PGX_AM_BS_GSM1109914","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.589000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109914","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538658","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109915","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarf","pgxind-kftx555y","pgxcs-kftwgom2",1685974082,0.586,777387726,0.27,908586356,0.316,"PGX_AM_BS_GSM1109915","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.590000",,,,,,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE45573","","arraymap import",,,,,,,,,,,,,,,
"5c86675409d374f2dc538659","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109916","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarh","pgxind-kftx5560","pgxcs-kftwgomk",1770157322,0.616,1237782329,0.431,532374993,0.185,"PGX_AM_BS_GSM1109916","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.592000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,
"5c86675509d374f2dc53865d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarn","pgxind-kftx5568","pgxcs-kftwgooj",1709210406,0.595,947343695,0.33,761866711,0.265,"PGX_AM_BS_GSM1109920","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.598000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109920","","arraymap import",,,,,,,,,,,,,,,
"5c86675509d374f2dc538661","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109924","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaru","pgxind-kftx556g","pgxcs-kftwgoqh",1899622852,0.661,985887199,0.343,913735653,0.318,"PGX_AM_BS_GSM1109924","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.603000",,,,,,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL8841","","arraymap import",,,,,,,,,,,,,,,
"5c86675509d374f2dc538664","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarz","pgxind-kftx556m","pgxcs-kftwgory",1537867147,0.535,870367630,0.303,667499517,0.232,"PGX_AM_BS_GSM1109927","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.608000",,,,,,,,,,,"geo:GSE45573","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1109927","","arraymap import",,,,,,,,,,,,,,,
"5c86675509d374f2dc538665","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109928","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas0","pgxind-kftx556o","pgxcs-kftwgosi",1430881274,0.498,704197534,0.245,726683740,0.253,"PGX_AM_BS_GSM1109928","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.609000",,,,,,,,,,,"geo:GPL8841","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197411","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas5","pgxind-kftx556u","pgxcs-kftwgp2d",1271015117,0.442,904887969,0.315,366127148,0.127,"PGX_AM_BS_GSM1197411","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.613000",,,,,,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE49324","",,,,,"geo:gpl","geo:GPL9777","","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d5f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas7","pgxind-kftx556x","pgxcs-kftwgp2v",608685209,0.212,312121579,0.109,296563630,0.103,"PGX_AM_BS_GSM1197412","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.615000",,,,,,,,,,,"geo:GSE49324","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL9777","",,,,,"geo:gsm","geo:GSM1197412","","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d63","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasd","pgxind-kftx5575","pgxcs-kftwgp5e",2234082717,0.777,2234082717,0.777,0,0,"PGX_AM_BS_GSM1197417","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.620000",,,,,,,,,,,"geo:GSE49324","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL9777","",,,,,"geo:gsm","geo:GSM1197417","","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d65","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197421","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasg","pgxind-kftx5579","pgxcs-kftwgp7e",1729490435,0.602,1257902651,0.438,471587784,0.164,"PGX_AM_BS_GSM1197421","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.623000",,,,,,,,,,,"geo:GSE49324","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d67","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197419","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjask","pgxind-kftx557d","pgxcs-kftwgp6e",1654212713,0.575,1091514020,0.38,562698693,0.196,"PGX_AM_BS_GSM1197419","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.626000",,,,,,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL9777","",,,,,"geo:gse","geo:GSE49324","","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d68","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197420","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasl","pgxind-kftx557f","pgxcs-kftwgp6v",1241237875,0.432,347069585,0.121,894168290,0.311,"PGX_AM_BS_GSM1197420","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.627000",,,,,,,,,,,"geo:GSE49324","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,
"5c86675709d374f2dc538d6a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma [recurrence]","geo:GSM1197423","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasp","pgxind-kftx557j","pgxcs-kftwgp8e",730172350,0.254,372324919,0.13,357847431,0.124,"PGX_AM_BS_GSM1197423","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.630000",,,,,,,,,,,"geo:GPL9777","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE49324","",,,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,
"5c86675909d374f2dc539d4f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated Liposarcoma [cell line DDLS8817]","geo:GPL9128","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasq","pgxind-kftx557l","pgxcs-kftwgp8w",1272814818,0.443,617417672,0.215,655397146,0.228,"PGX_AM_BS_GSM1228008","{}",0.12,52.2,"Point","GBR","Cambridge","United Kingdom","Cambridge, United Kingdom",52.2,0.12,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.632000",,,,,,,,,,,"geo:GSE50750","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24065146","Miller ML, Molinelli EJ et al. (2013): Drug synergy screen and network modeling...",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM1228008","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_M814","",,,,
"5c86675c09d374f2dc53a00b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","geo:GSM1280502","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau3","pgxind-kftx559a","pgxcs-kftwgpt4",1699977149,0.591,950495654,0.331,749481495,0.261,"PGX_AM_BS_GSM1280502","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.675000",,,,,,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL3718","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a00c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau5","pgxind-kftx559c","pgxcs-kftwgpv4",1541090236,0.536,859765918,0.299,681324318,0.237,"PGX_AM_BS_GSM1280506","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.676000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1280506","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a00d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","geo:GSM1280507","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau7","pgxind-kftx559e","pgxcs-kftwgpvm",318301570,0.111,291324331,0.101,26977239,0.009,"PGX_AM_BS_GSM1280507","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.678000",,,,,,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL3718","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a00e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau8","pgxind-kftx559g","pgxcs-kftwgptn",906535481,0.315,611361643,0.213,295173838,0.103,"PGX_AM_BS_GSM1280503","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.679000",,,,,,,,,,,"geo:GSE53021","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3718","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1280503","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a00f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE53021","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaua","pgxind-kftx559i","pgxcs-kftwgpu5",889838223,0.31,618081177,0.215,271757046,0.095,"PGX_AM_BS_GSM1280504","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.681000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gsm","geo:GSM1280504","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a011","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1280501","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaud","pgxind-kftx559m","pgxcs-kftwgpsn",243656666,0.085,210610302,0.073,33046364,0.011,"PGX_AM_BS_GSM1280501","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.683000",,,,,,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gpl","geo:GPL3718","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a019","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSM1280499","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjauq","pgxind-kftx55a2","pgxcs-kftwgprn",1925479044,0.67,1249812987,0.435,675666057,0.235,"PGX_AM_BS_GSM1280499","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.694000",,,,,,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3718","",,,,,"geo:gse","geo:GSE53021","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a01a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSE53021","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaus","pgxind-kftx55a4","pgxcs-kftwgps5",711510898,0.247,401570603,0.14,309940295,0.108,"PGX_AM_BS_GSM1280500","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.696000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,,"geo:gsm","geo:GSM1280500","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a01b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaut","pgxind-kftx55a6","pgxcs-kftwgpr6",1385110960,0.482,1022498046,0.356,362612914,0.126,"PGX_AM_BS_GSM1280498","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.697000",,,,,,,,,,,"geo:GSE53021","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3718","",,,,,"geo:gsm","geo:GSM1280498","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c86675c09d374f2dc53a01c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma","geo:GSM1280497","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjauv","pgxind-kftx55a8","pgxcs-kftwgpqo",2237740332,0.778,1313488811,0.457,924251521,0.321,"PGX_AM_BS_GSM1280497","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.699000",,,,,,,,,,,"geo:GSE53021","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,"pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5c8668e809d374f2dc5998b4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE20355","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjetq","pgxind-kftx5a60","pgxcs-kftwhy9b",830214230,0.289,547889412,0.191,282324818,0.098,"PGX_AM_BS_GSM509934","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.537000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gsm","geo:GSM509934","","arraymap import",,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509942","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeu3","pgxind-kftx5a6g","pgxcs-kftwhyd9",1695146944,0.59,1053183823,0.366,641963121,0.223,"PGX_AM_BS_GSM509942","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.549000",,,,,,,,,,,"geo:GSE20355","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998dd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509975","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevn","pgxind-kftx5a8a","pgxcs-kftwhytn",2424088286,0.843,1502341088,0.523,921747198,0.321,"PGX_AM_BS_GSM509975","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.594000",,,,,,,,,,,"geo:GSE20355","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998df","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509977","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevq","pgxind-kftx5a8e","pgxcs-kftwhyum",1678159991,0.584,1075313524,0.374,602846467,0.21,"PGX_AM_BS_GSM509977","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.597000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE20355","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998e7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-ES-1]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjew4","pgxind-kftx5a8u","pgxcs-kftwhz9u",1562972259,0.544,758362335,0.264,804609924,0.28,"PGX_AM_BS_GSM510008","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.609000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM510008","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0627","",,,,
"5c8668e909d374f2dc5998e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509986","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjew6","pgxind-kftx5a8w","pgxcs-kftwhyz1",559122638,0.194,368121039,0.128,191001599,0.066,"PGX_AM_BS_GSM509986","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.610000",,,,,,,,,,,"geo:GSE20355","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509993","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewi","pgxind-kftx5a9b","pgxcs-kftwhz2j",1547477920,0.538,1045848029,0.364,501629891,0.174,"PGX_AM_BS_GSM509993","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.620000",,,,,,,,,,,"PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gse","geo:GSE20355","",,,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewk","pgxind-kftx5a9d","pgxcs-kftwhz30",621376824,0.216,114639583,0.04,506737241,0.176,"PGX_AM_BS_GSM509994","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.622000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM509994","","arraymap import",,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A-673]","geo:GPL8634","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewx","pgxind-kftx5a9t","pgxcs-kftwhz6v",275966020,0.096,147376050,0.051,128589970,0.045,"PGX_AM_BS_GSM510002","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.632000",,,,,,,,,,,"geo:GSE20355","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"cellosaurus","cellosaurus:CVCL_0080","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM510002","",,,,
"5c8668e909d374f2dc5998fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RD-ES]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjex4","pgxind-kftx5aa1","pgxcs-kftwhz8v",1487068603,0.517,721917933,0.251,765150670,0.266,"PGX_AM_BS_GSM510006","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.638000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM510006","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_2169","",,,,
"5c8668e909d374f2dc5998fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RM-82]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjex5","pgxind-kftx5aa3","pgxcs-kftwhz9d",1713906666,0.596,1223377249,0.426,490529417,0.171,"PGX_AM_BS_GSM510007","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.640000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"geo:gsm","geo:GSM510007","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_9714","",,,,
"5c8668e909d374f2dc599901","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line STA-ET-2.1]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexc","pgxind-kftx5aab","pgxcs-kftwhzbb",1405392856,0.489,938298021,0.326,467094835,0.162,"PGX_AM_BS_GSM510011","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.645000",,,,,,,,,,,"geo:GPL8634","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,,"cellosaurus","cellosaurus:CVCL_9686","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM510011","",,,,
"5c8668e909d374f2dc599902","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing Sarcoma [Cell Line TC71]","geo:GSM510013","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexd","pgxind-kftx5aad","pgxcs-kftwhzca",1146741527,0.399,512406323,0.178,634335204,0.221,"PGX_AM_BS_GSM510013","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.647000",,,,,,,,,,,"cellosaurus:CVCL_2213","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,"geo:gse","geo:GSE20355","",,,,
"5c8668e909d374f2dc599904","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line VH-64]","cellosaurus:CVCL_9672","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexh","pgxind-kftx5aah","pgxcs-kftwhzdd",636238622,0.221,243341213,0.085,392897409,0.137,"PGX_AM_BS_GSM510015","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.650000",,,,,,,,,,,"geo:GSM510015","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL8634","",,,,,"geo:gse","geo:GSE20355","","arraymap import",,,,,,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,
"5c86690609d374f2dc59e8c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf8z","pgxind-kftx5aoq","pgxcs-kftwi2yl",2629816976,0.915,0,0,2629816976,0.915,"PGX_AM_BS_GSM637930","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.011000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637930","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf90","pgxind-kftx5aos","pgxcs-kftwi2z2",2629095210,0.914,0,0,2629095210,0.914,"PGX_AM_BS_GSM637931","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.012000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637931","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf92","pgxind-kftx5aou","pgxcs-kftwi2zj",2629322510,0.915,0,0,2629322510,0.915,"PGX_AM_BS_GSM637932","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.014000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637932","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637933","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf94","pgxind-kftx5aow","pgxcs-kftwi301",2629701416,0.915,0,0,2629701416,0.915,"PGX_AM_BS_GSM637933","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.015000",,,,,,,,,,,"PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE25985","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf95","pgxind-kftx5aoy","pgxcs-kftwi30i",2629785586,0.915,0,0,2629785586,0.915,"PGX_AM_BS_GSM637935","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.017000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"geo:gsm","geo:GSM637935","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf97","pgxind-kftx5ap0","pgxcs-kftwi310",2629768603,0.915,0,0,2629768603,0.915,"PGX_AM_BS_GSM637936","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.018000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637936","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf98","pgxind-kftx5ap2","pgxcs-kftwi31i",2629768983,0.915,0,0,2629768983,0.915,"PGX_AM_BS_GSM637938","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.020000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,,"geo:gsm","geo:GSM637938","","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637940","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9a","pgxind-kftx5ap4","pgxcs-kftwi31z",2629502545,0.915,0,0,2629502545,0.915,"PGX_AM_BS_GSM637940","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.021000",,,,,,,,,,,"geo:GSE25985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,,"pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","arraymap import",,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9c","pgxind-kftx5ap7","pgxcs-kftwi32h",2628994443,0.914,0,0,2628994443,0.914,"PGX_AM_BS_GSM637942","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.023000",,,,,,,,,,,"geo:GSE25985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6985","",,,,,"geo:gsm","geo:GSM637942","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1o","pgxind-kftx5cxa","pgxcs-kftwin50",714592224,0.249,530954318,0.185,183637906,0.064,"PGX_AM_BS_GSM816442","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.040000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,,"geo:gsm","geo:GSM816442","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816444","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1r","pgxind-kftx5cxe","pgxcs-kftwin60",505778859,0.176,330374721,0.115,175404138,0.061,"PGX_AM_BS_GSM816444","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.043000",,,,,,,,,,,"geo:GSE32964","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8ba9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816446","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1u","pgxind-kftx5cxi","pgxcs-kftwin6z",1302846801,0.453,1128488115,0.393,174358686,0.061,"PGX_AM_BS_GSM816446","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.046000",,,,,,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE32964","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816449","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1z","pgxind-kftx5cxp","pgxcs-kftwin8g",685989812,0.239,258901845,0.09,427087967,0.149,"PGX_AM_BS_GSM816449","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.050000",,,,,,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE32964","",,,,,"geo:gpl","geo:GPL6985","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2d","pgxind-kftx5cy5","pgxcs-kftwincx",340763743,0.119,145029000,0.05,195734743,0.068,"PGX_AM_BS_GSM816458","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.062000",,,,,,,,,,,"geo:GSE32964","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6985","",,,,,"geo:gsm","geo:GSM816458","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816459","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2f","pgxind-kftx5cy7","pgxcs-kftwindg",917267194,0.319,730233889,0.254,187033305,0.065,"PGX_AM_BS_GSM816459","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.063000",,,,,,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,,"geo:gse","geo:GSE32964","","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816461","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2i","pgxind-kftx5cyb","pgxcs-kftwineg",854030301,0.297,648098843,0.225,205931458,0.072,"PGX_AM_BS_GSM816461","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.066000",,,,,,,,,,,"geo:GPL6985","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE32964","",,,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816463","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2l","pgxind-kftx5cyf","pgxcs-kftwinff",1557424928,0.542,1192290399,0.415,365134529,0.127,"PGX_AM_BS_GSM816463","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.069000",,,,,,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE32964","",,,,,"geo:gpl","geo:GPL6985","","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca297","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838283","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjht7","pgxind-kftx5dv7","pgxcs-kftwivo7",1423101390,0.495,993227557,0.345,429873833,0.15,"PGX_AM_BS_GSM838283","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.894000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca298","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSE33881","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjht8","pgxind-kftx5dv9","pgxcs-kftwivoq",193796399,0.067,193759350,0.067,37049,0,"PGX_AM_BS_GSM838284","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.895000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838284","","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtc","pgxind-kftx5dvd","pgxcs-kftwivpq",1639228944,0.57,928576497,0.323,710652447,0.247,"PGX_AM_BS_GSM838286","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.898000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838286","","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838288","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtf","pgxind-kftx5dvh","pgxcs-kftwivqp",1557266809,0.542,869258204,0.302,688008605,0.239,"PGX_AM_BS_GSM838288","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.901000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhth","pgxind-kftx5dvj","pgxcs-kftwivr7",1124565450,0.391,795966085,0.277,328599365,0.114,"PGX_AM_BS_GSM838289","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.903000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838289","","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhti","pgxind-kftx5dvl","pgxcs-kftwivrp",1156184322,0.402,738914787,0.257,417269535,0.145,"PGX_AM_BS_GSM838290","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.904000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838290","","arraymap import",,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838291","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtk","pgxind-kftx5dvn","pgxcs-kftwivs6",165351906,0.058,137900179,0.048,27451727,0.01,"PGX_AM_BS_GSM838291","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.905000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtm","pgxind-kftx5dvp","pgxcs-kftwivso",2207386370,0.768,855361762,0.298,1352024608,0.47,"PGX_AM_BS_GSM838292","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.907000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838292","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2a3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838295","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtq","pgxind-kftx5dvv","pgxcs-kftwivu4",265899705,0.092,205401,0,265694304,0.092,"PGX_AM_BS_GSM838295","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.911000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838297","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtu","pgxind-kftx5dw0","pgxcs-kftwivv3",1930668988,0.672,1317222054,0.458,613446934,0.213,"PGX_AM_BS_GSM838297","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.914000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33881","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2aa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhu2","pgxind-kftx5dwb","pgxcs-kftwivxh",2174141379,0.756,878621119,0.306,1295520260,0.451,"PGX_AM_BS_GSM838302","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.921000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838302","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2ad","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838305","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhu7","pgxind-kftx5dwh","pgxcs-kftwivyy",278390639,0.097,21929888,0.008,256460751,0.089,"PGX_AM_BS_GSM838305","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.925000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2ae","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhu9","pgxind-kftx5dwj","pgxcs-kftwivzf",1302810822,0.453,567413213,0.197,735397609,0.256,"PGX_AM_BS_GSM838306","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.927000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838306","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838308","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuc","pgxind-kftx5dwn","pgxcs-kftwiw0e",771406084,0.268,608421682,0.212,162984402,0.057,"PGX_AM_BS_GSM838308","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.929000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838309","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhue","pgxind-kftx5dwp","pgxcs-kftwiw0v",209869415,0.073,76959934,0.027,132909481,0.046,"PGX_AM_BS_GSM838309","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.931000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838310","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuf","pgxind-kftx5dwr","pgxcs-kftwiw1d",1217255385,0.423,494446512,0.172,722808873,0.251,"PGX_AM_BS_GSM838310","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.932000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuh","pgxind-kftx5dwt","pgxcs-kftwiw1u",2075190216,0.722,722677236,0.251,1352512980,0.47,"PGX_AM_BS_GSM838311","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.933000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838311","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhui","pgxind-kftx5dwv","pgxcs-kftwiw2c",491350239,0.171,220329125,0.077,271021114,0.094,"PGX_AM_BS_GSM838312","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.935000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838312","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838313","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuk","pgxind-kftx5dwx","pgxcs-kftwiw2t",1933037755,0.672,723038941,0.251,1209998814,0.421,"PGX_AM_BS_GSM838313","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.936000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838314","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhum","pgxind-kftx5dwz","pgxcs-kftwiw3b",803491173,0.279,503139226,0.175,300351947,0.104,"PGX_AM_BS_GSM838314","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.938000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33881","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838315","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhun","pgxind-kftx5dx1","pgxcs-kftwiw3t",1949940043,0.678,829235467,0.288,1120704576,0.39,"PGX_AM_BS_GSM838315","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.939000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838316","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhup","pgxind-kftx5dx3","pgxcs-kftwiw4b",2191537374,0.762,1482831148,0.516,708706226,0.247,"PGX_AM_BS_GSM838316","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.941000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2ba","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhus","pgxind-kftx5dx7","pgxcs-kftwiw5a",74749178,0.026,70598606,0.025,4150572,0.001,"PGX_AM_BS_GSM838318","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.944000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838318","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuu","pgxind-kftx5dx9","pgxcs-kftwiw5r",2171575610,0.755,1080120127,0.376,1091455483,0.38,"PGX_AM_BS_GSM838319","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.945000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838319","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuv","pgxind-kftx5dxb","pgxcs-kftwiw69",306223876,0.107,35202762,0.012,271021114,0.094,"PGX_AM_BS_GSM838320","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.947000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838320","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2be","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSE33881","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuz","pgxind-kftx5dxf","pgxcs-kftwiw77",678835707,0.236,495731157,0.172,183104550,0.064,"PGX_AM_BS_GSM838322","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.950000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838322","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838323","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv0","pgxind-kftx5dxh","pgxcs-kftwiw7p",915059292,0.318,634487174,0.221,280572118,0.098,"PGX_AM_BS_GSM838323","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.951000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838324","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv2","pgxind-kftx5dxj","pgxcs-kftwiw87",2092793055,0.728,621405298,0.216,1471387757,0.512,"PGX_AM_BS_GSM838324","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.952000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv3","pgxind-kftx5dxl","pgxcs-kftwiw8p",1319749958,0.459,983456566,0.342,336293392,0.117,"PGX_AM_BS_GSM838325","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.954000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,,"geo:gsm","geo:GSM838325","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838327","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv7","pgxind-kftx5dxp","pgxcs-kftwiw9o",1406974910,0.489,1087086744,0.378,319888166,0.111,"PGX_AM_BS_GSM838327","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.957000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838328","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv8","pgxind-kftx5dxs","pgxcs-kftwiwa6",1801923850,0.627,658414221,0.229,1143509629,0.398,"PGX_AM_BS_GSM838328","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.958000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvb","pgxind-kftx5dxw","pgxcs-kftwiwb5",843270534,0.293,560487844,0.195,282782690,0.098,"PGX_AM_BS_GSM838330","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.961000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,,"geo:gsm","geo:GSM838330","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvd","pgxind-kftx5dxy","pgxcs-kftwiwbm",1416736312,0.493,522630883,0.182,894105429,0.311,"PGX_AM_BS_GSM838331","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.963000",,,,,,,,,,,"geo:GSE33881","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"geo:gsm","geo:GSM838331","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838332","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvf","pgxind-kftx5dy0","pgxcs-kftwiwc4",490699928,0.171,260043193,0.09,230656735,0.08,"PGX_AM_BS_GSM838332","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.964000",,,,,,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838333","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvg","pgxind-kftx5dy1","pgxcs-kftwiwcl",741657194,0.258,278915114,0.097,462742080,0.161,"PGX_AM_BS_GSM838333","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.965000",,,,,,,,,,,"geo:GPL5477","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33881","",,,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,
"5dc17b5f09d374f6dd77341c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","cellosaurus:CVCL_0042","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjtr5","pgxind-kftx5s7q","pgxcs-kftwmffm",1549575741,0.539,918057270,0.319,631518471,0.22,"PGX_AM_BS_GSM170250","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.183000",,,,,,,,,,,"geo:GSM170250","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL2879","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE7077","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5dc17b5f09d374f6dd773585","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U-2 OS]","geo:GSM879223","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjtr6","pgxind-kftx5s7s","pgxcs-kftwmfg0",1356867660,0.472,720797339,0.251,636070321,0.221,"PGX_AM_BS_GSM879223","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.185000",,,,,,,,"P15Y",,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0042","",,,"U-2 OS","cell line"
"5dc17be309d374f6dd79477f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","cellosaurus:CVCL_0312","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjude","pgxind-kftx5sz9","pgxcs-kftwmkea",722920466,0.251,116182894,0.04,606737572,0.211,"PGX_AM_BS_GSM170248","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.786000",,,,,,,,"P13Y",,,"geo:GSM170248","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"geo:gse","geo:GSE7077","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL2879","",,,,
"5dc17be709d374f6dd794832","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudj","pgxind-kftx5szg","pgxcs-kftwmkf8",585587290,0.204,338727043,0.118,246860247,0.086,"PGX_AM_BS_GSM256075","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.790000",,,,,,,,,,,"geo:GSM256075","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gse","geo:GSE10132","",,,,,"geo:gpl","geo:GPL6359","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794833","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudl","pgxind-kftx5szi","pgxcs-kftwmkfk",1474530670,0.513,845233049,0.294,629297621,0.219,"PGX_AM_BS_GSM256076","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.791000",,,,,,,,,,,"geo:GPL6359","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256076","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794834","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudm","pgxind-kftx5szk","pgxcs-kftwmkfv",1321785373,0.46,739532302,0.257,582253071,0.203,"PGX_AM_BS_GSM256077","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.792000",,,,,,,,,,,"geo:GPL6359","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256077","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd79483c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GPL6359","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudz","pgxind-kftx5t00","pgxcs-kftwmkif",1258439015,0.438,702147818,0.244,556291197,0.193,"PGX_AM_BS_GSM256085","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.800000",,,,,,,,,,,"geo:GSE10132","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","geo:gsm","geo:GSM256085","",,,,,"cellosaurus","cellosaurus:CVCL_0317","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794844","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjued","pgxind-kftx5t0g","pgxcs-kftwmkky",1324333498,0.461,843528829,0.293,480804669,0.167,"PGX_AM_BS_GSM256093","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.809000",,,,,,,,,,,"geo:GSM256093","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL6359","",,,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794846","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GPL6359","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjueg","pgxind-kftx5t0k","pgxcs-kftwmkll",1209191297,0.421,483524283,0.168,725667014,0.252,"PGX_AM_BS_GSM256095","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.811000",,,,,,,,,,,"geo:GSE10132","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256095","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd79484a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuen","pgxind-kftx5t0s","pgxcs-kftwmkmv",270007222,0.094,22192168,0.008,247815054,0.086,"PGX_AM_BS_GSM256099","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.815000",,,,,,,,,,,"geo:GSM256099","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL6359","",,,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd79484b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjueo","pgxind-kftx5t0u","pgxcs-kftwmkn7",480522067,0.167,207330990,0.072,273191077,0.095,"PGX_AM_BS_GSM256100","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.816000",,,,,,,,,,,"geo:GPL6359","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","geo:gsm","geo:GSM256100","",,,,,"cellosaurus","cellosaurus:CVCL_0317","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd79484f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSM256104","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuev","pgxind-kftx5t12","pgxcs-kftwmkog",1097077382,0.382,424032229,0.147,673045153,0.234,"PGX_AM_BS_GSM256104","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.820000",,,,,,,,,,,"cellosaurus:CVCL_0317","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","geo:gse","geo:GSE10132","",,,,,"geo:gpl","geo:GPL6359","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794851","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuez","pgxind-kftx5t16","pgxcs-kftwmkp2",599918722,0.209,323930893,0.113,275987829,0.096,"PGX_AM_BS_GSM256106","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.822000",,,,,,,,,,,"geo:GPL6359","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,,"geo:gsm","geo:GSM256106","","arraymap import",,,,,,,,,,,,,,,
"5dc17be709d374f6dd794858","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjufa","pgxind-kftx5t1k","pgxcs-kftwmkr9",1436433927,0.5,689512490,0.24,746921437,0.26,"PGX_AM_BS_GSM256113","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.830000",,,,,,,,,,,"geo:GPL6359","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","geo:gsm","geo:GSM256113","",,,,,"cellosaurus","cellosaurus:CVCL_0317","","arraymap import",,,,,,,,,,,,,,,
"5dc17bf209d374f6dd796459","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","cellosaurus:CVCL_0426","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjugt","pgxind-kftx5t3g","pgxcs-kftwml3a",1729284741,0.601,1110759283,0.386,618525458,0.215,"PGX_AM_BS_GSM170251","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.870000",,,,,,,,,,,"geo:GSM170251","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE7077","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL2879","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5dc17c0109d374f6dd797070","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-3]","geo:GSM393031","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjujv","pgxind-kftx5t76","pgxcs-kftwmm0e",626214146,0.218,489713123,0.17,136501023,0.047,"PGX_AM_BS_GSM393031","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.952000",,,,,,,,,,,"cellosaurus:CVCL_5170","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3718","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd797071","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM393017","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjujw","pgxind-kftx5t78","pgxcs-kftwmlvh",349382382,0.122,381948,0,349000434,0.121,"PGX_AM_BS_GSM393017","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.953000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE15696","",,,,,,,,"arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd797076","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM393022","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk4","pgxind-kftx5t7i","pgxcs-kftwmlx3",760332152,0.264,3157632,0.001,757174520,0.263,"PGX_AM_BS_GSM393022","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.958000",,,,,,,,,,,"geo:GSE15696","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.56,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd797078","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk8","pgxind-kftx5t7m","pgxcs-kftwmlxq",2575077376,0.896,1351409861,0.47,1223667515,0.426,"PGX_AM_BS_GSM393024","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.961000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393024","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd797079","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk9","pgxind-kftx5t7o","pgxcs-kftwmly2",1678059018,0.584,1186016079,0.413,492042939,0.171,"PGX_AM_BS_GSM393025","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.962000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393025","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd79707b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-ES-1]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukd","pgxind-kftx5t7t","pgxcs-kftwmlys",881818415,0.307,201062203,0.07,680756212,0.237,"PGX_AM_BS_GSM393027","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.964000",,,,,,,,,,,"geo:GSE15696","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_0627","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM393027","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17c0109d374f6dd79707c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line ES-1-OT]","geo:GSM393028","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukf","pgxind-kftx5t7v","pgxcs-kftwmlz7",1350344004,0.47,884383305,0.308,465960699,0.162,"PGX_AM_BS_GSM393028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.966000",,,,,,,,,,,"cellosaurus:CVCL_5122","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3718","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd79707d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-1]","geo:GSM393029","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukh","pgxind-kftx5t7w","pgxcs-kftwmlzl",461454117,0.161,310691363,0.108,150762754,0.052,"PGX_AM_BS_GSM393029","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.967000",,,,,,,,,,,"cellosaurus:CVCL_5168","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL3718","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE15696","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17c0109d374f6dd79707e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-2]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuki","pgxind-kftx5t7z","pgxcs-kftwmm00",1437160405,0.5,17510813,0.006,1419649592,0.494,"PGX_AM_BS_GSM393030","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.968000",,,,,,,,,,,"geo:GSE15696","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393030","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_5169","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd797080","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-6]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukm","pgxind-kftx5t83","pgxcs-kftwmm18",963224119,0.335,479778139,0.167,483445980,0.168,"PGX_AM_BS_GSM393033","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.971000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_5172","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM393033","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd797082","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-8]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukp","pgxind-kftx5t87","pgxcs-kftwmm21",769415114,0.268,280959333,0.098,488455781,0.17,"PGX_AM_BS_GSM393035","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.973000",,,,,,,,,,,"geo:GSE15696","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393035","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_5174","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd797083","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-N-PI]","geo:GSM393036","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukr","pgxind-kftx5t89","pgxcs-kftwmm2g",658585294,0.229,307150604,0.107,351434690,0.122,"PGX_AM_BS_GSM393036","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.975000",,,,,,,,,,,"cellosaurus:CVCL_S664","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL3718","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE15696","","arraymap import",0.48,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd797087","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line KP-PN-TTBm2]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukx","pgxind-kftx5t8h","pgxcs-kftwmm3z",611637757,0.213,284270731,0.099,327367026,0.114,"PGX_AM_BS_GSM393040","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.979000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393040","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_5147","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17c0109d374f6dd797089","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RD-ES]","geo:GPL2004","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjul1","pgxind-kftx5t8l","pgxcs-kftwmm4q",1152168769,0.401,440996405,0.153,711172364,0.247,"PGX_AM_BS_GSM393042","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.982000",,,,,,,,,,,"geo:GSE15696","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393042","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_2169","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.62,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0109d374f6dd79708a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line UTP-ES1]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjul2","pgxind-kftx5t8n","pgxcs-kftwmm54",1395484188,0.485,754856400,0.263,640627788,0.223,"PGX_AM_BS_GSM393043","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.983000",,,,,,,,,,,"geo:GPL2004","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_DH85","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM393043","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17c0509d374f6dd797881","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSM879222","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjull","pgxind-kftx5t9b","pgxcs-kftwmm82",1797249074,0.625,913787260,0.318,883461814,0.307,"PGX_AM_BS_GSM879222","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.998000",,,,,,,,,,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0548","",,,"Saos-2","cell line"
"5dc17c0a09d374f6dd7980f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing's Sarcoma [cell line SKES1]","geo:GSM510017","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","EWING SARCOMA","icdot-C41.9","Bone, NOS","pgxbs-kftvjumd","pgxind-kftx5ta9","pgxcs-kftwmme1",986126033,0.343,161579938,0.056,824546095,0.287,"PGX_AM_BS_GSM510017","{}",-101.19,20.57,"Point","MEX","Salamanca","Mexico","Salamanca, Mexico",20.57,-101.19,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.018000",,,,,,,,,,,"geo:GSE20356","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0627","",,,"SKES1","cell line"
"5dc17c0a09d374f6dd7980f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing's Sarcoma [cell line SKES1]","geo:GSM510018","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","EWING SARCOMA","icdot-C41.9","Bone, NOS","pgxbs-kftvjumf","pgxind-kftx5tab","pgxcs-kftwmmei",790231297,0.275,51180713,0.018,739050584,0.257,"PGX_AM_BS_GSM510018","{}",-101.19,20.57,"Point","MEX","Salamanca","Mexico","Salamanca, Mexico",20.57,-101.19,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.020000",,,,,,,,,,,"geo:GSE20356","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0627","",,,"SKES1","cell line"
"5dc17c3f09d374f6dd79dc81","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma [cell line SW872]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuxh","pgxind-kftx5tnu","pgxcs-kftwmp5u",1006134071,0.35,474415118,0.165,531718953,0.185,"PGX_AM_BS_GSM482514","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.327000",,,,,,,,,,,"geo:GSE19399","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_1730","","arraymap import",0.5,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.46,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482514","",,,,
"5dc17c6e09d374f6dd7a2eef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS05]","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjv7q","pgxind-kftx5u07","pgxcs-kftwmrge",408344543,0.142,378230653,0.132,30113890,0.01,"PGX_AM_BS_GSM482504","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.592000",,,,,,,,,,,"geo:GSE19399","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM482504","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_5I00","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,
"5dc17c7b09d374f6dd7a432e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Monophasic synovial sarcoma [cell line HS-SY-2]","geo:GSM482569","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjva7","pgxind-kftx5u3c","pgxcs-kftwms1o",1300272173,0.452,175824597,0.061,1124447576,0.391,"PGX_AM_BS_GSM482569","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.667000",,,,,,,,,,,"cellosaurus:CVCL_8719","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE19399","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,,
"5dc17c8309d374f6dd7a5b5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS14]","geo:GSM879211","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbs","pgxind-kftx5u5b","pgxcs-kftwms72",0,0,0,0,0,0,"PGX_AM_BS_GSM879211","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.717000",,,,,,,,"P13Y",,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","cellosaurus","cellosaurus:CVCL_9990","",,,"IOR/OS14","cell line"
"5dc17c8409d374f6dd7a5d31","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS15]","geo:GSM879212","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbu","pgxind-kftx5u5d","pgxcs-kftwms7k",0,0,0,0,0,0,"PGX_AM_BS_GSM879212","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.718000",,,,,,,,,,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9991","",,,"IOR/OS15","cell line"
"5dc17c8409d374f6dd7a5e46","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS18]","geo:GSM879213","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbw","pgxind-kftx5u5f","pgxcs-kftwms82",2113352049,0.735,951924865,0.331,1161427184,0.404,"PGX_AM_BS_GSM879213","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.720000",,,,,,,,"P33Y",,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9993","",,,"IOR/OS18","metastasis"
"5dc17c8409d374f6dd7a61bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/SARG]","geo:GSM879215","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbx","pgxind-kftx5u5h","pgxcs-kftwms8k",0,0,0,0,0,0,"PGX_AM_BS_GSM879215","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.721000",,,,,,,,,,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9995","",,,"IOR/SARG","cell line"
"5dc17c9009d374f6dd7a6e78","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line MHM]","geo:GSM879218","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvf0","pgxind-kftx5u9b","pgxcs-kftwmsrc",1865160594,0.649,923077315,0.321,942083279,0.328,"PGX_AM_BS_GSM879218","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.803000",,,,,,,,"P41Y",,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_B426","",,,"MHM","metastasis"
"5dc17c9209d374f6dd7a741f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line HAL]","geo:GSM879207","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvfa","pgxind-kftx5u9n","pgxcs-kftwmstx",1669041877,0.581,757383055,0.263,911658822,0.317,"PGX_AM_BS_GSM879207","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.811000",,,,,,,,"P15Y",,,"geo:GSE36003","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_D788","",,,"HAL","cell line"
"5dc17ca709d374f6dd7a97c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pleomorphic liposarcoma [cell line LiSa-2]","geo:GSE19399","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvjp","pgxind-kftx5uf1","pgxcs-kftwmu3j",903906771,0.314,451447221,0.157,452459550,0.157,"PGX_AM_BS_GSM482515","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.943000",,,,,,,,,,,"geo:GPL3720","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_M821","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482515","",,,,
"5dc17cab09d374f6dd7aa40b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkc","pgxind-kftx5uft","pgxcs-kftwmuaa",1581196569,0.55,652082017,0.227,929114552,0.323,"PGX_AM_BS_GSM1012753","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.964000",,,,,,,,,,,"geo:GPL2004","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_W527","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gsm","geo:GSM1012753","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.82,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17cab09d374f6dd7aa40c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GPL2004","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvke","pgxind-kftx5ufv","pgxcs-kftwmu9v",1519445948,0.529,633843365,0.22,885602583,0.308,"PGX_AM_BS_GSM1012752","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.965000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012752","",,"pgxcohort-celllines","Cancer cell lines",,"cellosaurus","cellosaurus:CVCL_W527","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17cab09d374f6dd7aa40d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","cellosaurus:CVCL_W527","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkf","pgxind-kftx5ufx","pgxcs-kftwmuap",455672608,0.158,150603992,0.052,305068616,0.106,"PGX_AM_BS_GSM1012754","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.966000",,,,,,,,,,,"geo:GSM1012754","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE41263","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gpl","geo:GPL2004","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17cab09d374f6dd7aa40e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012755","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkh","pgxind-kftx5ufz","pgxcs-kftwmub3",1675555505,0.583,957514844,0.333,718040661,0.25,"PGX_AM_BS_GSM1012755","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.967000",,,,,,,,,,,"cellosaurus:CVCL_W527","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL2004","",,"pgxcohort-celllines","Cancer cell lines",,"geo:gse","geo:GSE41263","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17cb009d374f6dd7aa59c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkm","pgxind-kftx5ug5","pgxcs-kftwmurp",939920384,0.327,441476206,0.154,498444178,0.173,"PGX_AM_BS_GSM1012758","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.971000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012758","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17cb009d374f6dd7aa5ac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012728","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvlc","pgxind-kftx5uh1","pgxcs-kftwmuh1",1781401932,0.62,823461462,0.286,957940470,0.333,"PGX_AM_BS_GSM1012728","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.989000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2004","",,,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.74,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17cb009d374f6dd7aa5b5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012737","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvlr","pgxind-kftx5uhj","pgxcs-kftwmumy",1210406514,0.421,429206022,0.149,781200492,0.272,"PGX_AM_BS_GSM1012737","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.998000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE41263","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5b6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012738","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvlt","pgxind-kftx5uhl","pgxcs-kftwmun9",362231105,0.126,37442556,0.013,324788549,0.113,"PGX_AM_BS_GSM1012738","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.999000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5b7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012739","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, nos","pgxbs-kftvjvlu","pgxind-kftx5uhn","pgxcs-kftwmunl",1167846895,0.406,752273554,0.262,415573341,0.145,"PGX_AM_BS_GSM1012739","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5b9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvly","pgxind-kftx5uhr","pgxcs-kftwmuo7",1523070188,0.53,1134302565,0.395,388767623,0.135,"PGX_AM_BS_GSM1012741","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.003000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012741","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5ba","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012742","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvlz","pgxind-kftx5uht","pgxcs-kftwmuoj",964002832,0.335,563090376,0.196,400912456,0.139,"PGX_AM_BS_GSM1012742","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.004000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvm1","pgxind-kftx5uhv","pgxcs-kftwmuou",1278764123,0.445,646100728,0.225,632663395,0.22,"PGX_AM_BS_GSM1012743","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.005000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM1012743","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012744","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvm3","pgxind-kftx5uhx","pgxcs-kftwmup6",1002209325,0.349,429049051,0.149,573160274,0.199,"PGX_AM_BS_GSM1012744","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.006000",,,,,,,,,,,"geo:GPL3718","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE41263","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5bd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvm5","pgxind-kftx5uhz","pgxcs-kftwmuph",1799772824,0.626,974799154,0.339,824973670,0.287,"PGX_AM_BS_GSM1012745","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.007000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012745","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5c2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012750","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvmd","pgxind-kftx5ui9","pgxcs-kftwmur2",1634918613,0.569,956575905,0.333,678342708,0.236,"PGX_AM_BS_GSM1012750","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.012000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17cb009d374f6dd7aa5c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528054","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmg","pgxind-kftx5uid","pgxcs-kftwmus0",193948550,0.067,177615676,0.062,16332874,0.006,"PGX_AM_BS_GSM1528054","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.015000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17cb009d374f6dd7aa5c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528055","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmi","pgxind-kftx5uif","pgxcs-kftwmusi",1489799079,0.518,911176883,0.317,578622196,0.201,"PGX_AM_BS_GSM1528055","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.016000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17cb009d374f6dd7aa5c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528057","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvml","pgxind-kftx5uij","pgxcs-kftwmuth",1917786312,0.667,1383565577,0.481,534220735,0.186,"PGX_AM_BS_GSM1528057","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.019000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17cb009d374f6dd7aa5c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528059","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmp","pgxind-kftx5uio","pgxcs-kftwmuuh",164433106,0.057,1259971,0,163173135,0.057,"PGX_AM_BS_GSM1528059","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.022000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17cb009d374f6dd7aa5cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528061","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvms","pgxind-kftx5uis","pgxcs-kftwmuvg",1843936398,0.641,1299154444,0.452,544781954,0.189,"PGX_AM_BS_GSM1528061","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.025000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17cb009d374f6dd7aa5cc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1530028","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmu","pgxind-kftx5uiu","pgxcs-kftwmuvx",1847510121,0.643,1323358464,0.46,524151657,0.182,"PGX_AM_BS_GSM1530028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.026000",,,,,,,,,,,"geo:GSE41263","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559551","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe8","pgxind-kftx5woq","pgxcs-kftwn9tp",1436214339,0.5,1129135551,0.393,307078788,0.107,"PGX_AM_BS_GSM1559551","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.871000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559552","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe9","pgxind-kftx5wos","pgxcs-kftwn9u7",2174000976,0.756,1272532144,0.443,901468832,0.314,"PGX_AM_BS_GSM1559552","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.873000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559554","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxed","pgxind-kftx5wox","pgxcs-kftwn9v7",1315572458,0.458,1018900463,0.354,296671995,0.103,"PGX_AM_BS_GSM1559554","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.876000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3f3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559556","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxeg","pgxind-kftx5wp1","pgxcs-kftwn9w6",989120112,0.344,434524931,0.151,554595181,0.193,"PGX_AM_BS_GSM1559556","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.879000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559562","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxeq","pgxind-kftx5wpd","pgxcs-kftwn9z4",406309536,0.141,204030361,0.071,202279175,0.07,"PGX_AM_BS_GSM1559562","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.887000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce3fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559567","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxey","pgxind-kftx5wpn","pgxcs-kftwna1l",0,0,0,0,0,0,"PGX_AM_BS_GSM1559567","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.894000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce400","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559569","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxf1","pgxind-kftx5wpr","pgxcs-kftwna2l",0,0,0,0,0,0,"PGX_AM_BS_GSM1559569","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.897000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17dcb09d374f6dd7ce402","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559571","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxf4","pgxind-kftx5wpv","pgxcs-kftwna3k",1397681142,0.486,747658162,0.26,650022980,0.226,"PGX_AM_BS_GSM1559571","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.900000",,,,,,,,,,,"geo:GSE63891","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.64,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary"
"5dc17eda09d374f6dd7e5992","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze3","pgxind-kftx5yqh","pgxcs-kftwnofc",1935794411,0.673,884834173,0.308,1050960238,0.366,"PGX_AM_BS_GSM608963","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.506000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608963","",,,,,,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17eda09d374f6dd7e5993","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze5","pgxind-kftx5yqj","pgxcs-kftwnofo",1297643359,0.451,802834612,0.279,494808747,0.172,"PGX_AM_BS_GSM608964","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.508000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608964","",,,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0567","Afro-Caribbean",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17eda09d374f6dd7e5995","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608966","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze8","pgxind-kftx5yqn","pgxcs-kftwnogb",1604494403,0.558,792098610,0.276,812395793,0.283,"PGX_AM_BS_GSM608966","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.510000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e5996","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608967","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze9","pgxind-kftx5yqp","pgxcs-kftwnogn",1918270231,0.667,700571035,0.244,1217699196,0.424,"PGX_AM_BS_GSM608967","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.511000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0567","Afro-Caribbean",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17eda09d374f6dd7e5998","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzed","pgxind-kftx5yqt","pgxcs-kftwnoh9",1559601901,0.542,813233208,0.283,746368693,0.26,"PGX_AM_BS_GSM608969","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.513000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608969","",,,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17eda09d374f6dd7e5999","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzef","pgxind-kftx5yqv","pgxcs-kftwnohl",1339383050,0.466,880786230,0.306,458596820,0.16,"PGX_AM_BS_GSM608970","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.514000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608970","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e599d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzem","pgxind-kftx5yr3","pgxcs-kftwnoiu",1790941184,0.623,676384805,0.235,1114556379,0.388,"PGX_AM_BS_GSM608974","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.519000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608974","",,,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e59a3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzev","pgxind-kftx5yrg","pgxcs-kftwnokr",1548818303,0.539,674321557,0.235,874496746,0.304,"PGX_AM_BS_GSM608980","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.525000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608980","",,,,,,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e59a8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608985","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf4","pgxind-kftx5yrt","pgxcs-kftwnomf",1674322512,0.582,897573908,0.312,776748604,0.27,"PGX_AM_BS_GSM608985","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.531000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,
"5dc17eda09d374f6dd7e59ac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfa","pgxind-kftx5ys1","pgxcs-kftwnonp",2261001252,0.786,1467837725,0.511,793163527,0.276,"PGX_AM_BS_GSM608989","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.535000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608989","",,,,,,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.54,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e59ad","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfc","pgxind-kftx5ys3","pgxcs-kftwnoo1",1853179965,0.645,1245756237,0.433,607423728,0.211,"PGX_AM_BS_GSM608990","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.537000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608990","",,,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17eda09d374f6dd7e59bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfy","pgxind-kftx5ysw","pgxcs-kftwnosh",1028129069,0.358,522461419,0.182,505667650,0.176,"PGX_AM_BS_GSM609004","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.552000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609004","",,,,,,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17eda09d374f6dd7e59be","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzg3","pgxind-kftx5yt2","pgxcs-kftwnote",533475028,0.186,130746766,0.045,402728262,0.14,"PGX_AM_BS_GSM609007","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.556000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609007","",,,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0420","Peruvian",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17eda09d374f6dd7e59bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzg5","pgxind-kftx5yt4","pgxcs-kftwnotq",1488233682,0.518,615794708,0.214,872438974,0.303,"PGX_AM_BS_GSM609008","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.557000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609008","",,,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17eda09d374f6dd7e59c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608992","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzgf","pgxind-kftx5yth","pgxcs-kftwnooo",1499605953,0.522,960489933,0.334,539116020,0.188,"PGX_AM_BS_GSM608992","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.563000",,,,,,,,,,,"geo:GSE24715","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,
"5dc17ee409d374f6dd7e73ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GPL5750","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzhc","pgxind-kftx5yum","pgxcs-kftwnp1x",330780385,0.115,91309933,0.032,239470452,0.083,"PGX_AM_BS_GSM218576","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.584000",,,,,,,,,,,"geo:GSE8798","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:gse","geo:gsm","geo:GSM218576","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhd","pgxind-kftx5yuo","pgxcs-kftwnp28",921802483,0.321,331205643,0.115,590596840,0.205,"PGX_AM_BS_GSM218577","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.585000",,,,,,,,,,,"geo:GPL5750","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:gpl","geo:gsm","geo:GSM218577","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218578","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhf","pgxind-kftx5yuq","pgxcs-kftwnp2j",876140936,0.305,249713331,0.087,626427605,0.218,"PGX_AM_BS_GSM218578","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.586000",,,,,,,,,,,"geo:GSE8798","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL5750","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73f5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218584","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzhp","pgxind-kftx5yv1","pgxcs-kftwnp4f",1054083435,0.367,398022352,0.138,656061083,0.228,"PGX_AM_BS_GSM218584","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.593000",,,,,,,,,,,"geo:GSE8798","","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL5750","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218657","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhq","pgxind-kftx5yv3","pgxcs-kftwnp4r",1809939295,0.63,736652836,0.256,1073286459,0.373,"PGX_AM_BS_GSM218657","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.594000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17ee409d374f6dd7e73f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhs","pgxind-kftx5yv5","pgxcs-kftwnp52",2028442631,0.706,907661240,0.316,1120781391,0.39,"PGX_AM_BS_GSM218658","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.595000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM218658","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17ee409d374f6dd7e73fa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218661","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhx","pgxind-kftx5yvb","pgxcs-kftwnp61",82340753,0.029,7114491,0.002,75226262,0.026,"PGX_AM_BS_GSM218661","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.598000",,,,,,,,,,,"geo:GSE8798","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17ee409d374f6dd7e73fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218662","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzhz","pgxind-kftx5yvd","pgxcs-kftwnp6c",405823694,0.141,178083526,0.062,227740168,0.079,"PGX_AM_BS_GSM218662","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.599000",,,,,,,,,,,"geo:GSE8798","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,
"5dc17ee409d374f6dd7e73fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218664","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzi2","pgxind-kftx5yvh","pgxcs-kftwnp92",1803714502,0.627,995367446,0.346,808347056,0.281,"PGX_AM_BS_GSM218664","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.602000",,,,,,,,,,,"geo:GPL2005","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc17fd709d374f6dd7ed8b9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM207904","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvk11m","pgxind-kftx60s2","pgxcs-kftwo34p",17221313,0.006,16800417,0.006,420896,0,"PGX_AM_BS_GSM207904","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:28.099000",,,,,,,,,,,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8398","",,,,,"geo:gpl","geo:GPL2879","","arraymap import",,,,,,,,,,,,,,,
"5dc17fd809d374f6dd7ed8e4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM207911","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvk11y","pgxind-kftx60sg","pgxcs-kftwo36w",134674878,0.047,86328541,0.03,48346337,0.017,"PGX_AM_BS_GSM207911","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:28.106000",,,,,,,,,,,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8398","",,,,,"geo:gpl","geo:GPL2879","","arraymap import",,,,,,,,,,,,,,,
"5dc17fd909d374f6dd7eda44","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM207914","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvk122","pgxind-kftx60sm","pgxcs-kftwo37t",187246037,0.065,179252008,0.062,7994029,0.003,"PGX_AM_BS_GSM207914","{}",-3.7,40.42,"Point","ESP","Madrid","Spain","Madrid, Spain",40.42,-3.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:28.109000",,,,,,,,,1,11,"PMID:17952124","Ferreira BI, Alonso J et al. (2008): Array CGH and gene-expression profiling reveals...","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL2879","",,,,,"geo:gse","geo:GSE8398","","arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108568","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82j","pgxind-kftx69du","pgxcs-kftwpo9l",2670545460,0.929,1855508262,0.645,815037198,0.283,"PGX_AM_BS_GSM108568","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.167000",,,,,,,,,,,"geo:GSE4838","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3749","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108572","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82l","pgxind-kftx69dw","pgxcs-kftwpoa0",2421318648,0.842,1864726911,0.649,556591737,0.194,"PGX_AM_BS_GSM108572","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.168000",,,,,,,,,,,"geo:GSE4838","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3749","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GPL3749","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82n","pgxind-kftx69dy","pgxcs-kftwpoae",2525485061,0.878,2166551894,0.754,358933167,0.125,"PGX_AM_BS_GSM108972","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.170000",,,,,,,,,,,"geo:GSE4838","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM108972","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108975","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82q","pgxind-kftx69e2","pgxcs-kftwpobk",1948950785,0.678,1706491972,0.594,242458813,0.084,"PGX_AM_BS_GSM108975","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.172000",,,,,,,,,,,"geo:GPL3749","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE4838","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd837950","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSE4838","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82r","pgxind-kftx69e4","pgxcs-kftwpobz",1664430584,0.579,1411035072,0.491,253395512,0.088,"PGX_AM_BS_GSM109004","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.173000",,,,,,,,,,,"geo:GPL3749","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM109004","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc1840b09d374f6dd837951","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSE4838","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82t","pgxind-kftx69e6","pgxcs-kftwpob8",2659098403,0.925,2077115970,0.722,581982433,0.202,"PGX_AM_BS_GSM108974","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.175000",,,,,,,,,,,"geo:GPL3749","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM108974","",,,,,,,,"arraymap import",,,,,,,,,,,,,,,
"5dc185b009d374f6dd860d20","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma [Mafucci syndrome]","geo:GSM656407","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvkarr","pgxind-kftx6d1c","pgxcs-kftwq87e",276746531,0.096,220784524,0.077,55962007,0.019,"PGX_AM_BS_GSM656407","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:37.488000",,,,,,,,,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE26674","",,,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc185b009d374f6dd860d24","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma [Mafucci syndrome]","geo:GSM656419","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvkary","pgxind-kftx6d1l","pgxcs-kftwq88n",284531877,0.099,281459114,0.098,3072763,0.001,"PGX_AM_BS_GSM656419","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:37.492000",,,,,,,,,,,"geo:GPL6801","","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE26674","",,,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,
"5dc1878d09d374f6dd897985","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567027","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke6z","pgxind-kftx6gvc","pgxcs-kftwqrlw",458953597,0.16,303733123,0.106,155220474,0.054,"PGX_AM_BS_GSM567027","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.660000",,,,,,,,"P23Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary"
"5dc1878d09d374f6dd89798d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade I [Ollier patient]","geo:GSM567061","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7c","pgxind-kftx6gvs","pgxcs-kftwqrwi",154542511,0.054,419511,0,154123000,0.054,"PGX_AM_BS_GSM567061","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.671000",,,,,,,,"P42Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary"
"5dc1878d09d374f6dd89798e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade I [Ollier patient]","geo:GSM567069","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7e","pgxind-kftx6gvu","pgxcs-kftwqrxh",0,0,0,0,0,0,"PGX_AM_BS_GSM567069","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.672000",,,,,,,,"P23Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary"
"5dc1878d09d374f6dd897997","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567338","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7t","pgxind-kftx6gwd","pgxcs-kftwqs76",1717566648,0.597,983636526,0.342,733930122,0.255,"PGX_AM_BS_GSM567338","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.685000",,,,,,,,"P68Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.0399999999999999,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary"
"5dc1878d09d374f6dd897998","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567340","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7v","pgxind-kftx6gwf","pgxcs-kftwqsa2",0,0,0,0,0,0,"PGX_AM_BS_GSM567340","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.687000",,,,,,,,"P63Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary"
"5dc1878d09d374f6dd89799a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567344","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7y","pgxind-kftx6gwj","pgxcs-kftwqsc0",0,0,0,0,0,0,"PGX_AM_BS_GSM567344","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.690000",,,,,,,,"P48Y",,,"geo:GSE22965","","pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary"
"5f5a354582925370d25adf93","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638949",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkij1","pgxind-kftx6m7r","pgxcs-kftwsi47",1798084839,0.625,634630359,0.221,1163454480,0.405,"PGX_AM_BS_GSM1638949",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.381000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding",,,"P56Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf94","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638950",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkij3","pgxind-kftx6m7t","pgxcs-kftwsi4p",2061338509,0.717,1254446105,0.436,806892404,0.281,"PGX_AM_BS_GSM1638950",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.382000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding",,,"P39Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf9c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638959",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijg","pgxind-kftx6m8a","pgxcs-kftwsi8l",1010643965,0.352,817670616,0.284,192973349,0.067,"PGX_AM_BS_GSM1638959",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.393000","T2","NCITstage-C28054","Stage II","TNM-C48724","T2 Stage Finding",,,"P38Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917699",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijl","pgxind-kftx6m8g","pgxcs-kftwsia1",793272664,0.276,654852486,0.228,138420178,0.048,"PGX_AM_BS_GSM1917699",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.398000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding",,,"P64Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adfa0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917700",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijn","pgxind-kftx6m8i","pgxcs-kftwsiai",1081760010,0.376,770934553,0.268,310825457,0.108,"PGX_AM_BS_GSM1917700",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.399000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding",,,"P38Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae20f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine leiomyosarcoma","geo:GSM2753044",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterine, NOS","pgxbs-kftvkjbp","pgxind-kftx6n7u","pgxcs-kftwsr5u",694871713,0.242,530887763,0.185,163983950,0.057,"PGX_AM_BS_GSM2753044","{}",12.14,54.09,"Point","DEU","Rostock","Germany","Rostock, Germany",54.09,12.14,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:46.286000",,,,,,,,,,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:29963223","Holzmann C, Saager C et al. (2018): Malignant transformation of uterine leiomyoma to...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae29b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma lung metastasis [Li-Fraumeni Syndrome]","geo:GSM1568172",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkji0","pgxind-kftx6nfr","pgxcs-kftwst5m",1523549432,0.53,623982340,0.217,899567092,0.313,"PGX_AM_BS_GSM1568172","{}",-111.89,40.76,"Point","USA","Salt Lake City","United States of America","Salt Lake City, United States of America",40.76,-111.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:46.480000",,,,,,,,,,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:25762628","Ribi S, Baumhoer D et al. (2015): TP53 intron 1 hotspot rearrangements are...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae29c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma lung metastasis [Li-Fraumeni Syndrome]","geo:GSM1568173",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkji2","pgxind-kftx6nft","pgxcs-kftwst63",1928017089,0.671,1114829333,0.388,813187756,0.283,"PGX_AM_BS_GSM1568173","{}",-111.89,40.76,"Point","USA","Salt Lake City","United States of America","Salt Lake City, United States of America",40.76,-111.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:46.481000",,,,,,,,,,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:25762628","Ribi S, Baumhoer D et al. (2015): TP53 intron 1 hotspot rearrangements are...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354782925370d25ae30e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ovarian adenosarcoma","geo:GSM1638955",,"pgxfus-0002","no followup status","NCIT:C7317","Ovarian adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C56.9","Ovary","pgxbs-kftvkjn8","pgxind-kftx6nm8","pgxcs-kftwsus6",1230421522,0.428,702165748,0.244,528255774,0.184,"PGX_AM_BS_GSM1638955",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000992","ovary","{}","2020-09-10 17:46:46.642000","T2","NCITstage-C28054","Stage II","TNM-C48724","T2 Stage Finding",,,"P51Y",,,"geo:GPL18602",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklhu","pgxind-kftx6pxp","pgxcs-kftwyfkl",1225293726,0.426,521578076,0.181,703715650,0.245,"PGX_AM_BS_AE-MTAB_3034-OS011-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.761000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2d2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkli7","pgxind-kftx6py5","pgxcs-kftwyfs9",1044352754,0.363,853224776,0.297,191127978,0.066,"PGX_AM_BS_AE-MTAB_3034-OS034-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.772000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2d9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklij","pgxind-kftx6pyj","pgxcs-kftwyg1e",1397101961,0.486,788480802,0.274,608621159,0.212,"PGX_AM_BS_AE-MTAB_3034-OS053-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.782000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkliz","pgxind-kftx6pz4","pgxcs-kftwygb1",1370586535,0.477,476472299,0.166,894114236,0.311,"PGX_AM_BS_AE-MTAB_3034-OS088-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.797000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2e5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklj2","pgxind-kftx6pz8","pgxcs-kftwygcz",1488417332,0.518,788750329,0.274,699667003,0.243,"PGX_AM_BS_AE-MTAB_3034-OS098-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.800000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklji","pgxind-kftx6pzs","pgxcs-kftwygmo",1549076472,0.539,721425901,0.251,827650571,0.288,"PGX_AM_BS_AE-MTAB_3034-OS137-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.814000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkljk","pgxind-kftx6pzu","pgxcs-kftwygnn",1121306258,0.39,709749032,0.247,411557226,0.143,"PGX_AM_BS_AE-MTAB_3034-OS148-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.815000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2f3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkljp","pgxind-kftx6q00","pgxcs-kftwygqk",798349155,0.278,513304984,0.179,285044171,0.099,"PGX_AM_BS_AE-MTAB_3034-OS157-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.820000",,,,,,,,,,,"geo:GPL6801",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36305667b527f2dbe7e4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4q","pgxind-kftx6rzp","pgxcs-kftwzgwe",1250648244,0.435,892496897,0.31,358151347,0.125,"PGX_AM_BS_AE-MTAB_3998-OS001-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.614000",,,,,,,,"P4Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7e6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4t","pgxind-kftx6rzt","pgxcs-kftwzgyc",1452430035,0.505,856295894,0.298,596134141,0.207,"PGX_AM_BS_AE-MTAB_3998-OS007-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.617000",,,,,,,,"P74Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn56","pgxind-kftx6s09","pgxcs-kftwzh62",1638992602,0.57,716144891,0.249,922847711,0.321,"PGX_AM_BS_AE-MTAB_3998-OS031-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.628000",,,,,,,,"P51Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn59","pgxind-kftx6s0d","pgxcs-kftwzh80",1050326417,0.365,923114737,0.321,127211680,0.044,"PGX_AM_BS_AE-MTAB_3998-OS034-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.631000",,,,,,,,"P19Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5b","pgxind-kftx6s0f","pgxcs-kftwzh90",676842587,0.235,177525987,0.062,499316600,0.174,"PGX_AM_BS_AE-MTAB_3998-OS038-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.633000",,,,,,,,"P23Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5i","pgxind-kftx6s0n","pgxcs-kftwzhct",1827789424,0.636,815583556,0.284,1012205868,0.352,"PGX_AM_BS_AE-MTAB_3998-OS046-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.638000",,,,,,,,"P10Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5n","pgxind-kftx6s0t","pgxcs-kftwzhfq",1364140764,0.474,1115155219,0.388,248985545,0.087,"PGX_AM_BS_AE-MTAB_3998-OS050-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.643000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5o","pgxind-kftx6s0v","pgxcs-kftwzhgp",1340392621,0.466,657940678,0.229,682451943,0.237,"PGX_AM_BS_AE-MTAB_3998-OS053-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.644000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5s","pgxind-kftx6s0z","pgxcs-kftwzhim",1858747609,0.647,696442386,0.242,1162305223,0.404,"PGX_AM_BS_AE-MTAB_3998-OS059-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.647000",,,,,,,,"P13Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5u","pgxind-kftx6s11","pgxcs-kftwzhjl",875573309,0.305,1593278,0.001,873980031,0.304,"PGX_AM_BS_AE-MTAB_3998-OS060-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.648000",,,,,,,,"P5Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5v","pgxind-kftx6s13","pgxcs-kftwzhkk",1581969383,0.55,841797975,0.293,740171408,0.257,"PGX_AM_BS_AE-MTAB_3998-OS061-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.650000",,,,,,,,"P12Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5x","pgxind-kftx6s16","pgxcs-kftwzhlk",1641404150,0.571,924063518,0.321,717340632,0.25,"PGX_AM_BS_AE-MTAB_3998-OS062-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.651000",,,,,,,,"P10Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ff","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5y","pgxind-kftx6s18","pgxcs-kftwzhmj",1376534989,0.479,567435649,0.197,809099340,0.281,"PGX_AM_BS_AE-MTAB_3998-OS063-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.653000",,,,,,,,"P17Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe800","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn60","pgxind-kftx6s1a","pgxcs-kftwzhni",1117857699,0.389,405731127,0.141,712126572,0.248,"PGX_AM_BS_AE-MTAB_3998-OS065-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.654000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe801","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn62","pgxind-kftx6s1c","pgxcs-kftwzhog",1157675713,0.403,877837968,0.305,279837745,0.097,"PGX_AM_BS_AE-MTAB_3998-OS072-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.656000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe802","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn64","pgxind-kftx6s1e","pgxcs-kftwzhpg",1226447390,0.427,797286869,0.277,429160521,0.149,"PGX_AM_BS_AE-MTAB_3998-OS073-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.657000",,,,,,,,"P6Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe803","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn65","pgxind-kftx6s1g","pgxcs-kftwzhqf",959662412,0.334,464953418,0.162,494708994,0.172,"PGX_AM_BS_AE-MTAB_3998-OS075-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.659000",,,,,,,,"P3Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6i","pgxind-kftx6s1w","pgxcs-kftwzhy7",1377670451,0.479,516215991,0.18,861454460,0.3,"PGX_AM_BS_AE-MTAB_3998-OS088-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.670000",,,,,,,,"P58Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6k","pgxind-kftx6s1y","pgxcs-kftwzhz6",373232536,0.13,152601980,0.053,220630556,0.077,"PGX_AM_BS_AE-MTAB_3998-OS089-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.672000",,,,,,,,"P13Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6l","pgxind-kftx6s20","pgxcs-kftwzi05",1230579822,0.428,558066072,0.194,672513750,0.234,"PGX_AM_BS_AE-MTAB_3998-OS097-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.673000",,,,,,,,"P36Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6n","pgxind-kftx6s22","pgxcs-kftwzi14",1225136346,0.426,924501509,0.322,300634837,0.105,"PGX_AM_BS_AE-MTAB_3998-OS099-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.675000",,,,,,,,"P9Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe810","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6q","pgxind-kftx6s26","pgxcs-kftwzi5h",1723982010,0.6,996068054,0.346,727913956,0.253,"PGX_AM_BS_AE-MTAB_3998-OS102-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.677000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe811","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6s","pgxind-kftx6s28","pgxcs-kftwzi6h",1313633672,0.457,838724628,0.292,474909044,0.165,"PGX_AM_BS_AE-MTAB_3998-OS103-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.679000",,,,,,,,"P60Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe812","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6t","pgxind-kftx6s2b","pgxcs-kftwzi7g",1596616157,0.555,799757006,0.278,796859151,0.277,"PGX_AM_BS_AE-MTAB_3998-OS104-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.680000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe815","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6y","pgxind-kftx6s2h","pgxcs-kftwziav",1598077074,0.556,927683597,0.323,670393477,0.233,"PGX_AM_BS_AE-MTAB_3998-OS109-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.685000",,,,,,,,"P13Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe816","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn70","pgxind-kftx6s2j","pgxcs-kftwzibu",1409847864,0.49,280221349,0.097,1129626515,0.393,"PGX_AM_BS_AE-MTAB_3998-OS112-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.686000",,,,,,,,"P23Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe817","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn72","pgxind-kftx6s2l","pgxcs-kftwzict",1884057497,0.655,1014909523,0.353,869147974,0.302,"PGX_AM_BS_AE-MTAB_3998-OS114-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.688000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe818","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn73","pgxind-kftx6s2n","pgxcs-kftwzids",1790600121,0.623,1022849220,0.356,767750901,0.267,"PGX_AM_BS_AE-MTAB_3998-OS115-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.689000",,,,,,,,"P16Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe820","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7g","pgxind-kftx6s33","pgxcs-kftwzilm",1679115161,0.584,705619778,0.245,973495383,0.339,"PGX_AM_BS_AE-MTAB_3998-OS126-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.701000",,,,,,,,"P6Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe824","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7n","pgxind-kftx6s3b","pgxcs-kftwzipk",1359643815,0.473,937314940,0.326,422328875,0.147,"PGX_AM_BS_AE-MTAB_3998-OS130-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.707000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe825","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7o","pgxind-kftx6s3d","pgxcs-kftwziqj",2022437717,0.703,1058790381,0.368,963647336,0.335,"PGX_AM_BS_AE-MTAB_3998-OS131-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.708000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe826","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7q","pgxind-kftx6s3f","pgxcs-kftwziri",1630741384,0.567,824795485,0.287,805945899,0.28,"PGX_AM_BS_AE-MTAB_3998-OS133-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.710000",,,,,,,,"P18Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe828","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7t","pgxind-kftx6s3j","pgxcs-kftwziti",1095968672,0.381,220797229,0.077,875171443,0.304,"PGX_AM_BS_AE-MTAB_3998-OS136-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.713000",,,,,,,,"P16Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe829","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7v","pgxind-kftx6s3l","pgxcs-kftwziui",1573414274,0.547,864294486,0.301,709119788,0.247,"PGX_AM_BS_AE-MTAB_3998-OS137-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.714000",,,,,,,,"P17Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7w","pgxind-kftx6s3n","pgxcs-kftwzivh",975392020,0.339,719134148,0.25,256257872,0.089,"PGX_AM_BS_AE-MTAB_3998-OS139-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.715000",,,,,,,,"P23Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn80","pgxind-kftx6s3r","pgxcs-kftwzixe",589851486,0.205,83580726,0.029,506270760,0.176,"PGX_AM_BS_AE-MTAB_3998-OS141-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.718000",,,,,,,,"P12Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn83","pgxind-kftx6s3w","pgxcs-kftwzizc",1454466084,0.506,543160549,0.189,911305535,0.317,"PGX_AM_BS_AE-MTAB_3998-OS145-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.721000",,,,,,,,"P24Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe830","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn86","pgxind-kftx6s40","pgxcs-kftwzj1a",1086491150,0.378,857499508,0.298,228991642,0.08,"PGX_AM_BS_AE-MTAB_3998-OS148-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.724000",,,,,,,,"P15Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe831","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn88","pgxind-kftx6s42","pgxcs-kftwzj29",1468541077,0.511,836241903,0.291,632299174,0.22,"PGX_AM_BS_AE-MTAB_3998-OS149-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.725000",,,,,,,,"P26Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe832","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8a","pgxind-kftx6s44","pgxcs-kftwzj39",1145000304,0.398,526242887,0.183,618757417,0.215,"PGX_AM_BS_AE-MTAB_3998-OS151-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.726000",,,,,,,,"P19Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe835","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8e","pgxind-kftx6s4a","pgxcs-kftwzj65",1837891540,0.639,675193397,0.235,1162698143,0.404,"PGX_AM_BS_AE-MTAB_3998-OS156-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.731000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe836","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8g","pgxind-kftx6s4c","pgxcs-kftwzj74",869484234,0.302,560187689,0.195,309296545,0.108,"PGX_AM_BS_AE-MTAB_3998-OS157-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.732000",,,,,,,,"P10Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe837","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8i","pgxind-kftx6s4e","pgxcs-kftwzj83",528300509,0.184,207374004,0.072,320926505,0.112,"PGX_AM_BS_AE-MTAB_3998-OS159-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.733000",,,,,,,,"P42Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe839","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8l","pgxind-kftx6s4i","pgxcs-kftwzjc5",1236004048,0.43,854953693,0.297,381050355,0.133,"PGX_AM_BS_AE-MTAB_3998-OS161-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.736000",,,,,,,,"P19Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8n","pgxind-kftx6s4k","pgxcs-kftwzjd6",1839278122,0.64,708389104,0.246,1130889018,0.393,"PGX_AM_BS_AE-MTAB_3998-OS162-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.738000",,,,,,,,"P14Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8q","pgxind-kftx6s4o","pgxcs-kftwzjf4",751852613,0.262,529067762,0.184,222784851,0.077,"PGX_AM_BS_AE-MTAB_3998-OS170-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.741000",,,,,,,,"P16Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8t","pgxind-kftx6s4s","pgxcs-kftwzjh3",1375148182,0.478,766441824,0.267,608706358,0.212,"PGX_AM_BS_AE-MTAB_3998-OS178-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.743000",,,,,,,,"P19Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8v","pgxind-kftx6s4u","pgxcs-kftwzji3",429438845,0.149,354411050,0.123,75027795,0.026,"PGX_AM_BS_AE-MTAB_3998-OS181-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.745000",,,,,,,,"P9Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe840","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8w","pgxind-kftx6s4w","pgxcs-kftwzjj2",1391415576,0.484,802841414,0.279,588574162,0.205,"PGX_AM_BS_AE-MTAB_3998-OS183-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.746000",,,,,,,,"P16Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe842","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8z","pgxind-kftx6s50","pgxcs-kftwzjl0",1341753245,0.467,571535930,0.199,770217315,0.268,"PGX_AM_BS_AE-MTAB_3998-OS188-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.749000",,,,,,,,"P8Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe845","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn94","pgxind-kftx6s57","pgxcs-kftwzjny",1961075673,0.682,1021983408,0.355,939092265,0.327,"PGX_AM_BS_AE-MTAB_3998-OS224-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.753000",,,,,,,,"P11Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe849","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9b","pgxind-kftx6s5f","pgxcs-kftwzjru",1818158339,0.632,1018695392,0.354,799462947,0.278,"PGX_AM_BS_AE-MTAB_3998-OS228-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.759000",,,,,,,,"P13Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9e","pgxind-kftx6s5j","pgxcs-kftwzjts",965879557,0.336,791017957,0.275,174861600,0.061,"PGX_AM_BS_AE-MTAB_3998-OS231-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.762000",,,,,,,,"P13Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9g","pgxind-kftx6s5l","pgxcs-kftwzjur",524335102,0.182,215466198,0.075,308868904,0.107,"PGX_AM_BS_AE-MTAB_3998-OS232-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.763000",,,,,,,,"P21Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9k","pgxind-kftx6s5r","pgxcs-kftwzjxo",1820158210,0.633,947832897,0.33,872325313,0.303,"PGX_AM_BS_AE-MTAB_3998-OS236-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.767000",,,,,,,,"P19Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe854","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9t","pgxind-kftx6s61","pgxcs-kftwzk2i",1053975244,0.367,773034464,0.269,280940780,0.098,"PGX_AM_BS_AE-MTAB_3998-OS252-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.775000",,,,,,,,"P16Y",,,"geo:GPL16131",,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a366e6b8c1d6d377c1937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvks8i","pgxind-kftx6xzf","pgxcs-kftwtx28",2143458545,0.746,1205494141,0.419,937964404,0.326,"PGX_AM_BS_CELLLINE_CCLE_BROAD-143B_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.053000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2270",,,,,,,,,,,,,,,,"143B",
"5f5a366e6b8c1d6d377c1950","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvks9n","pgxind-kftx6y0u","pgxcs-kftwtxem",409584369,0.142,271033702,0.094,138550667,0.048,"PGX_AM_BS_CELLLINE_CCLE_BROAD-A673_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.090000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0080",,,,,,,,,,,,,,,,"A-673",
"5f5a366e6b8c1d6d377c197c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksbm","pgxind-kftx6y3c","pgxcs-kftwty2f",294802381,0.103,80735188,0.028,214067193,0.074,"PGX_AM_BS_CELLLINE_CCLE_BROAD-CADOES1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.156000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1103",,,,,,,,,,,,,,,,"CADO-ES1",
"5f5a366e6b8c1d6d377c1988","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6476","Dedifferentiated chondrosarcoma","icdom-92433","Dedifferentiated chondrosarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksc5","pgxind-kftx6y40","pgxcs-kftwty8b",2093850697,0.728,1037719312,0.361,1056131385,0.367,"PGX_AM_BS_CELLLINE_CCLE_BROAD-CAL78_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.174000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1809",,,,,,,,,,,,,,,,"CAL-78",
"5f5a366e6b8c1d6d377c19f0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksgv","pgxind-kftx6y9x","pgxcs-kftwtzpg",1317991519,0.458,651234998,0.227,666756521,0.232,"PGX_AM_BS_CELLLINE_CCLE_BROAD-EW8_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.328000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_V618",,,,,,,,,,,,,,,,"EW-8",
"5f5a366e6b8c1d6d377c19f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksgx","pgxind-kftx6y9z","pgxcs-kftwtzpx",1891990954,0.658,883389188,0.307,1008601766,0.351,"PGX_AM_BS_CELLLINE_CCLE_BROAD-EWS502_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.330000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_S740",,,,,,,,,,,,,,,,"EWS-502",
"5f5a366e6b8c1d6d377c19f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksha","pgxind-kftx6yaf","pgxcs-kftwtztv",1634468367,0.569,750845233,0.261,883623134,0.307,"PGX_AM_BS_CELLLINE_CCLE_BROAD-G292CLONEA141B1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.342000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2909",,,,,,,,,,,,,,,,"G-292 clone A141B1",
"5f5a366e6b8c1d6d377c1a01","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated pleomorphic sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvkshn","pgxind-kftx6yaw","pgxcs-kftwtzxs",1526516299,0.531,895209219,0.311,631307080,0.22,"PGX_AM_BS_CELLLINE_CCLE_BROAD-GCT_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:56.354000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1229",,,,,,,,,,,,,,,,"GCT",
"5f5a366e6b8c1d6d377c1a4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkskz","pgxind-kftx6yf1","pgxcs-kftwu10d",979150070,0.341,265264663,0.092,713885407,0.248,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HOS_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.466000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0312",,,,,,,,,,,,,,,,"HOS",
"5f5a366e6b8c1d6d377c1a64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.4","Skeletal muscle","pgxbs-kftvksm5","pgxind-kftx6ygg","pgxcs-kftwu1ci",2110019958,0.734,1082596507,0.377,1027423451,0.357,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HS729_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:46:56.502000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0871",,,,,,,,,,,,,,,,"Hs 729.T",
"5f5a366e6b8c1d6d377c1a7e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","Connective and soft tissue, NOS","pgxbs-kftvksnb","pgxind-kftx6yhx","pgxcs-kftwu1rh",186620992,0.065,68412445,0.024,118208547,0.041,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HT1080_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:56.539000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0317",,,,,,,,,,,,,,,,"HT-1080",
"5f5a366e6b8c1d6d377c1a85","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksnm","pgxind-kftx6yib","pgxcs-kftwu1ux",1584253550,0.551,760341633,0.264,823911917,0.287,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HTK_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.549000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2522",,,,,,,,,,,,,,,,"HTK-",
"5f5a366f6b8c1d6d377c1b31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvksve","pgxind-kftx6ys2","pgxcs-kftwu4cg",377050915,0.131,275781918,0.096,101268997,0.035,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MESSA_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:46:56.815000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1404",,,,,,,,,,,,,,,,"MES-SA",
"5f5a366f6b8c1d6d377c1b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksvm","pgxind-kftx6ysd","pgxcs-kftwu4ex",1690368393,0.588,788482463,0.274,901885930,0.314,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MG63_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.822000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0426",,,,,,,,,,,,,,,,"MG-63",
"5f5a366f6b8c1d6d377c1b3a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksvt","pgxind-kftx6ysl","pgxcs-kftwu4gv",1129739330,0.393,294730470,0.103,835008860,0.29,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MHHES1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.827000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1411",,,,,,,,,,,,,,,,"MHH-ES-1",
"5f5a366f6b8c1d6d377c1be8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C7155","Primary central chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkt3o","pgxind-kftx6z2f","pgxcs-kftwu6zn",1462636362,0.509,692769954,0.241,769866408,0.268,"PGX_AM_BS_CELLLINE_CCLE_BROAD-OUMS27_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.089000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_3090",,,,,,,,,,,,,,,,"OUMS-27",
"5f5a366f6b8c1d6d377c1c1a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.4","Skeletal muscle","pgxbs-kftvkt5w","pgxind-kftx6z57","pgxcs-kftwu7qs",1388670803,0.483,517763740,0.18,870907063,0.303,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RD_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:46:57.163000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1649",,,,,,,,,,,,,,,,"RD",
"5f5a366f6b8c1d6d377c1c1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkt5y","pgxind-kftx6z59","pgxcs-kftwu7r9",1565857138,0.545,798980444,0.278,766876694,0.267,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RDES_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.164000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2169",,,,,,,,,,,,,,,,"RD-ES",
"5f5a366f6b8c1d6d377c1c25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6e","pgxind-kftx6z5t","pgxcs-kftwu7w7",1860803474,0.647,888995865,0.309,971807609,0.338,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.179000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",
"5f5a366f6b8c1d6d377c1c26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6g","pgxind-kftx6z5v","pgxcs-kftwu7wo",1658654654,0.577,549769474,0.191,1108885180,0.386,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH41_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.181000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2176",,,,,,,,,,,,,,,,"Rh41",
"5f5a366f6b8c1d6d377c1c28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","Ovary","pgxbs-kftvkt6j","pgxind-kftx6z5z","pgxcs-kftwu7xo",1530041480,0.532,737601161,0.257,792440319,0.276,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RKN_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000992","ovary","{}","2020-09-10 17:46:57.184000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_3156",,,,,,,,,,,,,,,,"RKN",
"5f5a366f6b8c1d6d377c1c36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6041","Thyroid gland sarcoma","icdom-88003","Sarcoma, NOS","icdot-C73.9","Thyroid gland","pgxbs-kftvkt76","pgxind-kftx6z6s","pgxcs-kftwu84h",1761557134,0.613,823388269,0.286,938168865,0.326,"PGX_AM_BS_CELLLINE_CCLE_BROAD-S117_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002046","thyroid gland","{}","2020-09-10 17:46:57.204000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1674",,,,,,,,,,,,,,,,"S-117",
"5f5a366f6b8c1d6d377c1c4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt82","pgxind-kftx6z7x","pgxcs-kftwu8e9",1939688127,0.675,973563105,0.339,966125022,0.336,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SJRH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.234000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",
"5f5a366f6b8c1d6d377c1c4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkt84","pgxind-kftx6z80","pgxcs-kftwu8eq",937702424,0.326,680057691,0.237,257644733,0.09,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SJSA1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.235000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_1697",,,,,,,,,,,,,,,,"SJSA-1",
"5f5a366f6b8c1d6d377c1c4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkt89","pgxind-kftx6z86","pgxcs-kftwu8g7",1950528912,0.678,1198120853,0.417,752408059,0.262,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SKES1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.240000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0627",,,,,,,,,,,,,,,,"SK-ES-1",
"5f5a366f6b8c1d6d377c1c50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C40318","Vulvar leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS","icdot-C51.9","Vulva","pgxbs-kftvkt8c","pgxind-kftx6z8a","pgxcs-kftwu8h7",1913263435,0.665,867342681,0.302,1045920754,0.364,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SKLMS1_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0011387","constrictor vulvae muscle","{}","2020-09-10 17:46:57.243000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0628",,,,,,,,,,,,,,,,"SK-LMS-1",
"5f5a366f6b8c1d6d377c1cce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkte0","pgxind-kftx6zff","pgxcs-kftwuabg",1295110436,0.45,674157989,0.234,620952447,0.216,"PGX_AM_BS_CELLLINE_CCLE_BROAD-TC71_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.432000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_2213",,,,,,,,,,,,,,,,"TC-71",
"5f5a366f6b8c1d6d377c1cf5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvktfq","pgxind-kftx6zhn","pgxcs-kftwuauf",1555060673,0.541,741101488,0.258,813959185,0.283,"PGX_AM_BS_CELLLINE_CCLE_BROAD-U2OS_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.491000",,,,,,,,"P69Y",,,"geo:GPL6801",,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,,"cellosaurus:CVCL_0042",,,,,,,,,,,,,,,,"U2OS",
"5f5a36736b8c1d6d377c26d9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwk7","pgxind-kftx73gj","pgxcs-kftwvabg",1070976211,0.373,683586722,0.238,387389489,0.135,"PGX_AM_BS_MSK_IMPACT_2017-P_0000092_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.055000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2772","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkwr3","pgxind-kftx73p8","pgxcs-kftwvcf8",172842609,0.06,14502355,0.005,158340254,0.055,"PGX_AM_BS_MSK_IMPACT_2017-P_0000253_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:01.269000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2773","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkwr5","pgxind-kftx73pa","pgxcs-kftwvcfp",1842109576,0.641,1347610038,0.469,494499538,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0000257_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:01.270000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c27ce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwv9","pgxind-kftx73ue","pgxcs-kftwvdpf",671780075,0.234,417303979,0.145,254476096,0.089,"PGX_AM_BS_MSK_IMPACT_2017-P_0000355_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.398000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkx4z","pgxind-kftx746l","pgxcs-kftwvgqq",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_MSK_IMPACT_2017-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.076000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28dc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkx7h","pgxind-kftx749p","pgxcs-kftwvhiy",1971481480,0.686,1011896313,0.352,959585167,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000629_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.154000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2932","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkxbc","pgxind-kftx74ek","pgxcs-kftwviqa",953444543,0.332,496826315,0.173,456618228,0.159,"PGX_AM_BS_MSK_IMPACT_2017-P_0000708_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:02.274000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2935","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxbh","pgxind-kftx74eq","pgxcs-kftwvitn",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_MSK_IMPACT_2017-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.278000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2975","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkxec","pgxind-kftx74id","pgxcs-kftwvjoh",234300217,0.081,30439715,0.011,203860502,0.071,"PGX_AM_BS_MSK_IMPACT_2017-P_0000779_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:02.368000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2996","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondroblastic Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxft","pgxind-kftx74k7","pgxcs-kftwvk6g",2244284503,0.781,951329041,0.331,1292955462,0.45,"PGX_AM_BS_MSK_IMPACT_2017-P_0000815_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.414000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29a8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxgm","pgxind-kftx74l7","pgxcs-kftwvkf2",585939240,0.204,215972540,0.075,369966700,0.129,"PGX_AM_BS_MSK_IMPACT_2017-P_0000835_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.439000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29b3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkxh3","pgxind-kftx74lu","pgxcs-kftwvkkc",2351408247,0.818,1228344608,0.427,1123063639,0.391,"PGX_AM_BS_MSK_IMPACT_2017-P_0000845_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:02.455000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29b8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Breast Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C5184","Breast Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C50.9","Breast, NOS","pgxbs-kftvkxhc","pgxind-kftx74m4","pgxcs-kftwvkmp",1116717761,0.388,774791884,0.269,341925877,0.119,"PGX_AM_BS_MSK_IMPACT_2017-P_0000850_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000310","breast","{}","2020-09-10 17:47:02.462000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29be","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxhl","pgxind-kftx74mg","pgxcs-kftwvkpj",1762734198,0.613,619185595,0.215,1143548603,0.398,"PGX_AM_BS_MSK_IMPACT_2017-P_0000856_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.470000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a37","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4303","Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxn0","pgxind-kftx74tb","pgxcs-kftwvmdq",1826663761,0.635,867344061,0.302,959319700,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.641000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a52","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkxo8","pgxind-kftx74uv","pgxcs-kftwvmsu",1786926410,0.622,826241231,0.287,960685179,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0001002_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:02.679000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxoy","pgxind-kftx74vr","pgxcs-kftwvn0i",1614701731,0.562,874062447,0.304,740639284,0.258,"PGX_AM_BS_MSK_IMPACT_2017-P_0001016_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.702000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a71","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxpl","pgxind-kftx74wm","pgxcs-kftwvn7p",614223480,0.214,509630916,0.177,104592564,0.036,"PGX_AM_BS_MSK_IMPACT_2017-P_0001035_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.722000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a9f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrp","pgxind-kftx74z7","pgxcs-kftwvnvt",1547408929,0.538,909092070,0.316,638316859,0.222,"PGX_AM_BS_MSK_IMPACT_2017-P_0001087_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.787000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2aa0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrr","pgxind-kftx74z9","pgxcs-kftwvnwb",983611990,0.342,347949266,0.121,635662724,0.221,"PGX_AM_BS_MSK_IMPACT_2017-P_0001088_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.788000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2ae3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","High-Grade Endometrial Stromal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrioid Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxut","pgxind-kftx7532","pgxcs-kftwvosq",255421582,0.089,165741335,0.058,89680247,0.031,"PGX_AM_BS_MSK_IMPACT_2017-P_0001164_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium",,"2020-09-10 17:47:02.883000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b12","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxwx","pgxind-kftx755q","pgxcs-kftwvphn",884449609,0.308,566694542,0.197,317755067,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0001211_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.951000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxx5","pgxind-kftx7560","pgxcs-kftwvpk1",988167851,0.344,687425175,0.239,300742676,0.105,"PGX_AM_BS_MSK_IMPACT_2017-P_0001217_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.958000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b2a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxy0","pgxind-kftx7573","pgxcs-kftwvpt3",294623198,0.102,150322639,0.052,144300559,0.05,"PGX_AM_BS_MSK_IMPACT_2017-P_0001233_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.985000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b97","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky2w","pgxind-kftx75d7","pgxcs-kftwvrds",2662660842,0.926,1571680810,0.547,1090980032,0.379,"PGX_AM_BS_MSK_IMPACT_2017-P_0001343_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:03.138000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2bf6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvky76","pgxind-kftx75ik","pgxcs-kftwvspo",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_MSK_IMPACT_2017-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.272000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c00","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky7m","pgxind-kftx75j4","pgxcs-kftwvsuj",1765639897,0.614,1144803350,0.398,620836547,0.216,"PGX_AM_BS_MSK_IMPACT_2017-P_0001448_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.286000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c12","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvky8f","pgxind-kftx75k4","pgxcs-kftwvt39",545060945,0.19,189928721,0.066,355132224,0.124,"PGX_AM_BS_MSK_IMPACT_2017-P_0001465_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:03.312000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky90","pgxind-kftx75kv","pgxcs-kftwvt9i",883913624,0.307,529617474,0.184,354296150,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0001482_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.330000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c41","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyaj","pgxind-kftx75ms","pgxcs-kftwvtpu",1508997567,0.525,610683034,0.212,898314533,0.312,"PGX_AM_BS_MSK_IMPACT_2017-P_0001515_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.377000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c48","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyau","pgxind-kftx75n7","pgxcs-kftwvtvf",279963391,0.097,43069545,0.015,236893846,0.082,"PGX_AM_BS_MSK_IMPACT_2017-P_0001521_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.387000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyb7","pgxind-kftx75nn","pgxcs-kftwvtzc",1039500909,0.362,404453761,0.141,635047148,0.221,"PGX_AM_BS_MSK_IMPACT_2017-P_0001527_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.399000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkyc0","pgxind-kftx75oo","pgxcs-kftwvu81",398909680,0.139,54551003,0.019,344358677,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0001544_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:03.424000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c67","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyc8","pgxind-kftx75oy","pgxcs-kftwvuah",1908282000,0.664,885350995,0.308,1022931005,0.356,"PGX_AM_BS_MSK_IMPACT_2017-P_0001549_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.431000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c7f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkydb","pgxind-kftx75qb","pgxcs-kftwvum3",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.466000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c91","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkye3","pgxind-kftx75rc","pgxcs-kftwvuus",872011022,0.303,553238004,0.192,318773018,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0001596_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.491000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c9c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyel","pgxind-kftx75ry","pgxcs-kftwvv28",659462096,0.229,339765115,0.118,319696981,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0001606_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.506000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ca2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyev","pgxind-kftx75sa","pgxcs-kftwvv55",2056552603,0.715,1392860870,0.484,663691733,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0001612_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.514000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2cca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sclerosing Epithelioid Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C49027","Sclerosing Epithelioid Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkygn","pgxind-kftx75uk","pgxcs-kftwvvoe",1204118760,0.419,900681765,0.313,303436995,0.106,"PGX_AM_BS_MSK_IMPACT_2017-P_0001652_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.570000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2cfe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyiz","pgxind-kftx75xi","pgxcs-kftwvwfr",1703396901,0.592,1090264615,0.379,613132286,0.213,"PGX_AM_BS_MSK_IMPACT_2017-P_0001701_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.644000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d08","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyjf","pgxind-kftx75y2","pgxcs-kftwvwkn",1131721099,0.394,500521202,0.174,631199897,0.22,"PGX_AM_BS_MSK_IMPACT_2017-P_0001711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.657000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyjz","pgxind-kftx75yr","pgxcs-kftwvwqd",1875053770,0.652,1226334481,0.427,648719289,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0001725_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.674000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyme","pgxind-kftx761t","pgxcs-kftwvxib",550597916,0.192,250049708,0.087,300548208,0.105,"PGX_AM_BS_MSK_IMPACT_2017-P_0001780_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.750000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkymf","pgxind-kftx761v","pgxcs-kftwvxis",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_MSK_IMPACT_2017-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.752000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d6c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Myxoid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40175","Uterine Corpus Myxoid Leiomyosarcoma","icdom-88963","Myxoid leiomyosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvkynw","pgxind-kftx763p","pgxcs-kftwvxyo",1421122049,0.494,743071941,0.258,678050108,0.236,"PGX_AM_BS_MSK_IMPACT_2017-P_0001814_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:03.799000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d79","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyoh","pgxind-kftx764f","pgxcs-kftwvy4w",2392857986,0.832,1369311414,0.476,1023546572,0.356,"PGX_AM_BS_MSK_IMPACT_2017-P_0001827_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.817000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d86","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvkyp3","pgxind-kftx7656","pgxcs-kftwvyb4",1142405830,0.397,683290449,0.238,459115381,0.16,"PGX_AM_BS_MSK_IMPACT_2017-P_0001838_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:03.835000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2da2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyqd","pgxind-kftx766r","pgxcs-kftwvyqq",785943978,0.273,490835952,0.171,295108026,0.103,"PGX_AM_BS_MSK_IMPACT_2017-P_0001863_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.875000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2da8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyqn","pgxind-kftx7673","pgxcs-kftwvytn",763247993,0.265,642729756,0.224,120518237,0.042,"PGX_AM_BS_MSK_IMPACT_2017-P_0001870_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.883000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyvl","pgxind-kftx76d8","pgxcs-kftww0bj",2222309090,0.773,639592211,0.222,1582716879,0.551,"PGX_AM_BS_MSK_IMPACT_2017-P_0001982_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.036000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyvw","pgxind-kftx76dm","pgxcs-kftww0ex",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.046000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkywt","pgxind-kftx76eq","pgxcs-kftww0oh",1884098681,0.655,1149095090,0.4,735003591,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0002008_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.075000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyxg","pgxind-kftx76fj","pgxcs-kftww0v8",2017618406,0.702,840379847,0.292,1177238559,0.409,"PGX_AM_BS_MSK_IMPACT_2017-P_0002020_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.095000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkyy0","pgxind-kftx76g9","pgxcs-kftww13i",2446428671,0.851,1498163839,0.521,948264832,0.33,"PGX_AM_BS_MSK_IMPACT_2017-P_0002034_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:04.113000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e68","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4258","Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type ","icdot-C49.4","Connective, subcutaneous and other soft tissues of abdomen","pgxbs-kftvkyzd","pgxind-kftx76hy","pgxcs-kftww1hx",1665399234,0.579,919344898,0.32,746054336,0.259,"PGX_AM_BS_MSK_IMPACT_2017-P_0002066_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:47:04.155000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e72","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyzt","pgxind-kftx76ij","pgxcs-kftww1mr",1248501047,0.434,749066940,0.261,499434107,0.174,"PGX_AM_BS_MSK_IMPACT_2017-P_0002077_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.169000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e8a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkz0x","pgxind-kftx76jw","pgxcs-kftww1y8",1277349756,0.444,826218832,0.287,451130924,0.157,"PGX_AM_BS_MSK_IMPACT_2017-P_0002100_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.202000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e94","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz1e","pgxind-kftx76kg","pgxcs-kftww231",1655841016,0.576,1117856279,0.389,537984737,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0002111_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.217000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2eaa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkz2f","pgxind-kftx76lp","pgxcs-kftww2fq",1522946498,0.53,543757502,0.189,979188996,0.341,"PGX_AM_BS_MSK_IMPACT_2017-P_0002134_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:04.247000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ed7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz4i","pgxind-kftx76o9","pgxcs-kftww319",2026595829,0.705,1336535102,0.465,690060727,0.24,"PGX_AM_BS_MSK_IMPACT_2017-P_0002179_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.310000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f0e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz6z","pgxind-kftx76rd","pgxcs-kftww3tu",617184290,0.215,152913935,0.053,464270355,0.161,"PGX_AM_BS_MSK_IMPACT_2017-P_0002226_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.387000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f0f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz71","pgxind-kftx76rf","pgxcs-kftww3ub",580578108,0.202,123518989,0.043,457059119,0.159,"PGX_AM_BS_MSK_IMPACT_2017-P_0002226_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.388000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz83","pgxind-kftx76sp","pgxcs-kftww45d",1275909524,0.444,695992710,0.242,579916814,0.202,"PGX_AM_BS_MSK_IMPACT_2017-P_0002250_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.421000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz8e","pgxind-kftx76t4","pgxcs-kftww48s",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_MSK_IMPACT_2017-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.431000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f3b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkz91","pgxind-kftx76tw","pgxcs-kftww4fm",1313620580,0.457,664611949,0.231,649008631,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0002272_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.451000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzae","pgxind-kftx76vl","pgxcs-kftww4wi",1410462024,0.491,1260161295,0.438,150300729,0.052,"PGX_AM_BS_MSK_IMPACT_2017-P_0002301_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.494000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f8e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzct","pgxind-kftx76yl","pgxcs-kftww5ly",806483716,0.281,454274769,0.158,352208947,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0002356_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.568000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2fa1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzdo","pgxind-kftx76zn","pgxcs-kftww5x7",713891383,0.248,588446881,0.205,125444502,0.044,"PGX_AM_BS_MSK_IMPACT_2017-P_0002378_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.595000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2fe8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzgw","pgxind-kftx773o","pgxcs-kftww6vf",1895290519,0.659,892776171,0.311,1002514348,0.349,"PGX_AM_BS_MSK_IMPACT_2017-P_0002448_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.694000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3007","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzib","pgxind-kftx775f","pgxcs-kftww7ch",947328596,0.33,728957909,0.254,218370687,0.076,"PGX_AM_BS_MSK_IMPACT_2017-P_0002476_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.738000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c302a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzjw","pgxind-kftx777e","pgxcs-kftww7ta",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_MSK_IMPACT_2017-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.787000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c302f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzk4","pgxind-kftx777p","pgxcs-kftww7vp",490865133,0.171,376726582,0.131,114138551,0.04,"PGX_AM_BS_MSK_IMPACT_2017-P_0002519_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.794000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c306f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzn1","pgxind-kftx77bb","pgxcs-kftww8sp",1233230956,0.429,524267569,0.182,708963387,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0002588_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.884000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c30a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzpe","pgxind-kftx77e9","pgxcs-kftww9hn",2224200502,0.774,985355971,0.343,1238844531,0.431,"PGX_AM_BS_MSK_IMPACT_2017-P_0002641_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.957000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c30ed","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzsr","pgxind-kftx77if","pgxcs-kftwwajk",1850871450,0.644,959232020,0.334,891639430,0.31,"PGX_AM_BS_MSK_IMPACT_2017-P_0002720_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.060000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3113","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzug","pgxind-kftx77kk","pgxcs-kftwwb3x",1675979165,0.583,1112100586,0.387,563878579,0.196,"PGX_AM_BS_MSK_IMPACT_2017-P_0002757_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.114000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3119","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzup","pgxind-kftx77kx","pgxcs-kftwwb6t",2684117091,0.934,1653522360,0.575,1030594731,0.358,"PGX_AM_BS_MSK_IMPACT_2017-P_0002764_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.122000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c314c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzx0","pgxind-kftx77ns","pgxcs-kftwwbvc",956090515,0.333,563284599,0.196,392805916,0.137,"PGX_AM_BS_MSK_IMPACT_2017-P_0002817_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.194000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c314e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzx3","pgxind-kftx77nw","pgxcs-kftwwbwb",509338167,0.177,479396752,0.167,29941415,0.01,"PGX_AM_BS_MSK_IMPACT_2017-P_0002819_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.196000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3170","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzyl","pgxind-kftx77pu","pgxcs-kftwwcf5",794130440,0.276,307526662,0.107,486603778,0.169,"PGX_AM_BS_MSK_IMPACT_2017-P_0002851_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.244000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl00v","pgxind-kftx77so","pgxcs-kftwwd3h",537736543,0.187,0,0,537736543,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0002899_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.314000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl03q","pgxind-kftx77w9","pgxcs-kftwwe0j",2638130232,0.918,1803423896,0.627,834706336,0.29,"PGX_AM_BS_MSK_IMPACT_2017-P_0002972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.405000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3273","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0a7","pgxind-kftx784i","pgxcs-kftwwg2w",1660100495,0.577,1343236192,0.467,316864303,0.11,"PGX_AM_BS_MSK_IMPACT_2017-P_0003123_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.620000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3282","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl0av","pgxind-kftx785c","pgxcs-kftwwga5",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_MSK_IMPACT_2017-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:05.641000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0cr","pgxind-kftx787n","pgxcs-kftwwgu8",2121237127,0.738,969988431,0.337,1151248696,0.4,"PGX_AM_BS_MSK_IMPACT_2017-P_0003180_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.699000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32dd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0ey","pgxind-kftx78af","pgxcs-kftwwhjx",469804345,0.163,357447102,0.124,112357243,0.039,"PGX_AM_BS_MSK_IMPACT_2017-P_0003228_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.768000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32e1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0f5","pgxind-kftx78an","pgxcs-kftwwhlu",2083081650,0.725,1276410978,0.444,806670672,0.281,"PGX_AM_BS_MSK_IMPACT_2017-P_0003232_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.773000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32f2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0fw","pgxind-kftx78bm","pgxcs-kftwwhu0",1385994230,0.482,797638087,0.277,588356143,0.205,"PGX_AM_BS_MSK_IMPACT_2017-P_0003249_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.797000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3308","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0gw","pgxind-kftx78cv","pgxcs-kftwwi6u",573937558,0.2,481957551,0.168,91980007,0.032,"PGX_AM_BS_MSK_IMPACT_2017-P_0003271_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.827000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c331c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl0hs","pgxind-kftx78e0","pgxcs-kftwwigg",2106785816,0.733,1368624467,0.476,738161349,0.257,"PGX_AM_BS_MSK_IMPACT_2017-P_0003290_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.855000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c331d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0hu","pgxind-kftx78e2","pgxcs-kftwwigy",88610288,0.031,48710483,0.017,39899805,0.014,"PGX_AM_BS_MSK_IMPACT_2017-P_0003291_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:05.857000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c338c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0mv","pgxind-kftx78kc","pgxcs-kftwwk0a",1176804444,0.409,665499204,0.231,511305240,0.178,"PGX_AM_BS_MSK_IMPACT_2017-P_0003415_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.011000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl0nv","pgxind-kftx78ll","pgxcs-kftwwkat",2813191820,0.979,1549776365,0.539,1263415455,0.439,"PGX_AM_BS_MSK_IMPACT_2017-P_0003440_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:06.042000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33cb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0pq","pgxind-kftx78nx","pgxcs-kftwwkx1",2233495212,0.777,871405812,0.303,1362089400,0.474,"PGX_AM_BS_MSK_IMPACT_2017-P_0003484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.099000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0qc","pgxind-kftx78on","pgxcs-kftwwl3b",1152779656,0.401,721547528,0.251,431232128,0.15,"PGX_AM_BS_MSK_IMPACT_2017-P_0003496_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.117000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33ea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl0r6","pgxind-kftx78pp","pgxcs-kftwwlby",599945461,0.209,445277599,0.155,154667862,0.054,"PGX_AM_BS_MSK_IMPACT_2017-P_0003512_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:06.142000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34e4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl12d","pgxind-kftx793x","pgxcs-kftwwour",2252801853,0.784,968165868,0.337,1284635985,0.447,"PGX_AM_BS_MSK_IMPACT_2017-P_0003754_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.498000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34f7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl138","pgxind-kftx794z","pgxcs-kftwwp3w",669065053,0.233,501755611,0.175,167309442,0.058,"PGX_AM_BS_MSK_IMPACT_2017-P_0003771_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.525000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c351b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl14w","pgxind-kftx7970","pgxcs-kftwwpnm",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_MSK_IMPACT_2017-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.575000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3537","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl166","pgxind-kftx798l","pgxcs-kftwwq12",1757056470,0.611,967506755,0.337,789549715,0.275,"PGX_AM_BS_MSK_IMPACT_2017-P_0003835_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.614000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3554","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl17g","pgxind-kftx79a8","pgxcs-kftwwqex",682415100,0.237,437007645,0.152,245407455,0.085,"PGX_AM_BS_MSK_IMPACT_2017-P_0003862_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.654000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35a0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1ax","pgxind-kftx79ed","pgxcs-kftwwrhj",1776713986,0.618,1136657600,0.395,640056386,0.223,"PGX_AM_BS_MSK_IMPACT_2017-P_0003948_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.760000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35bd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl1c9","pgxind-kftx79fz","pgxcs-kftwwrxn",978754554,0.34,468720877,0.163,510033677,0.177,"PGX_AM_BS_MSK_IMPACT_2017-P_0003980_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:06.801000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1cw","pgxind-kftx79gq","pgxcs-kftwws40",1859509504,0.647,798787285,0.278,1060722219,0.369,"PGX_AM_BS_MSK_IMPACT_2017-P_0003998_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.819000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c360b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1ft","pgxind-kftx79kd","pgxcs-kftwwszt",1521727730,0.529,918019578,0.319,603708152,0.21,"PGX_AM_BS_MSK_IMPACT_2017-P_0004070_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.911000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3617","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1gd","pgxind-kftx79l1","pgxcs-kftwwt7o",2398601856,0.834,1472230885,0.512,926370971,0.322,"PGX_AM_BS_MSK_IMPACT_2017-P_0004082_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.927000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c362f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1hg","pgxind-kftx79md","pgxcs-kftwwtja",1408509098,0.49,911482895,0.317,497026203,0.173,"PGX_AM_BS_MSK_IMPACT_2017-P_0004107_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.961000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3645","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1if","pgxind-kftx79nl","pgxcs-kftwwttv",423127645,0.147,347483980,0.121,75643665,0.026,"PGX_AM_BS_MSK_IMPACT_2017-P_0004128_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.991000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3658","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1ja","pgxind-kftx79oo","pgxcs-kftwwu2z",976812541,0.34,840986147,0.293,135826394,0.047,"PGX_AM_BS_MSK_IMPACT_2017-P_0004145_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.018000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3664","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl1jt","pgxind-kftx79pc","pgxcs-kftwwu8s",1422984600,0.495,622700815,0.217,800283785,0.278,"PGX_AM_BS_MSK_IMPACT_2017-P_0004157_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:07.035000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3690","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1lr","pgxind-kftx79ru","pgxcs-kftwwuw6",1610496875,0.56,639239338,0.222,971257537,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0004198_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.096000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36a3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl1mm","pgxind-kftx79sw","pgxcs-kftwwv5b",936840304,0.326,527768684,0.184,409071620,0.142,"PGX_AM_BS_MSK_IMPACT_2017-P_0004217_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:07.123000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1nq","pgxind-kftx79ub","pgxcs-kftwwvhd",1227784147,0.427,717104919,0.249,510679228,0.178,"PGX_AM_BS_MSK_IMPACT_2017-P_0004241_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.158000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1oz","pgxind-kftx79vw","pgxcs-kftwwvwx",1579890071,0.55,684049311,0.238,895840760,0.312,"PGX_AM_BS_MSK_IMPACT_2017-P_0004267_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.197000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1p3","pgxind-kftx79w0","pgxcs-kftwwvxw",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.199000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1q4","pgxind-kftx79xb","pgxcs-kftwww90",1946734707,0.677,1237475237,0.43,709259470,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0004291_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.232000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1qp","pgxind-kftx79y1","pgxcs-kftwwwfa",905339565,0.315,673577421,0.234,231762144,0.081,"PGX_AM_BS_MSK_IMPACT_2017-P_0004306_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.250000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c372f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1sw","pgxind-kftx7a0s","pgxcs-kftwwx54",2019223117,0.702,1262914924,0.439,756308193,0.263,"PGX_AM_BS_MSK_IMPACT_2017-P_0004357_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.318000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c374f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1uc","pgxind-kftx7a2m","pgxcs-kftwwxkm",1315647522,0.458,904253518,0.315,411394004,0.143,"PGX_AM_BS_MSK_IMPACT_2017-P_0004385_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.363000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3766","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1ve","pgxind-kftx7a3w","pgxcs-kftwwxvr",715830519,0.249,3826734,0.001,712003785,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0004408_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.395000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3769","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1vi","pgxind-kftx7a42","pgxcs-kftwwxx7",89381810,0.031,63340013,0.022,26041797,0.009,"PGX_AM_BS_MSK_IMPACT_2017-P_0004411_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.399000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c379e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1xw","pgxind-kftx7a73","pgxcs-kftwwyp5",474536863,0.165,452900597,0.158,21636266,0.008,"PGX_AM_BS_MSK_IMPACT_2017-P_0004467_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.474000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37b6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1yz","pgxind-kftx7a8g","pgxcs-kftwwz0r",2083785420,0.725,1332142628,0.463,751642792,0.261,"PGX_AM_BS_MSK_IMPACT_2017-P_0004499_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.507000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1z8","pgxind-kftx7a8s","pgxcs-kftwwz3n",1576603670,0.548,610936958,0.212,965666712,0.336,"PGX_AM_BS_MSK_IMPACT_2017-P_0004505_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.516000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1zk","pgxind-kftx7a96","pgxcs-kftwwz71",1736077259,0.604,679424955,0.236,1056652304,0.368,"PGX_AM_BS_MSK_IMPACT_2017-P_0004512_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.525000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c380b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl22s","pgxind-kftx7adb","pgxcs-kftwx07v",846623832,0.294,415711647,0.145,430912185,0.15,"PGX_AM_BS_MSK_IMPACT_2017-P_0004590_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.626000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3819","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl23f","pgxind-kftx7ae4","pgxcs-kftwx0er",1321180326,0.46,964731573,0.336,356448753,0.124,"PGX_AM_BS_MSK_IMPACT_2017-P_0004603_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.646000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c381a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epithelioid Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3714","Epithelioid Sarcoma","icdom-88043","Epithelioid sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl23h","pgxind-kftx7ae6","pgxcs-kftwx0f9",27231729,0.009,27229876,0.009,1853,0,"PGX_AM_BS_MSK_IMPACT_2017-P_0004604_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.647000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3854","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl263","pgxind-kftx7ahg","pgxcs-kftwx19a",968909615,0.337,248691613,0.087,720218002,0.251,"PGX_AM_BS_MSK_IMPACT_2017-P_0004657_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.729000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c386e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl279","pgxind-kftx7aix","pgxcs-kftwx1lr",852446520,0.297,499844476,0.174,352602044,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0004682_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.766000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3871","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl27d","pgxind-kftx7aj3","pgxcs-kftwx1n7",560478792,0.195,364348863,0.127,196129929,0.068,"PGX_AM_BS_MSK_IMPACT_2017-P_0004685_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.770000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c38d2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2bq","pgxind-kftx7aon","pgxcs-kftwx31x",1969485477,0.685,997259242,0.347,972226235,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0004780_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.906000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c391c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mesenchymal Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3737","Mesenchymal Chondrosarcoma","icdom-92403","Mesenchymal chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl2f2","pgxind-kftx7ast","pgxcs-kftwx41f",911756165,0.317,618468465,0.215,293287700,0.102,"PGX_AM_BS_MSK_IMPACT_2017-P_0004854_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.008000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3966","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2ie","pgxind-kftx7awz","pgxcs-kftwx52z",1775275501,0.617,710629719,0.247,1064645782,0.37,"PGX_AM_BS_MSK_IMPACT_2017-P_0004922_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.112000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c399a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2kp","pgxind-kftx7azx","pgxcs-kftwx5u2",1656348827,0.576,637480869,0.222,1018867958,0.354,"PGX_AM_BS_MSK_IMPACT_2017-P_0004973_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.185000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2se","pgxind-kftx7b9m","pgxcs-kftwx88s",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_MSK_IMPACT_2017-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.423000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Endometrial Stromal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrial Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2sr","pgxind-kftx7ba2","pgxcs-kftwx8co",1012830777,0.352,686909657,0.239,325921120,0.113,"PGX_AM_BS_MSK_IMPACT_2017-P_0005156_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.434000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3ad9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2z1","pgxind-kftx7bhs","pgxcs-kftwxabq",1789943867,0.623,870810893,0.303,919132974,0.32,"PGX_AM_BS_MSK_IMPACT_2017-P_0005301_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.628000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3af1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl303","pgxind-kftx7bj5","pgxcs-kftwxan9",706497134,0.246,389381719,0.135,317115415,0.11,"PGX_AM_BS_MSK_IMPACT_2017-P_0005323_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.662000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3b39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl33d","pgxind-kftx7bn8","pgxcs-kftwxbzq",1025698164,0.357,796992161,0.277,228706003,0.08,"PGX_AM_BS_MSK_IMPACT_2017-P_0005396_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.761000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3b73","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl360","pgxind-kftx7bqg","pgxcs-kftwxdl6",1132037378,0.394,682605051,0.237,449432327,0.156,"PGX_AM_BS_MSK_IMPACT_2017-P_0005465_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.842000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3b89","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl370","pgxind-kftx7brp","pgxcs-kftwxe8l",1777622629,0.618,513564718,0.179,1264057911,0.44,"PGX_AM_BS_MSK_IMPACT_2017-P_0005484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.873000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3ba9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Secondary Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53704","Secondary Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl38f","pgxind-kftx7bti","pgxcs-kftwxf3f",1599942498,0.557,865273345,0.301,734669153,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0005517_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.918000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3be6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3b5","pgxind-kftx7bwx","pgxcs-kftwxgut",861661718,0.3,421553739,0.147,440107979,0.153,"PGX_AM_BS_MSK_IMPACT_2017-P_0005578_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.003000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bec","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3bf","pgxind-kftx7bx9","pgxcs-kftwxh05",2523720085,0.878,1526452909,0.531,997267176,0.347,"PGX_AM_BS_MSK_IMPACT_2017-P_0005584_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.012000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bfe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3c8","pgxind-kftx7bya","pgxcs-kftwxhhs",136524052,0.047,134599119,0.047,1924933,0.001,"PGX_AM_BS_MSK_IMPACT_2017-P_0005601_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.037000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3eh","pgxind-kftx7c14","pgxcs-kftwxiyj",904424859,0.315,537086684,0.187,367338175,0.128,"PGX_AM_BS_MSK_IMPACT_2017-P_0005648_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.107000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c67","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3gy","pgxind-kftx7c49","pgxcs-kftwxkig",865828996,0.301,169039526,0.059,696789470,0.242,"PGX_AM_BS_MSK_IMPACT_2017-P_0005716_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.189000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3i2","pgxind-kftx7c5q","pgxcs-kftwxl6p",1716057347,0.597,1006662736,0.35,709394611,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0005740_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.225000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cd0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3lp","pgxind-kftx7ca9","pgxcs-kftwxngf",2441400607,0.849,1258571182,0.438,1182829425,0.411,"PGX_AM_BS_MSK_IMPACT_2017-P_0005820_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.340000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cf5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3ne","pgxind-kftx7ccc","pgxcs-kftwxohy",1182939973,0.411,613491922,0.213,569448051,0.198,"PGX_AM_BS_MSK_IMPACT_2017-P_0005856_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.394000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d2e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3pz","pgxind-kftx7cfl","pgxcs-kftwxq3h",46618985,0.016,13870403,0.005,32748582,0.011,"PGX_AM_BS_MSK_IMPACT_2017-P_0005917_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.479000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3q1","pgxind-kftx7cfn","pgxcs-kftwxq6q",1127424875,0.392,270144867,0.094,857280008,0.298,"PGX_AM_BS_MSK_IMPACT_2017-P_0005918_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.480000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3sb","pgxind-kftx7cik","pgxcs-kftwxrmi",457630184,0.159,406508969,0.141,51121215,0.018,"PGX_AM_BS_MSK_IMPACT_2017-P_0005969_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.554000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d6d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3st","pgxind-kftx7cj6","pgxcs-kftwxrx3",347562308,0.121,59726792,0.021,287835516,0.1,"PGX_AM_BS_MSK_IMPACT_2017-P_0005977_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.570000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d77","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Clear Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3745","Clear Cell Sarcoma of Soft Tissue","icdom-90443","Clearcellsarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3ta","pgxind-kftx7cjr","pgxcs-kftwxs6q",565857884,0.197,315562980,0.11,250294904,0.087,"PGX_AM_BS_MSK_IMPACT_2017-P_0005989_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.585000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d83","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl3tt","pgxind-kftx7ckg","pgxcs-kftwxsi7",1173391758,0.408,602450171,0.21,570941587,0.199,"PGX_AM_BS_MSK_IMPACT_2017-P_0006001_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:09.602000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3da1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3v6","pgxind-kftx7cm5","pgxcs-kftwxtcj",1452504538,0.505,956817158,0.333,495687380,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0006033_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.646000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3dba","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Follicular Dendritic Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9281","Follicular Dendritic Cell Sarcoma","icdom-97583","Follicular dendritic cell sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl3wa","pgxind-kftx7cnj","pgxcs-kftwxu2s",655502640,0.228,380223641,0.132,275278999,0.096,"PGX_AM_BS_MSK_IMPACT_2017-P_0006059_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:09.682000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3def","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Alveolar Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3yo","pgxind-kftx7cqj","pgxcs-kftwxvjt",605307450,0.211,291121285,0.101,314186165,0.109,"PGX_AM_BS_MSK_IMPACT_2017-P_0006113_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.759000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e1d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl40s","pgxind-kftx7ct5","pgxcs-kftwxwuv",1532381479,0.533,1073158437,0.373,459223042,0.16,"PGX_AM_BS_MSK_IMPACT_2017-P_0006160_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.825000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e66","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl443","pgxind-kftx7cx9","pgxcs-kftwxyx3",577633126,0.201,386818818,0.135,190814308,0.066,"PGX_AM_BS_MSK_IMPACT_2017-P_0006232_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.928000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e99","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl46f","pgxind-kftx7d05","pgxcs-kftwy0bz",904322069,0.315,790765642,0.275,113556427,0.039,"PGX_AM_BS_MSK_IMPACT_2017-P_0006284_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.999000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3ea4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl46x","pgxind-kftx7d0s","pgxcs-kftwy0mm",642913569,0.224,298744854,0.104,344168715,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0006297_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:10.015000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3ea9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl475","pgxind-kftx7d12","pgxcs-kftwy0rf",845660124,0.294,814278150,0.283,31381974,0.011,"PGX_AM_BS_MSK_IMPACT_2017-P_0006303_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.022000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3fbd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4jp","pgxind-kftx7dgo","pgxcs-kftwy8ii",1436150960,0.5,1377303077,0.479,58847883,0.02,"PGX_AM_BS_MSK_IMPACT_2017-P_0006577_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.409000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3fce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4kh","pgxind-kftx7dhn","pgxcs-kftwy918",1047533944,0.364,915417212,0.318,132116732,0.046,"PGX_AM_BS_MSK_IMPACT_2017-P_0006594_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.433000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c408e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4t5","pgxind-kftx7dsf","pgxcs-kftwyef8",1190729261,0.414,922511033,0.321,268218228,0.093,"PGX_AM_BS_MSK_IMPACT_2017-P_0006784_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:10.706000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40d2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4w7","pgxind-kftx7dw9","pgxcs-kftwygdg",1124511246,0.391,720364813,0.251,404146433,0.141,"PGX_AM_BS_MSK_IMPACT_2017-P_0006851_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.800000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xl","pgxind-kftx7dy0","pgxcs-kftwyh98",1966368148,0.684,1266881592,0.441,699486556,0.243,"PGX_AM_BS_MSK_IMPACT_2017-P_0006882_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.843000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xo","pgxind-kftx7dy4","pgxcs-kftwyhb5",1335102639,0.464,845265660,0.294,489836979,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0006884_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.846000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4154","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl522","pgxind-kftx7e3l","pgxcs-kftwyk18",1290952034,0.449,802391700,0.279,488560334,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0006985_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:10.981000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4176","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl53l","pgxind-kftx7e5i","pgxcs-kftwyl0x",1025471291,0.357,503540205,0.175,521931086,0.182,"PGX_AM_BS_MSK_IMPACT_2017-P_0007021_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.029000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c41cf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl57l","pgxind-kftx7eal","pgxcs-kftwynk0",1149237655,0.4,866407454,0.301,282830201,0.098,"PGX_AM_BS_MSK_IMPACT_2017-P_0007111_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.155000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4212","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5an","pgxind-kftx7eeg","pgxcs-kftwypel",843024823,0.293,466267608,0.162,376757215,0.131,"PGX_AM_BS_MSK_IMPACT_2017-P_0007176_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.248000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4295","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5gk","pgxind-kftx7elv","pgxcs-kftwyt4j",1900689466,0.661,970173437,0.337,930516029,0.324,"PGX_AM_BS_MSK_IMPACT_2017-P_0007344_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.431000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c42b4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5hx","pgxind-kftx7enm","pgxcs-kftwyu0c",1371207245,0.477,746343877,0.26,624863368,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0007376_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.474000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4314","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl5m9","pgxind-kftx7et3","pgxcs-kftwywqm",1097321686,0.382,384896662,0.134,712425024,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0007522_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:11.608000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4318","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mf","pgxind-kftx7etb","pgxcs-kftwywui",1434674993,0.499,811542800,0.282,623132193,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0007526_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.613000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c431c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mm","pgxind-kftx7etj","pgxcs-kftwywyf",1760024173,0.612,1200829466,0.418,559194707,0.195,"PGX_AM_BS_MSK_IMPACT_2017-P_0007530_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.619000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4323","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mx","pgxind-kftx7etx","pgxcs-kftwyx7k",1383883312,0.481,1130091286,0.393,253792026,0.088,"PGX_AM_BS_MSK_IMPACT_2017-P_0007536_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.628000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4332","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl5nl","pgxind-kftx7eur","pgxcs-kftwyxm3",1445797744,0.503,796746352,0.277,649051392,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0007552_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:11.649000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c433b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5nz","pgxind-kftx7eva","pgxcs-kftwyxux",1250885598,0.435,731750454,0.255,519135144,0.181,"PGX_AM_BS_MSK_IMPACT_2017-P_0007562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.662000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4364","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epithelioid Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3714","Epithelioid Sarcoma","icdom-88043","Epithelioid sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5pt","pgxind-kftx7exl","pgxcs-kftwyz10",742867453,0.258,479278891,0.167,263588562,0.092,"PGX_AM_BS_MSK_IMPACT_2017-P_0007605_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.718000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c437c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5qw","pgxind-kftx7eyy","pgxcs-kftwyzqk",1308605530,0.455,664154712,0.231,644450818,0.224,"PGX_AM_BS_MSK_IMPACT_2017-P_0007640_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.752000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c437d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sclerosing Epithelioid Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C49027","Sclerosing Epithelioid Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5qx","pgxind-kftx7ez0","pgxcs-kftwyzrk",726646974,0.253,237477409,0.083,489169565,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0007641_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.753000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4391","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl5ru","pgxind-kftx7f04","pgxcs-kftwz0ax",1279351440,0.445,529088737,0.184,750262703,0.261,"PGX_AM_BS_MSK_IMPACT_2017-P_0007660_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:11.781000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4398","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5s5","pgxind-kftx7f0i","pgxcs-kftwz0hp",661646715,0.23,551039418,0.192,110607297,0.038,"PGX_AM_BS_MSK_IMPACT_2017-P_0007667_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.791000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5tw","pgxind-kftx7f2r","pgxcs-kftwz1lh",1543680658,0.537,777148534,0.27,766532124,0.267,"PGX_AM_BS_MSK_IMPACT_2017-P_0007735_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.847000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5wl","pgxind-kftx7f66","pgxcs-kftwz3c0",2391020577,0.832,1376453906,0.479,1014566671,0.353,"PGX_AM_BS_MSK_IMPACT_2017-P_0007815_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.931000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4427","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5yk","pgxind-kftx7f8q","pgxcs-kftwz4l1",2006113281,0.698,1094844875,0.381,911268406,0.317,"PGX_AM_BS_MSK_IMPACT_2017-P_0007871_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.991000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4435","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5z7","pgxind-kftx7f9m","pgxcs-kftwz4yv",988954487,0.344,960061393,0.334,28893094,0.01,"PGX_AM_BS_MSK_IMPACT_2017-P_0007886_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.011000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl65c","pgxind-kftx7fhm","pgxcs-kftwz8vr",1871715756,0.651,1320605792,0.459,551109964,0.192,"PGX_AM_BS_MSK_IMPACT_2017-P_0008051_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.203000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44f2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl67o","pgxind-kftx7fkj","pgxcs-kftwzab2",1748628177,0.608,1209853468,0.421,538774709,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0008125_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.274000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl685","pgxind-kftx7fl5","pgxcs-kftwzaly",1497537939,0.521,725409120,0.252,772128819,0.269,"PGX_AM_BS_MSK_IMPACT_2017-P_0008135_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.289000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4537","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ar","pgxind-kftx7fof","pgxcs-kftwzcab",1238680384,0.431,553784047,0.193,684896337,0.238,"PGX_AM_BS_MSK_IMPACT_2017-P_0008191_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:12.370000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4565","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ct","pgxind-kftx7fr1","pgxcs-kftwzdl3",62705559,0.022,31179031,0.011,31526528,0.011,"PGX_AM_BS_MSK_IMPACT_2017-P_0008263_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.434000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c45c5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6h2","pgxind-kftx7fwh","pgxcs-kftwzgb1",548499154,0.191,129519009,0.045,418980145,0.146,"PGX_AM_BS_MSK_IMPACT_2017-P_0008376_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.567000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c45ed","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Follicular Dendritic Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9281","Follicular Dendritic Cell Sarcoma","icdom-97583","Follicular dendritic cell sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6iu","pgxind-kftx7fyq","pgxcs-kftwzhg7",759410158,0.264,489561963,0.17,269848195,0.094,"PGX_AM_BS_MSK_IMPACT_2017-P_0008421_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.623000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c460d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ka","pgxind-kftx7g0k","pgxcs-kftwzidb",1958905869,0.681,971059418,0.338,987846451,0.344,"PGX_AM_BS_MSK_IMPACT_2017-P_0008455_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.667000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4614","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6kl","pgxind-kftx7g0z","pgxcs-kftwzik5",1659507912,0.577,1335621197,0.465,323886715,0.113,"PGX_AM_BS_MSK_IMPACT_2017-P_0008462_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.677000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4638","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mesenchymal Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3737","Mesenchymal Chondrosarcoma","icdom-92403","Mesenchymal chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6m8","pgxind-kftx7g31","pgxcs-kftwzjli",358239806,0.125,79660686,0.028,278579120,0.097,"PGX_AM_BS_MSK_IMPACT_2017-P_0008517_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.726000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c463b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl6md","pgxind-kftx7g37","pgxcs-kftwzjog",704197413,0.245,490617349,0.171,213580064,0.074,"PGX_AM_BS_MSK_IMPACT_2017-P_0008520_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:12.730000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4641","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6mn","pgxind-kftx7g3j","pgxcs-kftwzjua",111217258,0.039,64703624,0.023,46513634,0.016,"PGX_AM_BS_MSK_IMPACT_2017-P_0008526_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.739000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46a9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6rd","pgxind-kftx7g9f","pgxcs-kftwzmrp",1462557043,0.509,953684723,0.332,508872320,0.177,"PGX_AM_BS_MSK_IMPACT_2017-P_0008663_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.884000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46aa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6re","pgxind-kftx7g9h","pgxcs-kftwzmso",1636495581,0.569,878896219,0.306,757599362,0.264,"PGX_AM_BS_MSK_IMPACT_2017-P_0008663_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.886000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46ca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6sv","pgxind-kftx7gbb","pgxcs-kftwznps",1669658879,0.581,1040988381,0.362,628670498,0.219,"PGX_AM_BS_MSK_IMPACT_2017-P_0008695_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.930000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6tl","pgxind-kftx7gc8","pgxcs-kftwzo5a",1727033662,0.601,1103204104,0.384,623829558,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0008720_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.952000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c471c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6wl","pgxind-kftx7gg0","pgxcs-kftwzq25",2146345769,0.747,1114313676,0.388,1032032093,0.359,"PGX_AM_BS_MSK_IMPACT_2017-P_0008791_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.043000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c472e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6xe","pgxind-kftx7gh0","pgxcs-kftwzqjm",1376659569,0.479,691952725,0.241,684706844,0.238,"PGX_AM_BS_MSK_IMPACT_2017-P_0008817_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.068000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4750","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epithelioid Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3714","Epithelioid Sarcoma","icdom-88043","Epithelioid sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6yx","pgxind-kftx7giy","pgxcs-kftwzric",632417045,0.22,440245278,0.153,192171767,0.067,"PGX_AM_BS_MSK_IMPACT_2017-P_0008860_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.115000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c47d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl752","pgxind-kftx7gqn","pgxcs-kftwzvi3",1724987773,0.6,872579728,0.304,852408045,0.296,"PGX_AM_BS_MSK_IMPACT_2017-P_0009027_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.304000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4819","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl77z","pgxind-kftx7gub","pgxcs-kftwzxd6",804596401,0.28,385773724,0.134,418822677,0.146,"PGX_AM_BS_MSK_IMPACT_2017-P_0009103_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.395000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4834","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl798","pgxind-kftx7gvt","pgxcs-kftwzy39",1446744946,0.503,475748298,0.165,970996648,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0009144_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:13.432000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c486e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7bv","pgxind-kftx7gz4","pgxcs-kftwzzs0",1095710552,0.381,613329111,0.213,482381441,0.168,"PGX_AM_BS_MSK_IMPACT_2017-P_0009204_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.513000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl7fk","pgxind-kftx7h3p","pgxcs-kftx0233",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_MSK_IMPACT_2017-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:13.625000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7i5","pgxind-kftx7h6y","pgxcs-kftx03of",569078141,0.198,501702750,0.175,67375391,0.023,"PGX_AM_BS_MSK_IMPACT_2017-P_0009373_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.706000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7kz","pgxind-kftx7hbs","pgxcs-kftx05g5",1859051703,0.647,1146956370,0.399,712095333,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0009452_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.793000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4939","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l2","pgxind-kftx7hbw","pgxcs-kftx05i4",1568934998,0.546,782257709,0.272,786677289,0.274,"PGX_AM_BS_MSK_IMPACT_2017-P_0009454_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.796000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c493a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l4","pgxind-kftx7hby","pgxcs-kftx05j3",1595366628,0.555,977258039,0.34,618108589,0.215,"PGX_AM_BS_MSK_IMPACT_2017-P_0009455_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.798000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4949","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7ls","pgxind-kftx7hcr","pgxcs-kftx05zt",688263423,0.239,659545392,0.229,28718031,0.01,"PGX_AM_BS_MSK_IMPACT_2017-P_0009471_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.819000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4976","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7ns","pgxind-kftx7hf6","pgxcs-kftx078z",2150229386,0.748,1133896489,0.394,1016332897,0.354,"PGX_AM_BS_MSK_IMPACT_2017-P_0009525_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.881000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c497c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7o1","pgxind-kftx7hfi","pgxcs-kftx07es",1556662730,0.541,979281861,0.341,577380869,0.201,"PGX_AM_BS_MSK_IMPACT_2017-P_0009531_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.890000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4a12","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7ut","pgxind-kftx7hnu","pgxcs-kftx0bnb",808055788,0.281,671272153,0.233,136783635,0.048,"PGX_AM_BS_MSK_IMPACT_2017-P_0009729_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:14.109000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4a16","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7uz","pgxind-kftx7ho2","pgxcs-kftx0btd",518228227,0.18,73764928,0.026,444463299,0.155,"PGX_AM_BS_MSK_IMPACT_2017-P_0009733_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.114000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ad8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl83s","pgxind-kftx7hz2","pgxcs-kftx0fqr",699950379,0.243,559821889,0.195,140128490,0.049,"PGX_AM_BS_MSK_IMPACT_2017-P_0009968_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.384000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ae5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl84d","pgxind-kftx7hzs","pgxcs-kftx0fx0",2080349628,0.724,1075203494,0.374,1005146134,0.35,"PGX_AM_BS_MSK_IMPACT_2017-P_0009987_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.402000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4af6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl855","pgxind-kftx7i0r","pgxcs-kftx0g53",314468113,0.109,179881692,0.063,134586421,0.047,"PGX_AM_BS_MSK_IMPACT_2017-P_0010006_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.426000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b07","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl85x","pgxind-kftx7i1q","pgxcs-kftx0gd7",1701681014,0.592,836864262,0.291,864816752,0.301,"PGX_AM_BS_MSK_IMPACT_2017-P_0010023_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.450000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b0c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl865","pgxind-kftx7i20","pgxcs-kftx0gfl",1069688916,0.372,402461971,0.14,667226945,0.232,"PGX_AM_BS_MSK_IMPACT_2017-P_0010028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.457000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b3f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl88e","pgxind-kftx7i4x","pgxcs-kftx0h61",24789828,0.009,22036360,0.008,2753468,0.001,"PGX_AM_BS_MSK_IMPACT_2017-P_0010086_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.528000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ba0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl8cq","pgxind-kftx7iaf","pgxcs-kftx0iid",1222576190,0.425,817203160,0.284,405373030,0.141,"PGX_AM_BS_MSK_IMPACT_2017-P_0010206_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.664000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c1e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8ie","pgxind-kftx7ihl","pgxcs-kftx0kaz",1797065484,0.625,936115214,0.326,860950270,0.299,"PGX_AM_BS_MSK_IMPACT_2017-P_0010353_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.841000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c42","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8k1","pgxind-kftx7ijo","pgxcs-kftx0ksf",2313762437,0.805,1286612885,0.448,1027149552,0.357,"PGX_AM_BS_MSK_IMPACT_2017-P_0010398_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:14.891000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c92","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8nm","pgxind-kftx7io7","pgxcs-kftx0lxe",2714082960,0.944,1603381371,0.558,1110701589,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0010521_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.003000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4db1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl92t","pgxind-kftx7j4j","pgxcs-kftx0py4",257918129,0.09,110509408,0.038,147408721,0.051,"PGX_AM_BS_MSK_IMPACT_2017-P_0010856_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.404000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e3e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl995","pgxind-kftx7jcj","pgxcs-kftx0s05",921384079,0.32,642373476,0.223,279010603,0.097,"PGX_AM_BS_MSK_IMPACT_2017-P_0011028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:15.599000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e97","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9d6","pgxind-kftx7jhl","pgxcs-kftx0t9x",1907245035,0.663,1317534805,0.458,589710230,0.205,"PGX_AM_BS_MSK_IMPACT_2017-P_0011129_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.725000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4eab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9e2","pgxind-kftx7jip","pgxcs-kftx0tjl",1060382897,0.369,816333451,0.284,244049446,0.085,"PGX_AM_BS_MSK_IMPACT_2017-P_0011148_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.754000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4eae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl9e7","pgxind-kftx7jiv","pgxcs-kftx0tl2",2531622002,0.881,1774361079,0.617,757260923,0.263,"PGX_AM_BS_MSK_IMPACT_2017-P_0011151_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:15.759000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4ee9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9gu","pgxind-kftx7jm9","pgxcs-kftx0ufr",1486850347,0.517,899147294,0.313,587703053,0.204,"PGX_AM_BS_MSK_IMPACT_2017-P_0011220_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:15.842000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f04","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9i2","pgxind-kftx7jns","pgxcs-kftx0usp",1537361748,0.535,811132272,0.282,726229476,0.253,"PGX_AM_BS_MSK_IMPACT_2017-P_0011252_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:15.881000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f08","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9i9","pgxind-kftx7jo1","pgxcs-kftx0uum",108137297,0.038,35935169,0.012,72202128,0.025,"PGX_AM_BS_MSK_IMPACT_2017-P_0011256_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:15.886000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4258","Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type ","icdot-C49.4","Connective, subcutaneous and other soft tissues of abdomen","pgxbs-kftvl9jk","pgxind-kftx7jpo","pgxcs-kftx0v8j",289873194,0.101,237960735,0.083,51912459,0.018,"PGX_AM_BS_MSK_IMPACT_2017-P_0011292_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:47:15.928000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4f30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9k2","pgxind-kftx7jqa","pgxcs-kftx0vg0",1520194886,0.529,1041562753,0.362,478632133,0.166,"PGX_AM_BS_MSK_IMPACT_2017-P_0011304_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.943000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4f9a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Clear Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3745","Clear Cell Sarcoma of Soft Tissue","icdom-90443","Clearcellsarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9ot","pgxind-kftx7jwb","pgxcs-kftx0wxd",519945192,0.181,156214300,0.054,363730892,0.127,"PGX_AM_BS_MSK_IMPACT_2017-P_0011423_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.091000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4fc2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9qm","pgxind-kftx7jyl","pgxcs-kftx0xgn",943783329,0.328,421494956,0.147,522288373,0.182,"PGX_AM_BS_MSK_IMPACT_2017-P_0011466_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.146000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5006","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9tp","pgxind-kftx7k2f","pgxcs-kftx0yg2",941649297,0.328,621278961,0.216,320370336,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0011549_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.241000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5015","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvl9ud","pgxind-kftx7k3a","pgxcs-kftx0yn8",1751426112,0.609,1030743979,0.359,720682133,0.251,"PGX_AM_BS_MSK_IMPACT_2017-P_0011562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:16.262000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c501f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9ut","pgxind-kftx7k3u","pgxcs-kftx0ys1",1514397398,0.527,890997100,0.31,623400298,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0011575_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.275000",,,,,,,,"P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5156","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla8t","pgxind-kftx7klj","pgxcs-kftx136l",1753252958,0.61,1090584933,0.379,662668025,0.23,"PGX_AM_BS_MSK_IMPACT_2017-P_0012401_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:16.711000",,,,,,"NCITgrade-C14158","High Grade","P69Y",,,"PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcni","pgxind-kftx7nme","pgxcs-kftx1u12",1994035923,0.694,128517148,0.045,1865518775,0.649,"PGX_AM_BS_SARC_MSKCC-PT101MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.390000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnk","pgxind-kftx7nmg","pgxcs-kftx1u1k",488986425,0.17,134042111,0.047,354944314,0.123,"PGX_AM_BS_SARC_MSKCC-PT102MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.392000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnn","pgxind-kftx7nmk","pgxcs-kftx1u2j",1449296865,0.504,272393303,0.095,1176903562,0.409,"PGX_AM_BS_SARC_MSKCC-PT104MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.394000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58de","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnv","pgxind-kftx7nmu","pgxcs-kftx1u4z",1558111642,0.542,4100367,0.001,1554011275,0.541,"PGX_AM_BS_SARC_MSKCC-PT109MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.402000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58df","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnx","pgxind-kftx7nmx","pgxcs-kftx1u5h",1019494041,0.355,234811541,0.082,784682500,0.273,"PGX_AM_BS_SARC_MSKCC-PT10DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.403000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco0","pgxind-kftx7nn1","pgxcs-kftx1u6g",1281352699,0.446,634111957,0.221,647240742,0.225,"PGX_AM_BS_SARC_MSKCC-PT111MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.406000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco2","pgxind-kftx7nn3","pgxcs-kftx1u6x",1282389657,0.446,879645175,0.306,402744482,0.14,"PGX_AM_BS_SARC_MSKCC-PT112MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.408000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco5","pgxind-kftx7nn7","pgxcs-kftx1u7w",1551378913,0.54,347760368,0.121,1203618545,0.419,"PGX_AM_BS_SARC_MSKCC-PT114MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.411000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoe","pgxind-kftx7nnj","pgxcs-kftx1uav",524503418,0.182,137941916,0.048,386561502,0.134,"PGX_AM_BS_SARC_MSKCC-PT11DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.419000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58eb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcog","pgxind-kftx7nnl","pgxcs-kftx1ubc",400523879,0.139,65038700,0.023,335485179,0.117,"PGX_AM_BS_SARC_MSKCC-PT120MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.421000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ed","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoj","pgxind-kftx7nnp","pgxcs-kftx1ucb",1258463343,0.438,102334885,0.036,1156128458,0.402,"PGX_AM_BS_SARC_MSKCC-PT122MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.424000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoq","pgxind-kftx7nnx","pgxcs-kftx1ue9",1338945939,0.466,513157582,0.178,825788357,0.287,"PGX_AM_BS_SARC_MSKCC-PT126MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.430000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoz","pgxind-kftx7no9","pgxcs-kftx1uh6",535518766,0.186,259732419,0.09,275786347,0.096,"PGX_AM_BS_SARC_MSKCC-PT131MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.438000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp1","pgxind-kftx7nob","pgxcs-kftx1uhn",920603955,0.32,673814364,0.234,246789591,0.086,"PGX_AM_BS_SARC_MSKCC-PT132MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.440000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp6","pgxind-kftx7noi","pgxcs-kftx1uj4",1314013727,0.457,809160895,0.281,504852832,0.176,"PGX_AM_BS_SARC_MSKCC-PT135MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.444000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp8","pgxind-kftx7nok","pgxcs-kftx1ujl",806151868,0.28,175405021,0.061,630746847,0.219,"PGX_AM_BS_SARC_MSKCC-PT136MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.446000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpa","pgxind-kftx7nom","pgxcs-kftx1uk3",1132045013,0.394,348227590,0.121,783817423,0.273,"PGX_AM_BS_SARC_MSKCC-PT137MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.447000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpb","pgxind-kftx7noo","pgxcs-kftx1ukl",476783389,0.166,158316270,0.055,318467119,0.111,"PGX_AM_BS_SARC_MSKCC-PT138MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.449000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5900","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpf","pgxind-kftx7nos","pgxcs-kftx1ulk",1203403287,0.419,701119919,0.244,502283368,0.175,"PGX_AM_BS_SARC_MSKCC-PT13DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.452000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5919","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqj","pgxind-kftx7nq7","pgxcs-kftx1uzu",1550098832,0.539,1340634236,0.466,209464596,0.073,"PGX_AM_BS_SARC_MSKCC-PT162PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.487000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcql","pgxind-kftx7nq9","pgxcs-kftx1v0b",1448527219,0.504,676546404,0.235,771980815,0.269,"PGX_AM_BS_SARC_MSKCC-PT163PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.489000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqn","pgxind-kftx7nqb","pgxcs-kftx1v0t",1718739313,0.598,117050127,0.041,1601689186,0.557,"PGX_AM_BS_SARC_MSKCC-PT164PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.490000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqt","pgxind-kftx7nqj","pgxcs-kftx1v2s",1864069264,0.648,138844482,0.048,1725224782,0.6,"PGX_AM_BS_SARC_MSKCC-PT168PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.496000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5924","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr1","pgxind-kftx7nqt","pgxcs-kftx1v59",1743120740,0.606,115945013,0.04,1627175727,0.566,"PGX_AM_BS_SARC_MSKCC-PT172PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.503000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5925","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr3","pgxind-kftx7nqv","pgxcs-kftx1v5r",2117325085,0.736,108692000,0.038,2008633085,0.699,"PGX_AM_BS_SARC_MSKCC-PT173PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.505000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrb","pgxind-kftx7nr6","pgxcs-kftx1v86",1194942540,0.416,647115083,0.225,547827457,0.191,"PGX_AM_BS_SARC_MSKCC-PT178PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.512000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrg","pgxind-kftx7nrc","pgxcs-kftx1v9o",1855256692,0.645,243092224,0.085,1612164468,0.561,"PGX_AM_BS_SARC_MSKCC-PT180PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.517000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5938","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcry","pgxind-kftx7nry","pgxcs-kftx1vf0",583836264,0.203,348081995,0.121,235754269,0.082,"PGX_AM_BS_SARC_MSKCC-PT190SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.533000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c593a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcs1","pgxind-kftx7ns2","pgxcs-kftx1vfz",69980254,0.024,66632261,0.023,3347993,0.001,"PGX_AM_BS_SARC_MSKCC-PT192SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.535000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5950","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct1","pgxind-kftx7ntb","pgxcs-kftx1vqo",1478225081,0.514,30991039,0.011,1447234042,0.503,"PGX_AM_BS_SARC_MSKCC-PT24DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.567000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5953","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct6","pgxind-kftx7nti","pgxcs-kftx1vs6",454167397,0.158,262577017,0.091,191590380,0.067,"PGX_AM_BS_SARC_MSKCC-PT27DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.572000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5955","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct9","pgxind-kftx7ntm","pgxcs-kftx1vt6",614953792,0.214,414521682,0.144,200432110,0.07,"PGX_AM_BS_SARC_MSKCC-PT29DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.576000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c595c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctk","pgxind-kftx7nu0","pgxcs-kftx1vwk",205468058,0.071,147995906,0.051,57472152,0.02,"PGX_AM_BS_SARC_MSKCC-PT35DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.586000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5960","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctr","pgxind-kftx7nu8","pgxcs-kftx1w0o",1096257574,0.381,784490820,0.273,311766754,0.108,"PGX_AM_BS_SARC_MSKCC-PT39DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.592000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5964","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctx","pgxind-kftx7nug","pgxcs-kftx1w2m",1279773299,0.445,981108953,0.341,298664346,0.104,"PGX_AM_BS_SARC_MSKCC-PT42DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.598000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5965","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctz","pgxind-kftx7nui","pgxcs-kftx1w34",517848598,0.18,403267751,0.14,114580847,0.04,"PGX_AM_BS_SARC_MSKCC-PT43DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.599000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5968","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu4","pgxind-kftx7nuo","pgxcs-kftx1w4v",1319949881,0.459,720621204,0.251,599328677,0.208,"PGX_AM_BS_SARC_MSKCC-PT46DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.603000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5973","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcum","pgxind-kftx7nvb","pgxcs-kftx1wa9",270909575,0.094,99195805,0.035,171713770,0.06,"PGX_AM_BS_SARC_MSKCC-PT56GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.620000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5975","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcup","pgxind-kftx7nvf","pgxcs-kftx1wb9",1050202433,0.365,940960426,0.327,109242007,0.038,"PGX_AM_BS_SARC_MSKCC-PT58GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.623000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5976","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcur","pgxind-kftx7nvh","pgxcs-kftx1wbq",894305381,0.311,892932614,0.311,1372767,0,"PGX_AM_BS_SARC_MSKCC-PT59GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.624000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5979","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcuw","pgxind-kftx7nvn","pgxcs-kftx1wd6",550526481,0.191,258101072,0.09,292425409,0.102,"PGX_AM_BS_SARC_MSKCC-PT61GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.629000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c597a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcux","pgxind-kftx7nvp","pgxcs-kftx1wdo",1344205673,0.468,1177539106,0.41,166666567,0.058,"PGX_AM_BS_SARC_MSKCC-PT62GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.630000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c597b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcuz","pgxind-kftx7nvr","pgxcs-kftx1we5",659998720,0.23,658227386,0.229,1771334,0.001,"PGX_AM_BS_SARC_MSKCC-PT63GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.632000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5989","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvm","pgxind-kftx7nwk","pgxcs-kftx1wky",546403828,0.19,527780836,0.184,18622992,0.006,"PGX_AM_BS_SARC_MSKCC-PT76LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.652000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvs","pgxind-kftx7nws","pgxcs-kftx1wmx",994506594,0.346,926042242,0.322,68464352,0.024,"PGX_AM_BS_SARC_MSKCC-PT7DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.658000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvv","pgxind-kftx7nww","pgxcs-kftx1wnw",1579153643,0.549,1455312330,0.506,123841313,0.043,"PGX_AM_BS_SARC_MSKCC-PT81LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.662000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5993","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcw2","pgxind-kftx7nx4","pgxcs-kftx1wpv",1570118446,0.546,94066421,0.033,1476052025,0.513,"PGX_AM_BS_SARC_MSKCC-PT85LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.668000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5998","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwa","pgxind-kftx7nxe","pgxcs-kftx1wsb",1093427206,0.38,847781360,0.295,245645846,0.085,"PGX_AM_BS_SARC_MSKCC-PT8DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.675000",,,,,,,,"P66Y",,,"geo:GPL3718",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b05","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcp","pgxind-kftx7oi4","pgxcs-kftx21ya",1070976211,0.373,683586722,0.238,387389489,0.135,"PGX_AM_BS_USARC_MSK_2020-P_0000092_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.207000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b08","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcu","pgxind-kftx7oia","pgxcs-kftx21zq",671780075,0.234,417303979,0.145,254476096,0.089,"PGX_AM_BS_USARC_MSK_2020-P_0000355_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.211000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd2","pgxind-kftx7oil","pgxcs-kftx2240",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_USARC_MSK_2020-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.218000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd4","pgxind-kftx7oin","pgxcs-kftx224i",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.220000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","High-Grade Endometrial Stromal Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrioid Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd9","pgxind-kftx7oit","pgxcs-kftx226v",255421582,0.089,165741335,0.058,89680247,0.031,"PGX_AM_BS_USARC_MSK_2020-P_0001164_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium",,"2020-09-10 17:47:20.224000",,,,,,"NCITgrade-C14158","High Grade","P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b12","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldda","pgxind-kftx7oiv","pgxcs-kftx227d",884449609,0.308,566694542,0.197,317755067,0.111,"PGX_AM_BS_USARC_MSK_2020-P_0001211_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.225000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b13","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddc","pgxind-kftx7oix","pgxcs-kftx227u",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_USARC_MSK_2020-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.226000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b16","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddh","pgxind-kftx7oj3","pgxcs-kftx229b",1508997567,0.525,610683034,0.212,898314533,0.312,"PGX_AM_BS_USARC_MSK_2020-P_0001515_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.231000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddi","pgxind-kftx7oj5","pgxcs-kftx229s",1908282000,0.664,885350995,0.308,1022931005,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0001549_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.232000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b19","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddm","pgxind-kftx7oj9","pgxcs-kftx22ar",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_USARC_MSK_2020-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.235000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddp","pgxind-kftx7ojd","pgxcs-kftx22bq",659462096,0.229,339765115,0.118,319696981,0.111,"PGX_AM_BS_USARC_MSK_2020-P_0001606_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.238000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldds","pgxind-kftx7oji","pgxcs-kftx22co",1703396901,0.592,1090264615,0.379,613132286,0.213,"PGX_AM_BS_USARC_MSK_2020-P_0001701_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.241000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddt","pgxind-kftx7ojk","pgxcs-kftx22d6",550597916,0.192,250049708,0.087,300548208,0.105,"PGX_AM_BS_USARC_MSK_2020-P_0001780_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.242000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddv","pgxind-kftx7ojm","pgxcs-kftx22dn",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_USARC_MSK_2020-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.244000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b20","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Myxoid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40175","Uterine Corpus Myxoid Leiomyosarcoma","icdom-88963","Myxoid leiomyosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvlddx","pgxind-kftx7ojo","pgxcs-kftx22e5",1421122049,0.494,743071941,0.258,678050108,0.236,"PGX_AM_BS_USARC_MSK_2020-P_0001814_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.245000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b23","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde1","pgxind-kftx7oju","pgxcs-kftx22fl",1142405830,0.397,683290449,0.238,459115381,0.16,"PGX_AM_BS_USARC_MSK_2020-P_0001838_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.249000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b24","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlde3","pgxind-kftx7ojw","pgxcs-kftx22g2",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_USARC_MSK_2020-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.251000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlde5","pgxind-kftx7ojy","pgxcs-kftx22gk",1277349756,0.444,826218832,0.287,451130924,0.157,"PGX_AM_BS_USARC_MSK_2020-P_0002100_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.252000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde6","pgxind-kftx7ok0","pgxcs-kftx22h1",617184290,0.215,152913935,0.053,464270355,0.161,"PGX_AM_BS_USARC_MSK_2020-P_0002226_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.254000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b27","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde8","pgxind-kftx7ok2","pgxcs-kftx22hi",580578108,0.202,123518989,0.043,457059119,0.159,"PGX_AM_BS_USARC_MSK_2020-P_0002226_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.255000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde9","pgxind-kftx7ok4","pgxcs-kftx22hz",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_USARC_MSK_2020-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.257000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b29","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeb","pgxind-kftx7ok6","pgxcs-kftx22ih",1313620580,0.457,664611949,0.231,649008631,0.226,"PGX_AM_BS_USARC_MSK_2020-P_0002272_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.258000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlded","pgxind-kftx7ok8","pgxcs-kftx22iy",806483716,0.281,454274769,0.158,352208947,0.123,"PGX_AM_BS_USARC_MSK_2020-P_0002356_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.260000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeh","pgxind-kftx7okf","pgxcs-kftx22ke",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_USARC_MSK_2020-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.264000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeo","pgxind-kftx7okn","pgxcs-kftx22mc",956090515,0.333,563284599,0.196,392805916,0.137,"PGX_AM_BS_USARC_MSK_2020-P_0002817_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.270000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldew","pgxind-kftx7okx","pgxcs-kftx22oq",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_USARC_MSK_2020-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.277000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf1","pgxind-kftx7ol3","pgxcs-kftx22q5",2252801853,0.784,968165868,0.337,1284635985,0.447,"PGX_AM_BS_USARC_MSK_2020-P_0003754_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.282000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf2","pgxind-kftx7ol5","pgxcs-kftx22qn",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_USARC_MSK_2020-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.283000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldf5","pgxind-kftx7ol9","pgxcs-kftx22rn",978754554,0.34,468720877,0.163,510033677,0.177,"PGX_AM_BS_USARC_MSK_2020-P_0003980_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.286000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf7","pgxind-kftx7olb","pgxcs-kftx22s4",1859509504,0.647,798787285,0.278,1060722219,0.369,"PGX_AM_BS_USARC_MSK_2020-P_0003998_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.288000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf9","pgxind-kftx7old","pgxcs-kftx22sm",1591578863,0.554,821294518,0.286,770284345,0.268,"PGX_AM_BS_USARC_MSK_2020-P_0004070_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.289000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b40","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfc","pgxind-kftx7olg","pgxcs-kftx22tk",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_USARC_MSK_2020-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.292000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b41","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfd","pgxind-kftx7oli","pgxcs-kftx22u2",474536863,0.165,452900597,0.158,21636266,0.008,"PGX_AM_BS_USARC_MSK_2020-P_0004467_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.293000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b43","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfh","pgxind-kftx7olm","pgxcs-kftx22v0",1321180326,0.46,964731573,0.336,356448753,0.124,"PGX_AM_BS_USARC_MSK_2020-P_0004603_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.296000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b47","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfn","pgxind-kftx7olu","pgxcs-kftx22wy",1656348827,0.576,637480869,0.222,1018867958,0.354,"PGX_AM_BS_USARC_MSK_2020-P_0004973_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.302000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfs","pgxind-kftx7om0","pgxcs-kftx22yf",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_USARC_MSK_2020-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.306000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Endometrial Stromal Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrial Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfu","pgxind-kftx7om2","pgxcs-kftx22yx",1012830777,0.352,686909657,0.239,325921120,0.113,"PGX_AM_BS_USARC_MSK_2020-P_0005156_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.308000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldg0","pgxind-kftx7omb","pgxcs-kftx230v",642913569,0.224,298744854,0.104,344168715,0.12,"PGX_AM_BS_USARC_MSK_2020-P_0006297_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.314000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldg9","pgxind-kftx7oml","pgxcs-kftx233a",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_USARC_MSK_2020-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.321000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b56","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldgc","pgxind-kftx7omp","pgxcs-kftx2349",1751426112,0.609,1030743979,0.359,720682133,0.251,"PGX_AM_BS_USARC_MSK_2020-P_0011562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.324000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgh","pgxind-kftx7omv","pgxcs-kftx235r",1529333291,0.532,704343806,0.245,824989485,0.287,"PGX_AM_BS_USARC_MSK_2020-P_0013445_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.329000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgo","pgxind-kftx7on3","pgxcs-kftx237p",1929358679,0.671,1060764012,0.369,868594667,0.302,"PGX_AM_BS_USARC_MSK_2020-P_0014134_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.334000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgr","pgxind-kftx7on7","pgxcs-kftx238p",1306368521,0.454,786495027,0.274,519873494,0.181,"PGX_AM_BS_USARC_MSK_2020-P_0014873_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.337000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b61","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgu","pgxind-kftx7onb","pgxcs-kftx239o",2457582799,0.855,1626180341,0.566,831402458,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0015013_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.340000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgw","pgxind-kftx7ond","pgxcs-kftx23c7",1432085823,0.498,891546929,0.31,540538894,0.188,"PGX_AM_BS_USARC_MSK_2020-P_0015053_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.342000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgz","pgxind-kftx7onh","pgxcs-kftx23d9",617282939,0.215,521861663,0.182,95421276,0.033,"PGX_AM_BS_USARC_MSK_2020-P_0015258_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.345000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b65","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh1","pgxind-kftx7onj","pgxcs-kftx23dq",2080228242,0.724,1056465704,0.367,1023762538,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0015609_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.346000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b68","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvldh6","pgxind-kftx7onq","pgxcs-kftx23f8",1003099532,0.349,518776575,0.18,484322957,0.168,"PGX_AM_BS_USARC_MSK_2020-P_0016672_T03_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.351000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b69","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh7","pgxind-kftx7ons","pgxcs-kftx23fq",2117167530,0.736,1093405738,0.38,1023761792,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0017242_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.352000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldhf","pgxind-kftx7oo2","pgxcs-kftx23i5",1770331476,0.616,1034171659,0.36,736159817,0.256,"PGX_AM_BS_USARC_MSK_2020-P_0018223_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.359000",,,,,,,,"P60Y",,,"PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,